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MAPK    Mitogen-activated protein kinase 
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WASP    Wiskott-Aldrich Syndrome protein 
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Abstract 
Vascular smooth muscle cell (VSMC) phenotypic switching, from a contractile to a migratory 
phenotype, is essential for vascular repair and is compromised in ageing. Phenotypic transition 
involves dramatic actin reorganisation which is regulated by the linker of the nucleoskeleton and 
cytoskeleton (LINC) complex that spans the nuclear envelope (NE). The LINC complex 
physically anchors cytoskeletal filaments to the nucleoplasm via nesprin-SUN-nuclear lamina 
connections which enable rapid biophysical signalling between the nuclear interior and exterior. 
The nuclear lamina consists of A and B-type lamins that maintain nuclear architecture, however, 
the lamin A precursor protein, prelamin A, is a biomarker of VSMC ageing and this project 
investigates the impact of prelamin A upon LINC complex function.  
 
During VSMC ageing in-vitro, prelamin A accumulates at the presenescent growth phase which 
is associated with cellular elongation and focal adhesion reorganisation. Interference reflection 
imaging (IRM) and time-lapse microscopy revealed that presenescent VSMCs exhibit increased 
focal adhesion turnover with enhanced migratory speed and persistence. Importantly, prelamin 
A accumulation induced by siRNA-mediated knockdown of its processing enzyme, FACE-1, 
reiterates these morphological changes and enhances migratory persistence. Moreover, RhoA 
and Rac1 are well-established regulators of cell motility and their expression and activity 
diminishes in presenescent and FACE-1 depleted VSMCs. Fluorescence recovery after 
photobleaching (FRAP) also revealed that nuclear lamina disruption increases nesprin-2 
dynamics at the nuclear exterior. Thus, we suggest that prelamin A impacts on actin-regulated 
processes including cell shape and motility via the LINC complex. 
 
We utilised an siRNA-mediated approach to investigate the importance of other LINC complex 
components in regulating cell morphology and migration. Interestingly, SUN2 levels decrease 
during in-vitro VSMC ageing and SUN2 knockdown enhances the migratory speed of VSMCs 
and fibroblasts similarly to presenescent VSMCs. The role of nesprins in regulating cell 
phenotype varies between different cells, highlighting that LINC complex organisation and 
function is flexible and cell-type specific. 
 
Together, our data reveal that the LINC complex is a versatile structure that is specialised to cell 
function and is an important regulator of cellular morphology, focal adhesion organisation, Rho 
GTPase activity and migration. VSMC ageing is associated with prelamin A accumulation and 
loss of SUN2 expression which consequently deregulates LINC complex organisation and 
functioning. Therefore, LINC complex disruption gives rise to an aged VSMC phenotype which 
we predict may underlie cardiovascular diseases such as atherosclerosis. 
 
In addition, IRM captured the release of adhesion-like structures, termed cell traces, from the 
rear of migrating VSMCs that outline their migratory path. Cell traces form physical tracks that 
enhance the speed and migrational directionality of neighbouring VSMCs. Therefore, we predict 
that cell traces support VSMC migration to injury sites and are important for vessel repair.  
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1.1 The vessel wall: in health and disease 
 
The human vasculature comprises of a vast, organised network of blood 
vessels that deliver oxygen and nutrients to tissues whilst removing metabolic waste; 
processes that are essential for maintaining tissue homeostasis. The blood vessel wall 
consists of 3 distinct layers known as tunics. The tunica intima is the innermost layer 
comprising of endothelial cells that line the vessel lumen to form a physical barrier 
between blood and extravascular tissues. Endothelial cells also control vessel tone by 
the production and release of vasoactive substances such as nitric oxide.1 The middle 
layer or tunica media is primarily made up of vascular smooth muscle cells (VSMCs) 
that are arranged transversally to the longitudinal axis of the vessel.2 This is the 
thickest arterial layer and determines vessel diameter and blood flow via 
vasoconstriction/vasodilation. The outermost tunica adventitia contains fibroblasts 
embedded within an extracellular matrix (ECM) of collagen and elastic fibres.2, 3 The 
adventitial layer structurally supports the vessel, anchors nerve endings and produces 
reactive oxygen species (ROS) as well as numerous growth factors that regulate 
vascular remodelling.2, 4, 5 Additionally, fibroblasts play an important role in vessel repair 
as they are able to transform into myofibroblasts in response to injury.6 Figure 1.1 
illustrates the vessel wall composition.  
 
In addition to providing structural integrity, the endothelium, VSMCs and 
fibroblasts collectively regulate vessel tone, counteract changes in blood flow and 
protect the vessel against damage. This involves alterations in cell proliferation, cell 
migration, cell death and ECM production/degradation; all of which contribute towards 
remodelling of vessel size and composition.7 However, when these cellular processes 
are impaired, inappropriate vessel remodelling drives the pathogenesis of 
cardiovascular diseases including atherosclerosis and restenosis.8 
 
Atherosclerosis is a complex, age-related disease arising from mild 
inflammation in the arterial wall that progressively worsens over time due to 
irregularities in blood flow, lipid overload or hypertension.9 Atherosclerotic lesions are 
intimal thickenings of medium to large arteries that consist of a necrotic cell core, lipids 
and numerous cell types including monocyte-derived macrophages, neutrophils, 
endothelial cells and VSMCs.10 Continual exposure to atherosclerotic risk factors 
enhances macrophage and lymphocyte infiltration into the lesion and the release of 
hydrolytic enzymes, chemokines, cytokines and growth factors that further induce 
damage and necrosis.11 This inflammatory response stimulates VSMC proliferation and 
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migration from the vessel media into the intima. Intimal VSMC invasion is essential for 
vascular repair in early stages of atherosclerosis as increased collagen, elastin, 
proteoglycan and ECM deposition restructures the lesion and forms a fibrous cap to 
surround and stabilise the atherosclerotic plaque.12-14 However, as the atherosclerotic 
cap ages, it thins due to reduced VSMC, collagen and ECM content, thus increasing 
the likelihood of plaque rupture and thrombosis.15  
 
 
 
 
 
 
Figure 1.1: Schematic illustration of the 3 vessel wall layers. The tunica intima is comprised 
of a single endothelial cell layer that lines the vessel lumen. The tunica media mostly consists of 
VSMCs arranged circumferentially around the vessel wall and is important for maintaining 
vessel diameter and tone. The tunica adventitia lies in the outermost vessel layer and is 
comprised of fibroblasts embedded within an ECM of thick collagen bundles and elastic fibres.  
 
1.2 Vascular smooth muscle cell phenotypic switching  
 
As the major component of the arterial wall, VSMCs normally exist in a 
contractile, differentiated state to regulate vascular tone, blood pressure and blood 
flow.16 VSMCs in adult vessels are normally characterised by a low proliferation rate 
and the expression of numerous contractile markers including α-smooth muscle actin 
(α-SMA), smooth muscle-myosin heavy chain (SM-MHC), SM-22α and calponin.17 A 
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unique characteristic of VSMCs, distinguishing them from skeletal and cardiac muscle 
is their ability to transiently switch phenotype. This phenomenon, referred to as 
'phenotypic modulation' or 'phenotypic switching' is regulated by external physiological 
cues such as growth factors, mechanical stimuli from blood flow and pressure, cell 
matrix interactions and inflammatory mediators.17, 18 This is essential during vessel 
development and wound repair via modulation of cellular functions such as migration, 
proliferation and ECM production.19 For example, in response to vascular injury, 
VSMCs dedifferentiate from a contractile to a synthetic phenotype, whereby cells lose 
expression of contractile marker genes, become more migratory, proliferative and 
synthesise ECM components to aid the repair of vessel damage.  
 
However, VSMC plasticity can be detrimental to the vasculature as changes to 
physiological cues, such as hypertension, deregulate phenotypic switching leading to 
inappropriate VSMC migration and pathological vessel remodelling. This is a key event 
in the development of atherosclerosis as inefficient VSMC migration within the vessel 
wall reduces atherosclerotic plaque stability and increases the likelihood of plaque 
rupture.12 As atherosclerosis is a primary indicator of stroke and peripheral artery 
disease, improved understanding of the molecular mechanisms underlying VSMC 
phenotypic switching will benefit the development of therapeutics for cardiovascular 
disease.18, 20, 21 This is critical as atherosclerosis is ranked by the National Health 
Service (NHS) as the leading cause of death in the developed world.22 
 
1.3 Actin cytoskeleton remodelling during cell migration 
 
VSMC phenotypic transition from a contractile to a synthetic (proliferative and 
migratory) phenotype is associated with cytoskeletal reorganisation. The cell 
cytoskeleton is composed of an interconnected network of actin filaments, 
microtubules, intermediate filaments and a plethora of regulatory proteins. The 
cytoskeleton is characterised by three main functions: i) spatial organisation of 
intracellular organelles, ii) connection of the cell, physically and biochemically, to the 
external environment, and iii) control of cell shape change during cell movement.23, 24 
Therefore, the cytoskeleton and its structural organisation is fundamental to cell 
behaviour and its mechanical properties.  
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1.3.1 The cell migration cycle 
Filamentous actin (F-actin) is the key constituent of the actin cytoskeleton and 
occurs in cross-linked aggregates, linked to more than 150 actin-binding proteins.25 
This actin-rich framework supports the cell membrane and is dynamically remodelled 
via actin polymerisation (assembly) and depolymerisation (disassembly) to control cell 
shape and generate movement.26 Upon activation by pro-migratory stimuli, actin 
polymerisation at the cell leading edge produces actin-rich, finger-like extensions of cell 
membrane, termed filopodia, and large, broad, sheet-like protrusions, known as 
lamellipodia.27 Next, small, nascent focal adhesions assemble immediately behind the 
leading edge to attach cell membrane to the underlying ECM. Once matured, stable 
focal adhesions form anchors which the cell uses to pull itself over the ECM.28 Actin-
myosin crosslinking within the cell body generates contractile force to propel the cell 
forwards whilst the cytoskeleton remodels and mature focal adhesions at the cell rear 
disassemble to detach from the ECM.19, 28 Figure 1.2 depicts the stages involved in cell 
migration.  
 
In a migratory cell, focal adhesions are rapidly turned over; new focal adhesions 
continuously form at the leading edge whilst mature adhesions are disassembled at the 
rear.29 However, the mechanisms of rear-end detachment and processes involved in 
adhesion disassembly are not clearly defined. Breaking cell-ECM contact requires a 
combination of high contractile force and proteolytic degradation of localised ECM by 
matrix metalloproteinases (MMPs) and cathepsins.30 Contractility-promoted release 
occurs when actin-myosin interactions generate forces exceeding the adhesive 
strength of focal adhesions which directly detaches them from the substrate. In fish 
keratocytes, transient increases in cell tension activate stretch-activated calcium 
channels, leading to sudden influxes of extracellular calcium that further generate actin-
myosin contractile forces and promote rear-end retraction.31 In addition, the small Rho 
GTPases and their downstream signalling targets mediate cell contraction and 
retraction. In various cell types, Rho inhibition blocks stress fibre assembly and 
prevents rear-end release during cell migration.32-34 Calpains are calcium-dependent 
cysteine proteases that are also implicated in rear-end detachment as they destabilise 
focal adhesions and reduce VSMC adhesiveness by cleavage of several focal 
adhesion proteins.35 Calpain-deficient embryonic fibroblasts exhibit impaired rear-end 
retraction, increased tail length and reduced cell migration.36  
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Figure 1.2: A schematic representation of the cell migration cycle. (A) Actin polymerisation 
at the leading edge extends cell membrane protrusions, lamellipodia and filopodia, in the 
direction of movement. (B) Focal adhesions simultaneously assemble at the leading edge to 
attach the cell to the ECM and disassemble at the rear to detach the cell from the ECM. (C) 
Actin-myosin crosslinking in the cell body generates contractile force to drive forward 
movement. Figure modified from Ananthakrishnan & Ehrlicher, 2007.
28
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1.4 The role of focal adhesions in cell migration  
 
Focal adhesions are specialised protein complexes at the basal surface of 
adherent cells that serve as traction points during cell migration. Fundamentally, focal 
adhesions physically link the actin cytoskeleton to the ECM and their formation is 
closely coupled with actin polymerisation and actin-myosin-generated tension.37, 38 The 
focal adhesion complex contains over 125 structural and regulatory proteins, many of 
which exhibit multiple protein-protein interactions, indicating considerable functional 
diversity.39-41 Hence, this structure forms a ‘bidirectional signalling hub’ through which 
chemical (growth factors, hormones, cytokines) and mechanical (tension, stretch, 
compression) signals are exchanged between the ECM and cell cytoskeleton.42-44 This 
communication between the extracellular environment and cell interior is essential for 
regulating cell behaviours including cytoskeletal remodelling, cell morphology, 
adhesion, spreading and motility.42, 45, 46  
 
Focal adhesions are mechanosensitive and past studies illustrate that focal 
adhesions form and enlarge under intense force and disassemble when force 
subsides.38 Initially, small (1-2 µm), nascent focal adhesions form in response to 
internal or external stress. Subsequent increases in intracellular contractility causes 
focal adhesions to develop into relatively large (2-6 µm), mature focal adhesions.38 
Small focal adhesions at the cell leading edge are highly dynamic and change their 
morphology, protein composition and phosphorylation state to promote cell migration, 
whereas, mature focal adhesions reside centrally within the cell and serve primarily as 
anchors to the ECM.47, 48 The ability of focal adhesions to continually remodel in 
response to mechanical cues makes them crucial for modifying cell behaviour 
according to their local surroundings.48, 49 
 
1.4.1 Integrins: central focal adhesion components 
 
Integrins are a family of transmembrane glycoprotein receptors that are 
composed of a large, ligand-binding extracellular domain and a short, cytoplasmic 
domain.50 Heterodimers of α-integrin and β-integrin form the core component of focal 
adhesions and in response to ligand binding, integrin activation and clustering 
subsequently recruits a plethora of proteins to the cytoplasmic surface of the cell 
membrane.51, 52 Talin directly binds β-integrin and indirectly binds F-actin via a 
hierarchical cascade of proteins including vinculin, paxillin, α-actinin and focal adhesion 
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kinase (FAK) (Figure 1.3).53-56 Therefore, activated integrins promote focal adhesion 
formation and provide structural linkage between the ECM, intracellular signalling 
machinery and actin cytoskeleton.  
 
 
 
 
Figure 1.3: Focal adhesions link the ECM to the actin cytoskeleton. (A) Schematic 
representation of a focal adhesion complex. Transmembrane integrins form the core component 
of focal adhesions and upon integrin activation, talin directly binds integrin on the cytoplasmic 
face of the cell membrane. This subsequently leads to the recruitment of a hierarchical chain of 
adaptor proteins including vinculin, paxillin and α-actinin that indirectly link the ECM and actin 
cytoskeleton. Image modified from Rao & Winter, 2009.
57
 (B) Immunofluorescence image 
illustrating vinculin (green) at the cell membrane connected to rhodamine phalloidin-stained F-
actin (red). Insert below displays image at a higher magnification. 
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1.4.2 Vinculin stabilises focal adhesion complexes 
Recent evidence reveals that vinculin is fundamental for focal adhesion formation. 
Under high tension, vinculin induces focal adhesion assembly and enlargement, 
whereas, at the rear of migrating cells, focal adhesion disassembly occurs when 
vinculin is under low tension.58 Vinculin directly interacts with F-actin and contains 
binding sites for numerous regulators of cytoskeletal dynamics.59 Furthermore, vinculin 
directly binds talin to promote integrin clustering, contractile force generation and focal 
adhesion stabilisation.54 Vinculin lies between integrin-talin and the actin cytoskeleton 
where it is pivotal for force transmission between the ECM and cell interior and 
regulates cellular tension.60 Therefore, vinculin is regarded as a mechanosensing 
protein that mediates mechanical signals between cell surface integrins and the cell 
cytoskeleton. In addition, studies demonstrate that contractile force exerted to the 
matrix is diminished in the absence of vinculin or enhanced when vinculin is present.61 
Vinculin's role is further implicated in mechanotransduction, as vinculin-deficient cells 
are less stiff, exert lower traction forces and exhibit impaired cell spreading and 
migration.62-64 Recent evidence also shows that intercellular forces coincide with vinculin 
accumulation at cell-cell adhesion contacts and vinculin is responsible for potentiating cadherin 
mechanosensory responses.
65
  Vinculin knockout mouse embryonic fibroblasts (MEFs) 
also have reduced adhesion to ECM proteins and possess smaller and fewer focal 
adhesions compared with control cells.62, 66-68 Therefore, force transmission across a 
cell is dependent on stable integrin-cytoskeletal connections that are mediated by the 
focal adhesion component, vinculin. 
 
1.4.3 Focal adhesions regulate cell signalling pathways 
Focal adhesions indirectly scaffold paxillin, a multi-domain protein that provides 
a platform for numerous structural and signalling proteins that regulate cytoskeletal 
organisation, cell adhesion and motility.69, 70 Force-dependent integrin activation also 
leads to the activation of FAK, Src family protein tyrosine kinases and p130cas.71 Auto-
phosphorylation of FAK promotes the binding of Src to further phosphorylate other sites 
present on FAK, ensuring full activation of its kinase activity.72 This subsequently 
activates the Rho GTPase or mitogen-activated protein kinase (MAPK) superfamily 
including extracellular signal-regulated kinases (ERK1/2), c-Jun amino-terminal kinases 
(JNK 1-3) and p38 kinases (α, β, γ, δ). This triggers the upregulation and activation of 
nuclear transcription factors such as the activator protein 1 (AP-1) and nuclear factor 
kappa B (NFKB) that regulate gene expression and protein synthesis.73 Thus, focal 
20 
 
adhesions play a critical role in various intracellular processes including cell 
proliferation, differentiation, migration and cell survival.  
 
 
1.5 Modes of cell migration 
 
Two distinct modes of cell migration exist that are classified into i) single 
(amoeboid or mesenchymal) and ii) collective (multicellular or streaming) cell 
migration.74 Cells migrate individually or collectively depending on their physiological 
purpose. Collective cell migration involves numerous cells that remain connected 
during movement and is relevant for tissue remodelling and repair as well as being 
implicated in cancer invasion and metastasis.75-77  Single cell migration is more 
dispersive, allowing cells to migrate over long distances which is important during 
development, immune cell trafficking and cancer metastasis.78-80  
 
  Amoeboid migration occurs in single, rounded cells that lack focal adhesions 
and stress fibres and exhibit low polarity, whereas, mesenchymal migration is 
dependent on high focal adhesion-ECM interactions and high cell contractility.81-84 
Conversely, multicellular migration involves a group of cells that migrate simultaneously 
in whole, coordinated clusters of strands or sheets.76, 77 This is reliant on stable cell-cell 
contact between leading cells and successive cells at the rear and lateral regions, 
enabling them to communicate and migrate as a single unit.85 VSMC cell-cell contacts 
are mediated by N-cadherin which is essential for VSMC survival, however, the role of 
N-cadherin in VSMC migration is controversial at present.86, 87 One study demonstrates 
that downregulation of N-cadherin enhances VSMC migration, whereas others illustrate 
that inhibition of N-cadherin significantly reduces VSMC migration.88 Alternatively, cell 
streaming or chain-like migration refers to cells following each other in a loose, head-
to-tail fashion along a narrow common track.89, 90 This requires less stable and short-
lived cell-cell contacts that are continuously disassembled and reproduced.91, 92 This 
mode of collective cell migration is important for long-range communication between 
cells and is mediated by cell-cell contacts as well as filopodial and lamellipodial 
extensions.92  
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1.6 The role of Rho GTPases in cell migration  
 
Rho GTPases are a G protein subfamily of the Ras superfamily, with Rho, Rac 
and Cdc42 being the most important regulators of actin cytoskeleton organisation and 
cell motility.93 Rho GTPases undergo conformational changes and cycle between a 
GDP-bound (inactive) form and GTP-bound (active) form (Figure 1.4). This is 
regulated by numerous cellular proteins including guanine nucleotide exchange factors 
(GEFs) that promote the exchange of GDP to GTP to activate GTPases and GTPase-
activating proteins (GAPs) that negatively regulate the switch by enhancing the intrinsic 
GTP hydrolysing activity of GTPases.94-96 Guanine nucleotide dissociation inhibitors 
(GDIs) sequester GDP-bound GTPases in the cytoplasm and prevent GDP nucleotide 
exchange to hinder their activation.97, 98 In the GTP-bound form, Rho GTPases 
phosphorylate and activate over 40 downstream effectors to mediate actin 
organisation, gene transcription, cell-cycle progression, cell adhesion and cell 
migration.99  
 
Rac and Cdc42 are activated during early migratory events and localise actin 
polymerisation to the cell leading edge where cell membrane protrudes forwards in 
lamellipodial and filopodial extensions. More specifically, Rac controls lamellipodial and 
focal adhesion formation, whereas, Cdc42 generates filopodia and maintains cell 
polarity.19, 45 During cell migration, Cdc42 positions microtubules and Golgi towards the 
direction of travel.100 Golgi-derived vesicles at the cell leading edge provide membrane 
and associated proteins required for forward protrusion.100 Studies demonstrate that 
Cdc42 inhibition prevents Golgi reorganisation and polarity is lost in these cells, 
resulting in protrusions around the entire cell periphery, not just at the leading edge.34 
Later, Rho activation is required for focal adhesion maturation and regulates actin 
bundling into stress fibres for cell body contraction and rear-end retraction.101  
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Figure 1.4: The Rho GTPase switch. Rho GTPases cycle between a GDP (inactive) and GTP 
(active) form. Guanine nucleotide exchange factors (GEFs) activate GTPases, GTPase-
activating proteins (GAPs) inactivate GTPases by enhancing GTP hydrolysis and guanine 
nucleotide dissociation inhibitors (GDIs) prevent activation by sequestering GTPases in the 
cytoplasm. Figure modified from Raftopoulou & Hall, 2004.
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1.6.1 Rho GTPase targets and downstream signalling 
The Rho GTPase signalling molecules, Cdc42, Rac and Rho have numerous 
downstream effectors that elicit a variety of responses involved in actin organisation. 
As illustrated in Figure 1.5, these mainly include the Wiskott-Aldrich Syndrome protein 
(WASP) family, the WASP family verprolin homology (WAVE) complex, P21-activated 
protein kinase (PAK) and Rho-associated protein kinase (ROCK). 
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1.6.1.1 The WASP Family  
The WASP family of proteins are downstream targets of Cdc42. Cdc42 exposes 
a domain near the WASP C-terminus able to interact and subsequently activate 
components of the actin-related protein (Arp2/3) complex.102 The highly conserved 
Arp2/3 complex is a stable assembly of two actin-related proteins (Arp 2 and 3) and 
once activated, Arp2/3 mimics the fast-growing, barbed end of the actin filament.103 
This supports the addition of globular, monomeric actin and filament elongation into 
filopodia, whilst also capping the nascent filament at its slow-growing, pointed end.102-
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Rac binds and activates the WAVE complex, a family of WASP-related proteins 
that also activates Arp2/3.105 This complex adjoins to the side of pre-existing F-actin to 
initiate filament branching at 70 degrees from host filaments, characteristic of the 
lamellipodium.26 Actin polymerisation continues within the lamellipodium until growth is 
terminated by capping proteins.105, 106  
 
1.6.1.2 PAK 
PAK is a downstream effector of both Rac and Cdc42 that regulates actin 
cytoskeletal dynamics and cell adhesion during migration. The primary function of PAK 
is phosphorylation and activation of LIM kinase (LIMK) which subsequently 
phosphorylates cofilin.107 Unphosphorylated cofilin depolymerises F-actin, whilst 
phosphorylation by LIMK disrupts cofilin-actin interactions, enabling actin 
polymerisation.107 PAK also directly phosphorylates myosin light chains to activate 
actin-myosin crosslinking.107 It has also been reported that PAK phosphorylates the 
actin-binding protein, I-caldesmon (the dominant form expressed in VSMCs), and its 
phosphorylation is necessary for stress fibre disassembly.108 In addition, PAK-mediated 
phosphorylation of cortactin reduces its binding to actin and reduces actin branching.109 
Therefore, PAK impacts on actin cytoskeleton remodelling and regulates actin-myosin 
contractility.  
 
1.6.1.3 Formins 
The formin family of proteins are the largest group of Rho GTPase effectors and 
are activated by Rho and Cdc42 to promote the extension of unbranched actin 
filaments.  Formins contain a highly conserved formin homology 2 (FH2), sufficient to 
promote actin assembly alone and a FH1 domain that binds profilin-actin to accelerate 
actin filament extension. Upon activation, formins dimerise, adopting a hoop-like 
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conformation, which binds the F-actin barbed end to obstruct capping proteins that 
usually prevent elongation. G-actin is inserted between the formin cap and the barbed 
end of the filament to polymerise actin at the leading edge into long parallel bundles of 
straight filaments characteristic of filopodia.110, 111 Formins also function alongside 
adenomatous polyposis coli (APC) protein that also shapes the actin cytoskeleton by 
binding to actin filaments and sequestering G-actin to aid filament extension. 
Synergistically, formins deter capping proteins and APC rapidly assembles actin 
filaments.112  
 
 
1.6.1.4 ROCK 
 Rho-activated ROCK phosphorylates the myosin-binding subunit of myosin 
light chain (MLC) phosphatase rendering it inactive.113 This indirectly increases MLC 
phosphorylation and stimulates the ATPase activity of myosin II to promote actin-
myosin interactions and generate contractile force for forward cell movement.113 
Tension exerted across the cell also induces conformational changes within adhesion 
proteins which regulates focal adhesion maturation and stability.114 Moreover, ROCK 
directly phosphorylates MLC and LIMK to inhibit cofilin, as described above.115, 116 
 
 
1.6.1.5 Other effectors of smooth muscle cell contractility 
In addition to GTP-binding proteins, arachidonic acid and protein kinase C (PKC) have 
also been linked to smooth muscle contraction in-vitro. These compounds mediate 
calcium sensitisation by inhibiting myosin phosphatase activity. Independently of Rho, 
arachidonic acid directly activates ROCK by releasing its autoinhibitory mechanism.117, 
118 Both ROCK and PKC also phosphorylate and activate CPI-17, a phosphorylation-
dependent inhibitor of myosin phosphatase activity.119, 120 In addition, calponin binding 
to F-actin exerts an inhibitory effect on actin-activated myosin ATPase activity and 
ROCK phosphorylates calponin to reduce the binding activity of calponin to F-actin.121 
This accumulative evidence suggests that the Rho/ROCK pathway and their 
associated downstream targets are particularly important for regulating smooth muscle 
contraction. Numerous studies have also demonstrated the importance of ERK1/2 as 
mediators of VSMC contraction.122-125 ERK1/2 most likely regulate contractility via 
phosphorylation and inactivation of the myosin ATPase inhibitory protein caldesmon.126  
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1.7 Nuclear regulation of cell migration 
 
So far, I have described the importance of the Rho GTPase family of proteins 
and their respective downstream signalling molecules in regulating actin remodelling, 
focal adhesion dynamics and cell migration. However, emerging evidence suggests 
that there is a direct, mechanical aspect to actin and focal adhesion organisation via 
the nucleus.127-130 Recent work highlights that physical interactions between the 
nucleus, intracellular cytoskeleton and cell membrane facilitate direct biophysical 
signalling throughout the cell which is important for efficient mechanotransduction; the 
translation of mechanical forces into biochemical signals.131 Mechanotransduction is a 
homeostatic process whereby deviations in local mechanical stimuli rapidly modulate 
cell behaviour to ensure tissue maintenance. Mechanical signals sensed by focal 
adhesion complexes are translated to the cell interior to subsequently regulate actin 
cytoskeleton organisation, gene expression, motility, proliferation and survival.132  
 
1.7.1 The nuclear envelope  
The nuclear envelope (NE) is a highly organised structure that physically 
divides the nucleoplasm and cytoplasm and plays an important role in regulating 
nuclear activity. It is composed of an inner nuclear membrane (INM) separated, by 
perinuclear space (PNS), from an outer nuclear membrane (ONM) that is continuous 
with nuclear pore complexes (NPCs) and endoplasmic reticulum (ER).133 The INM 
contains more than 70 transmembrane proteins, including lamina-associated proteins 
(LAPs), chromatin-binding proteins and emerin.134 These proteins are initially inserted 
into the ER and move through NPCs to the INM where they maintain their localisation 
by binding chromatin or tethering to the nuclear lamina.135-137 
 
1.7.2 The nuclear lamina and prelamin A processing 
The nuclear lamina is a filamentous meshwork lying beneath the INM that 
mainly consists of the type V intermediate filament proteins, A- and B-type nuclear 
lamins. These are encoded by the LMNA and LMNB genes, respectively. The LMNA 
gene encodes four A-type lamins (A, AD10, C & C2) with lamins A and C being the 
major isoforms of the nuclear lamina. Prelamin A is the precursor of lamin A that 
contains a nuclear localisation signal (NLS) required for direct transport into the 
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nucleus and a C-terminal CAAX motif that undergoes a series of post-translational 
modifications to form mature lamin A. The cysteine residue of CAAX is first 
farnesylated by farnesyl transferase, AAX is then removed by endoproteolytic cleavage 
and the farnesyl-cysteine residue is carboxymethylated by an isoprenylcysteine 
methyltransferase (ICMT). Further cleavage by the zinc metalloproteinase, FACE-
1/Zmpste24, removes 15 additional C-terminal amino acids, including the 
farnesylated/carboxymathylated cysteine, to release mature lamin A.138-141 (Figure 1.6) 
Mature A-type lamins are incorporated into the nuclear lamina where they maintain NE 
structure and stability as well as scaffolding important protein complexes for the 
regulation of DNA synthesis, DNA damage responses, chromatin organisation, gene 
transcription, cell-cycle progression and cell migration.142, 143  
 
 
 
Figure 1.6: Schematic representation of prelamin A processing. A-type lamins are 
generated from the precursor protein, prelamin A, by four post-translational modifications. Step 
1: Farnesylation of a cysteine residue on the C-terminal CAAX motif. Step 2: Endoproteolytic 
cleavage of the 3 terminal amino acids, AAX. Step 3: Carboxymethylation of farnesyl-cysteine. 
Step 4: Cleavage of 15 additional C-terminal amino acids by FACE-1/Zmpste24 produces 
mature lamin A. Image adapted from Kudlow et al., 2007.
141
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1.7.3 Nesprins  
 Nesprins (nuclear envelope spectrin repeat-containing proteins) are a 
ubiquitously expressed family of multi-isomeric spectrin repeat proteins that are highly 
conserved throughout evolution. They are the only spectrin repeat proteins to be 
identified at the NE and were originally discovered as VSMC differentiation markers in 
a cDNA library screen.144, 145 However, the role of nesprins as intracellular scaffolds 
and linkers is ever-expanding, with newly identified roles beyond those at the NE. Four 
nesprin genes (SYNE 1-4) have been identified to date, which encode proteins with 
distinct cellular functions. The largest nesprin proteins, nesprin-1 and -2, consist of a 
pair of N-terminal calponin homology (CH) domains, a central rod domain composed of 
multiple spectrin repeats and a C-terminal Klarsicht, Anc-1, Syne homology (KASH) 
transmembrane domain.146 After titin (3MDa), nesprin-1 and -2 are the largest proteins 
encoded by the human genome (approximately 1MDa and 800kDa, respectively) 
whereas nesprins-3 and -4 are much smaller (approximately 110kDa and 42kDa, 
respectively) and lack N-terminal CH domains (Figure 1.7).147-149  
 
 
 
 
 
Figure 1.7: Published nesprin genes (1-4). The giant isoforms (nesprin-1 and -2), consist of a 
pair of N-terminal calponin homology (CH) domains, a central rod domain composed of multiple 
spectrin repeats and a C-terminal Klarsicht, Anc-1, Syne-1 homology (KASH) transmembrane 
domain. Nesprin-3 and -4 are much smaller and lack the N-terminal CH domains yet retain their 
NE-targeting KASH domain. Image from Rajgor & Shanahan, 2013.
146
  
 
 
Giant nesprin isoforms localise to the ONM where they extend beyond the NE 
to form a filamentous network surrounding the nuclear surface.129 Via their spectrin 
repeats, nesprins provide platforms to facilitate protein-protein interactions that are 
important for maintaining nuclear integrity and function.145 Patients with Emery-Dreifuss 
muscular dystrophy (EDMD) exhibit nesprin mutations and present with mislocalised, 
reduced, or no NE nesprins and subsequently defective nuclear morphology.150 Recent 
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evidence indicates that nesprin-1 and -2 exhibit multiple initiation and termination sites 
allowing the generation of alternative N and C-terminally spliced isoforms.151, 152 These 
include shorter isoforms such as nesprin-1α and -2α as well as KASH-less nesprins 
that localise to multiple sub-cellular compartments, including the nucleoplasm and focal 
adhesions, with roles beyond the NE that have yet to be explored.153-155 The diversity of 
nesprin isoforms may be important for scaffolding variable protein complexes between 
cell types and maintaining tissue-specificity. The identified NE-localising nesprin-1 and 
-2 isoforms identified to date are illustrated in Figure 1.8. 
 
 
 
 
Figure 1.8: Published nesprin-1 and -2 isoforms. This figure illustrates KASH-containing 
nesprin-1 and -2 isoforms that localise to the NE. Diverse nesprin-1 and -2 isoforms are 
generated by alternative initiation and termination of transcription that represent smaller portions 
of the giant proteins. Image from Rajgor & Shanahan, 2013.
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1.7.4 The LINC complex  
The linker of the nucleoskeleton and cytoskeleton (LINC) complex is a unique 
NE-spanning structure that physically anchors the nuclear lamina to cytoskeletal 
filaments creating a continuum between the nuclear exterior and interior. The KASH 
domain of nesprin-1/2 specifically targets them to the ONM via interactions with the C-
terminus of Sad1p-UNC84 (SUN) proteins, SUN1 and SUN2, located in the PNS.127, 156 
In turn, the nucleoplasmic N-terminus of SUN1/2 tethers lamin A/C, emerin and 
chromatin on the INM surface.145 In addition, INM-associated nesprin isoforms have 
been identified as nucleoplasmic binding partners of lamin A/C, emerin and SUN1/2 
that further stabilise the LINC complex.150, 157 Data show that SUN1/2 depletion or 
dominant-negative overexpression leads to the displacement of endogenous nesprins 
from the NE to the ER and expansion of the PNS, highlighting that SUN proteins are 
integral for nesprin localisation and normal segregation of the INM and ONM.128, 158 
SUN1/2 proteins serve as scaffolds to maintain nuclear architecture, chromatin 
dynamics and genomic stability but more crucially, SUN-KASH bridging between the 
nuclear lamina and cell cytoskeleton appears to be essential for 
mechanotransduction.159, 160 In support of this theory, recent data also highlights the 
role of nuclear lamins as important force-transmitting filaments to molecules inside the 
nucleoplasm.161 This implicates a pivotal role of the LINC complex in intracellular 
communication between the cytoskeleton and genome. Many studies are now 
attempting to further elucidate the importance of the LINC complex in cellular 
functioning such as mechanotransduction signalling, gene regulation, cell proliferation 
and migration.146, 162-165  
 
1.7.5 LINC complex diversity 
Variable N-terminal motifs enable nesprins in the ONM to interact with different 
cytoskeletal components including plectin, F-actin or microtubules.147-149 Nesprin-1/2 
contain N-terminal CH domains that interact directly with F-actin and indirectly with 
focal adhesions.147, 153, 166 Evidence demonstrates that that F-actin depolymerisation 
induces nuclear morphology changes and mislocalises nesprin-2 from the NE into 
actin-rich foci.167 Nesprin-3 contains a plectin-binding motif that facilitates interactions 
with cytoplasmic intermediate filaments and nesprin-4 has a kinesin-binding function 
that supports interactions with microtubules to regulate cell polarity.148, 149 Evidence 
suggests that nesprins 1-3 also physically and functionally interact with one another 
creating a lattice surrounding the NE.168 Furthermore, recent studies illustrate that 
SUN2 forms a trimeric structure that interacts with 3 independent KASH proteins in a 
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3:3 ratio, thus suggesting that SUN can associate with more than one nesprin variant at 
once.156 This highlights the complexity of the LINC complex and suggests that diverse 
nesprin isoforms and their varying interactions with SUN allow the LINC complex to 
specifically tailor itself according to different cell functions. At present it is unknown 
whether SUN1 and 2 form homodimeric or heterodimeric structures. Nesprins also 
undergo isoform switching during phenotypic modulation, suggesting that nesprin and 
LINC adaptability could be essential for VSMC switching.169 Figure 1.9 provides a 
schematic representation of the LINC complex. 
 
 
 
Figure 1.9: The LINC complex physically anchors the nuclear lamina to cytoskeletal 
filaments. The LINC complex spans the NE and consists of nesprins, SUN and nuclear lamina 
proteins. KASH targets nesprin to the ONM via interactions with trimeric SUN structures in the 
PNS, which in turn interact with lamin A/C and emerin on the INM. Nesprins form a protein 
scaffold that connects intranuclear structures, via this bridging complex at the NE, to 
cytoplasmic actin filaments, intermediate filaments and microtubules. Image from Rajgor & 
Shanahan, 2013.
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1.7.6 The LINC complex in human disease: nuclear envelopathies 
The importance of the LINC complex is highlighted by evidence associating 
mutations in NE proteins with a group of human diseases termed ‘nuclear 
envelopathies’ or ‘laminopathies’. These are a family of early-onset degenerative 
disorders caused by mutations in the genes encoding nesprin (SYNE), lamin (LMNA), 
emerin (EMD) and, more recently, SUN proteins (SUN).150, 157, 170 Such mutations are 
associated with diseases including EDMD, Hutchinson-Gilford progeria syndrome 
(HGPS), atypical Werner syndrome (WS), dilated cardiomyopathy (DCM) and 
Dunnigan-type familial partial lipodystrophy (FPLD) that are clinically characterised by 
premature ageing, ataxia, atherosclerosis, cardiomyopathy, muscular dystrophy and 
lipodystrophy (see Table 1.1).171 Therefore, nuclear envelopathy/laminopathy models 
are commonly used to gain mechanistic insight into ageing and interrogate the 
importance of the LINC complex on cellular functions. Increasing evidence illustrates 
that LINC complex disruption by these genetic mutations severely impacts upon 
mechanotransduction and cell motility as described below.  
 
Table 1.1: Clinical characteristics of nuclear envelopathies.  Nuclear envelopathies occur 
as a result of mutations in LINC complex components. The table below illustrates the mutations 
associated with each disease and the clinical phenotypes arising from these mutations.    
Nuclear 
Envelopathies 
Gene 
mutation 
Clinical 
Characteristics 
Reference 
Hutchinson-Gilford 
progeria syndrome 
(HGPS) 
 
LMNA  Premature ageing, hair loss, 
loss of subcutaneous fat, 
premature atherosclerosis, 
myocardial infarction 
172-175 
Atypical Werner 
syndrome (WS) 
 
LMNA  Premature ageing, premature 
atherosclerosis, cataracts, 
muscle wasting 
176, 177 
Emery-Dreifuss muscular 
dystrophy (EDMD) 
 
LMNA, EMD, 
SYNE-1/2 or 
SUN1/2 
Early contractures of the 
neck/elbows/Achilles tendons, 
muscle weakening and 
wasting, cardiac conduction 
defects  
150, 157, 170, 
172, 178-180 
Dilated cardiomyopathy 
(DCM) 
 
LMNA or SYNE1 Ventricular dilatation, systolic 
dysfunction, arrhythmias, 
conduction defects 
181-183 
Dunnigan-type familial 
partial lipodystrophy 
(FPLD) 
 
LMNA Dramatic absence of adipose 
tissue in the limb/trunk and 
accumulation in the neck/face, 
increased susceptibility to 
atherosclerosis/diabetes 
184, 185 
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1.7.6.1 LINC complex disruption impairs cell migration 
Mutations in NE proteins have been shown to impact on actin cytoskeleton 
organisation and actin-mediated cellular processes, as described below. Studying the 
implications of nuclear lamina disruption on cell structure and migrational behaviour 
reveals that cell motility is defective in laminopathic cells.186 More recent evidence 
shows that fibroblasts from EDMD patients exhibit nuclear shape defects and 
alterations in cell adhesion and migration.162 Lamin A/C deficient MEFs have a 
dysfunctional cytoskeleton, diminished ability to polarise at the edge of a wound and 
significantly reduced migration into a wound healing assay.187 Furthermore, cells 
derived from HGPS and EDMD mouse models are defined by cytoplasmic elasticity, 
weakened cell adhesion and slow wound closure.172 On the contrary, skin fibroblasts 
from EDMD patients are associated with enhanced cell polarity and migration speed.188 
Overall, these data indicate that NE mutations impact on LINC complex integrity and 
compromise actin organisation, adhesion formation and cell migration.   
 
1.7.6.2 LINC complex disruption impairs mechanotransduction signalling 
Emerging evidence indicates that direct linkage between the cell cytoskeleton 
and nucleus by the LINC complex facilitates mechanotransduction signalling 
throughout the cell. Cytoskeletal structures normally withstand mechanical stresses 
and maintain their integrity independent of dynamic remodelling at the molecular level, 
however, LINC complex alterations disturb actin architecture and severely affect the 
mechanical properties of the cell.187 Cells derived from HGPS and EDMD mice have 
significantly weakened cytoplasmic stiffness, most likely resulting from disrupted actin 
organisation.172 Also, lamin A/C deficient MEFs exhibit nuclear fragility and reduced 
mechanical stiffness, thus, hindering their ability to respond to mechanical stress.189 
Impaired nesprin functionality reduces cellular tension and induces defects in 
mechanical force transmission between the cytoplasm and nucleus.182, 190, 191 Moreover, 
overexpressing dominant-negative nesprin-2 and SUN protein mislocalises 
endogenous nesprin from the NE and weakens intracellular force transmission.165 This 
detailed study also revealed that strain-induced nuclear deformations are reduced in 
LINC complex disrupted cells and cytoskeleton organisation, cell polarisation and 
migration are also impaired.165 Mechanically-induced actin polymerisation normally 
facilitates nuclear import of the mechanosensitive transcription factor, 
megakaryoblastic leukaemia 1 (MKL1, also known as MRTF-A) to activate regulatory  
genes of cell motility and contractility.192 Recent evidence demonstrates that lamin 
mutant cells have altered actin organisation and dynamics, resulting in diminished 
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nuclear translocation and downstream signalling of MKL1.193 Collectively, this evidence 
emphasises that the LINC complex is crucial for efficient mechanotransduction and 
implicates LINC complex weakening in the progression of nuclear envelopathies. 
 
1.7.6.3 LINCing the cell membrane, actin cytoskeleton and nuclear lamina 
 Accumulating evidence implicates both focal adhesions at the cell membrane 
and the LINC complex at the NE in mechanical signal transmission throughout the cell 
as both vinculin and nesprin interact with and regulate F-actin. This suggests that the 
LINC complex extends beyond the NE, creating a mechanically-coupled system 
between the cell membrane, actin cytoskeleton and nucleus (Figure 1.10).42, 147 The 
actin cap is a unique structure of thick F-actin bundles tightly covering the apical 
surface of the nucleus via direct connection to LINC complexes.194 A recent study 
identifies a subset of focal adhesions terminating in the actin cap termed actin cap 
associated focal adhesions (ACAFAs) that are composed of vinculin, paxillin, talin, 
zyxin and talin; proteins that are thought to be important mechanosensors.195 LINC 
complex disruption, by dominant-negative KASH expression, subsequently disrupts 
actin cap structure, reduces ACAFA number and impairs mechanosensing responses, 
suggesting that the LINC complex creates a physical pathway between the cell 
membrane and nucleus.195 In support of this, force application to the cytoskeleton or 
cell membrane subsequently induces nuclear deformations and activation of 
mechanosensitive genes.164 Moreover, lamin A deficient cells exhibit reduced 
mechanosensitive gene expression and reduced nuclear rigidity in response to 
mechanical distortion.186 Lamin mutant cells also have diminished vinculin expression 
and fewer focal adhesions compared with wild-type cells.193 Studies also demonstrate 
that uncoupling of the nucleus from the actin cytoskeleton diminishes the cellular 
tension required for mechanical signal propagation and consequently impairs focal 
adhesion stability and cell motility.172, 196  Earlier studies demonstrate that pulling cell 
membrane integrins using a microneedle distorts the nucleus, whereas pulling on 
metabolic receptors has no effect.197 This body of evidence indicates that a continuous 
connection exists between focal adhesions and the nucleus, most likely via the LINC 
complex, which is crucial for actin organisation, mechanotransduction signalling and 
cell migration.  
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Figure 1.10: The LINC complex physically connects the cell membrane, actin 
cytoskeleton and nucleus. Proposed model of the LINC complex based on current literature. 
Focal adhesions at the cell membrane bind F-actin that subsequently connects to the nucleus 
via nesprin-SUN-nuclear lamina interactions across the NE. This is important for structurally 
linking the cell surface to the nuclear interior and mediating mechanotransduction throughout 
the cell. Figure modified from Rajgor & Shanahan, 2013.
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1.8 VSMC ageing 
 
Ageing progressively impairs cell function and is a major risk factor for 
cardiovascular disease, the most prominent cause of morbidity and mortality in the 
elderly.198, 199 After the age of 50, the number of human life years remaining is 
determined predominantly by ageing which results from a complex interaction of 
genetic and environmental factors.200, 201 Ultimately, system failure occurs due to a loss 
of physiological response to stress, including physical and chemical insults, infections, 
tumours and trauma.202  
 
It is well established that human cells have a finite lifespan and as cells age 
they lose their proliferative capacity, leading to a state of irreversible cell-cycle arrest 
and altered functionality, a phenomenon referred to as ‘cellular senescence’.203 In-vitro, 
VSMCs exhibit limited growth potential; they are initially highly proliferative at early 
passage numbers and, following serial passaging, proliferation rate declines when cells 
enter a phase termed ‘presenescence’. Following further passaging, VSMCs ultimately 
become senescent and are terminally differentiated.204 Furthermore, VSMCs from old 
donors reach replicative senescence earlier than those from younger donors.204 
Therefore, senescent VSMCs increase with age and these cells are associated with a 
large, flattened appearance, reduced telomere length, reduced Ki67-positive staining 
and increased senescence-associated β-galactosidase (SAβG) activity.205, 206 There is 
also an increased expression of negative cell cycle regulators such as p53 and p16 
that promote growth arrest and senescence.205 As the senescent phenotype is 
characterised by growth arrest, resistance to apoptosis and altered gene expression, it 
is believed to be a protective mechanism against tumorigenesis.207 However, VSMC 
senescence is also associated with adverse vascular modifications and VSMCs 
derived from atherosclerotic plaques exhibit slower proliferation rates and undergo 
senescence earlier than normal cells.205 Much research now focuses on defining the 
VSMC ageing process and how senescence is implicated in cardiovascular diseases 
such as atherosclerosis, hypertension, stroke and heart failure. 
 
1.8.1 VSMC senescence drives the development of atherosclerosis 
The inflammatory response associated with atherosclerotic plaque development 
stimulates VSMC dedifferentiation, resulting in enhanced VSMC proliferation and 
migration from the vessel media into the intima. As previously described, VSMC-
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derived collagen, elastin, proteoglycans and other ECM components are essential for 
the formation of a fibrous cap that stabilises the atherosclerotic plaque.13 However, cap 
thinning occurs during ageing due to fewer intimal VSMCs and loss of ECM 
production.12-15 Studies demonstrate that VSMCs in advanced atherosclerotic plaques 
exhibit a decline in proliferative capacity compared with early lesions, suggesting that 
the predominance of senescent VSMCs within the plaque contribute to age-associated 
cap thinning and plaque instability.13, 208, 209 Furthermore, senescent cells demonstrate 
an age-related upregulation of genes that promote plaque instability including 
plasminogen activator inhibitor-1 (PAI-1) and MMPs.210, 211 Plaque instability ultimately 
leads to sudden plaque rupture, a precursor of myocardial infarction and strokes, thus 
illustrating the urgency for improved understanding of the mechanisms underlying 
cellular senescence.  
 
 VSMC-derived ECM provides tensile strength to the vessel wall and ECM 
modifications normally enable the vessel to accommodate hemodynamic forces. 
However, age-associated ECM destabilisation, resulting from an overproduction of 
collagen and diminished elastin, increases vessel rigidity, reduces vessel compliance 
and leads to thickening of the vessel wall.198, 212, 213  VSMC ageing is also associated 
with vessel calcification which contributes towards aortic stiffness and is a prominent 
feature of atherosclerosis.214 This body of evidence suggests that VSMC ageing is 
associated with numerous structural and functional changes to the vessel wall, 
including loss of vessel elasticity, luminal enlargement and intimal thickening, all of 
which favour atherosclerotic plaque formation.215, 216 Therefore, VSMCs can be 
regarded as both protective and detrimental in vessel homeostasis; they play an 
essential role in cap stability which prevents plaque rupture whilst facilitating arterial 
thickening that enhances the severity of atherosclerosis.  
 
1.8.2 The impact of senescence on VSMC phenotype  
 Traditionally, VSMC ageing is associated with a progressive decline in 
proliferative and migratory capacity.13, 15, 208, 209 However, more recent work suggests 
that ageing promotes VSMC phenotypic switching and enhances VSMC proliferation 
and intimal migration, leading to remodelling of the vasculature.217 This emphasises a 
gap within the current literature that does not clearly delineate the impact of ageing on 
VSMC phenotype.  
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Previous in-vitro studies reveal an age-related reduction in the proliferative 
activity of human VSMCs which corresponds with a decline in their migrational 
ability.218 This was supported in a recent study illustrating that induced human VSMC 
senescence by serum response factor (SRF) depletion inhibits proliferation, reduces F-
actin formation and compromises cell migration.219 Conversely, a study comparing 
aortic explants from young and old rats, reveals that aged VSMCs exhibit greater 
proliferative capacity with a 59.3% higher migration rate than that of younger 
counterparts.220 In-vitro studies comparing early-passage and presenescent VSMCs 
also demonstrate that proliferation rates increase with age.221 Moreover, VSMCs 
isolated from aged rats dedifferentiated more substantially and replicated more actively 
than those from new-born or young adult rats.222 223 Therefore, a growing body of 
literature illustrates that ageing induces VSMC proliferation and migration within the 
vessel and contributes to the progression of atherosclerosis.10, 224, 225 
 
Due to conflicting evidence, the impact of ageing on VSMC proliferative and 
migratory capacity remains undefined. These differences may be a result of studies 
using a variety of experimental systems to define and measure cell migration. Above I 
have collated literature from both human and rodent studies. Although rodents have 
been used to model VSMC behaviour, species variation exists and may account for the 
observed differences in VSMC migration during ageing. Whether helpful or harmful, 
VSMCs are heavily implicated in atherosclerosis and improved knowledge of the 
relationship between ageing and VSMC phenotype is crucial to understanding the role 
of VSMCs in this disease.  
 
1.8.3 Progerin and prelamin A drive VSMC ageing 
Amongst the myriad of factors that contribute towards the onset and 
progression of vascular ageing, it has come to light that progerin and prelamin A are 
causal of premature ageing and are associated with advanced atherosclerosis. The 
laminopathic disease, HGPS is one of the most severe forms of progeria affecting 1 in 
4 million people worldwide.175 HGPS patients have a toxic accumulation of progerin, a 
prelamin A splice variant, that undergoes normal farnesylation but lacks the FACE-1 
cleavage site to generate mature lamin A.174, 226 This results in permanently 
farnesylated progerin which exhibits high hydrophobicity and greater affinity for the 
nuclear membrane than lamin A.138, 143, 227 Moreover, HGPS is also induced by FACE-1 
mutations, which cause the NE accumulation of permanently farnesylated prelamin 
A.228, 229 Studying HGPS provides an insight into the molecular mechanisms underlying 
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cellular ageing as progerin accelerates senescence by inducing telomere shortening, 
laminal thickening and disrupting nuclear integrity.230-232 This consequently alters the 
nuclear position of chromosome territories that normally interact with lamin A, resulting 
in a loss of chromatin and disrupted transcriptional activity.233 Progerin accumulation at 
the NE also impairs mitosis and cell cycle progression.234 Treatment with 
farnesyltransferase inhibitors (FTIs) blocks progerin targeting the NE and reduces the 
abundance of nuclear morphology defects that are associated with HGPS.235 HGPS 
grossly affects VSMCs, the primary targets for progerin accumulation, suggesting that 
VSMCs are especially sensitive to ageing.236, 237 Furthermore, HGPS patients develop 
premature atherosclerosis due to profound VSMC dysfunction and usually die of 
myocardial infarction or stroke in their second decade of life.143, 173, 238  
 
Normally, prelamin A is efficiently converted to lamin A in a number of 
processing steps that are outlined in section 1.7.2. However, in the absence of FACE-
1, prelamin A processing is defective and lamin A production is hindered.239 Recent 
studies in our laboratory identify prelamin A as a novel biomarker of normal VSMC 
ageing that mirrors progerin accumulation at the NE.204 Significant prelamin A 
accumulation was detected in both in-vitro and in-vivo aged, but otherwise healthy, 
VSMCs and human vessels (Figure 1.11), as well as atherosclerotic lesions, 
suggesting that lamin A processing is hindered during ageing.204 As illustrated in Table 
1.2, prelamin A accumulates in presenescent VSMCs that maintain proliferative 
capacity, suggesting that prelamin A is a driving force behind VSMC senescence and 
does not accumulate as a consequence of it.204 Data from our laboratory also reveal 
that increased prelamin A induces defective DNA damage repair and nuclear 
dysmorphologies that are characteristic of ageing.204 Therefore, the accumulation of 
prelamin A at the NE disrupts nuclear integrity and accelerates cellular senescence, 
ageing and age-related pathologies.  
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Figure 1.11: Prelamin A accumulates during in-vitro and in-vivo VSMC ageing. (A) 
Immunofluorescent images illustrating the absence of prelamin A in early-passage VSMCs 
(passage 6) derived from a 33-year-old female (33F). Following in-vitro passaging (passage 6-
14), prelamin A (red) accumulates at the NE. (B) Aged VSMCs derived from a 70-year-old 
female (70F) positively stained for prelamin A, which was absent in young, healthy VSMCs from 
an 18 year-old male donor (18M). Figure modified from Ragnauth et al., 2010.
204
  
 
 
Table 1.2: Stages of VSMC growth in-vitro. At early passage numbers, VSMCs are highly 
proliferative (2-3 day population doubling time) and stain positively for proliferation marker Ki67. 
Following serial in-vitro passaging, VSMCs become presenescent; they stain positively for Ki67, 
yet proliferation rate is reduced (3-7 day population doubling time). Also, DNA damage marker 
and prelamin A accumulates. Finally, VSMCs become senescent at late passage numbers 
when they cease to proliferate and have increased DNA damage, prelamin A and SaβG 
staining. Data unpublished from Shanahan group (Warren et al).  
 
 Proliferative 
VSMCs 
Presenescent 
VSMCs 
Senescent 
VSMCs 
Ki67   x 
Prelamin A X   
DNA damage X   
SaβG X X  
Population doubling time 2-3 days 3-7 days - 
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1.9 Hypothesis & Project Aims 
 
Prelamin A accumulates at the NE during VSMC ageing and induces nuclear 
dysmorphology.204 Increasing evidence illustrates that loss of nuclear integrity alters 
LINC complex organisation at the NE, subsequently leading to defective cell adhesion, 
migration and mechanotransduction.162, 165, 172, 188 Therefore, a fully-functional LINC 
complex is fundamental for cell functioning however prelamin A accumulation is 
thought to compromise LINC complex organisation. We hypothesise that prelamin A 
accumulation will impact on: 
 F-actin organisation and cytoskeletal remodelling 
 Focal adhesion organisation and dynamics 
 Migrational capacity 
 
My specific objectives were: 
 
1) To characterise VSMC morphological changes associated with in-vitro ageing 
and prelamin A accumulation, specifically actin cytoskeleton and focal adhesion 
formation.  
 
2) To investigate the impact of in-vitro VSMC ageing and prelamin A accumulation 
on LINC complex organisation in VSMCs and other cell types. 
 
3) To determine whether in-vitro ageing or prelamin A accumulation affects the 
activity of classical signalling pathways (Rho GTPases) involved in regulating 
cell motility. 
 
4) To study VSMC migration in-vitro and characterise any motility changes 
associated with ageing, prelamin A accumulation or other LINC complex 
alterations.  
 
 
Clarifying our understanding of prelamin A and the phenotypic modulations 
associated with VSMC ageing is important in identifying future therapeutic targets for 
age-related vascular diseases, primarily atherosclerosis.   
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Chapter 2: Materials and Methods 
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2.1 Cell culture 
2.1.1 Human vascular smooth muscle cells (VSMCs) 
 
VSMCs were originally isolated from medial explants of human aortic tissue. 
VSMCs from 3 patients (35-year-old female (35F), 52-year-old male (52M), 54-year-old 
male (54M)) were cultured in M199 medium complemented with 20% foetal bovine 
serum (FBS), 1% penicillin/streptomycin and 200 μM L-Glutamine. VSMCs were 
washed using Earle’s balanced salt solution (EBSS) and passaged at a 1:2 split ratio 
when 60-70% confluent. The VSMC isolate used for each experiment is described 
within the Figure legend, Mostly 35F VSMCs were used due to their accessibility and 
time restraints, In the future, experiments will be conducted using all 3 VSMC isolates.  
 
2.1.2 MRC-5 cells 
 
Human embryonic lung fibroblast (MRC-5) cells were purchased from the 
European cell collection of cell cultures (ECACC) and cultured in Dulbecco's modified 
eagle medium (DMEM) complemented with 10% FBS, 1% penicillin/streptomycin and 
200 μM L-Glutamine. MRC-5 cells were washed using phosphate buffered saline (PBS) 
and passaged at a 1:3 split ratio when 80-90% confluent. 
 
2.1.3 Human osteosarcoma cell line (U2OS) 
 
Human osteosarcoma (U2OS) cells were purchased from the American Type 
Culture Collection (ATCC). This cell line was cultured in DMEM complemented with 
10% FBS, 1% penicillin/streptomycin and 200 μM L-Glutamine. U2OS cells were 
washed using PBS and passaged at a 1:10 split ratio when 80-90% confluent. 
 
 All cells were cultured in a humidified incubator at 37°C with a 4% C02 
atmosphere. At 60-90% confluency, culture medium was aspirated and cells were 
washed thoroughly using a balanced salt solution. Trypsin (0.02%) was added for 3-5 
min at 37°C to detach cells from the flask surface during passaging. Serum-containing 
medium was used to inactivate trypsin and cells were seeded into fresh culture flasks 
(Corning Life Sciences). For storage, cell stocks were initially frozen in freezing 
medium at -80°C before being transferred to liquid nitrogen. 
43 
 
2.1.4 siRNA-mediated interference 
 
MRC-5 cells (25,000 cells/well of a chamber slide or 200,000 cells/T75 culture 
flask) or VSMCs (10,000 cells/well of 24-well plate or 200,000 cells/T75 culture flask) 
were seeded at a medium density and incubated overnight. The next day, for each mL 
of medium, 0.5 µL siRNA oligo (20 µM stock; sequences shown in Table 2.1) was 
added to 108 µL serum-free medium in an eppendorf tube with 7 µL Hiperfect reagent. 
The transfection mix was vortexed for 5 sec and incubated for 10 min at room 
temperature (RT) to allow transfection complex formation. During this time, cells were 
washed twice and fresh medium (12 mL/T75 culture flask, 4 mL/T25 culture flask, 1 
mL/chamber slide well, 500 µL/well of 24-well plate) reapplied. The transfection mix 
was then added and incubated for 72 hours before cells were prepared for 
immunofluorescence microscopy or Western blot analysis.     
 
2.1.4.1 siRNA strategy 
In these experiments, ON-TARGET plus reagent (Thermo Scientific 
Dharmacon) combining multiple siRNAs to target distinct regions of the same target 
gene was used. Because single siRNA reduces target gene expression by less than 
50%, this pooling strategy increases the chance of reducing target gene expression. To 
overcome problems associated with multiple siRNAs increasing the chances of off-
target effects , ON-TARGET plus reagent has 2 important modifications i) the sense 
strand is modified to prevent nitration with RISC and favour antisense strand uptake 
and ii) the antisense strand seed region is modified to minimise seed-related off-
targeting. Evidence has shown that compared to a single siRNA, ON-TARGET plus 
significantly reduces off-target effects with unmatched potency and specificity.240 
However, contradicting evidence shows that combination siRNAs do not function 
synergistically to affect target gene expression and suggests that less active siRNAs 
interfere with the efficiency of higher efficacy siRNAs. Because more potent siRNAs 
share sequence characteristics, recent evidence demonstrates that single algorithm-
designed siRNAs (Cenix BioScience) are more potent and more effective (>85% 
reduction in target gene expression). Studies directly comparing the alternative 
strategies show that both single and pooled siRNAs provided false negative/positive 
results and variable off target effects.241 It is suggested that several individual siRNAs 
per target gene in individual transfections is the most effective approach to confirm that 
obtained results are specific to  reduction of gene expression and not off-target effects 
of single or siRNA pools.241 Therefore, this approach may be better suited to 
experiments in the future.  
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Table 2.1: Oligonucleotides used for siRNA-mediated knockdown 
siRNA oligo Source Sequence (5’ to 3’) 
Control Qiagen AAACCCUCUGAACAGACGACGUU 
Human FACE-1/ ZMPSTE24 
(ON-TARGETplus, smart 
pool) 
Thermo Scientific 
Dharmacon 
CGGCAGAGAAGGAUAAUA 
UGGGAAGGCUAAAGACUUA 
GGUCAGGACUCUAUUCAGA 
GAUCAUGGAUUCUGAAACA 
Lamin A  
(ON-TARGETplus, smart 
pool) 
Thermo Scientific 
Dharmacon 
CGUGUGCGCUCGCUGGAAA 
UGAAAGCGCGCAAUACCAA 
UCACAGCACGCACGCACUA 
GAAGGAGGGUGACCUGAUA 
Nesprin-1 calponin homology 
2 (N1CH2) (Figure 2.1A) 
Thermo Scientific 
Dharmacon 
UGAACGAGGCCGAGAGAGAUU 
Nesprin-2 calponin homology 
5 (N2CH5) (Figure 2.1B) 
Thermo Scientific 
Dharmacon 
GCCUUCACGUGCUGGAUAAUU 
 
Human Rac1 
(ON-TARGETplus, smart 
pool) 
Thermo Scientific 
Dharmacon 
GUGAUUUCAUAGCGAGUUU 
GUAGUUCUCAGAUGCGUAA 
AUGAAAGUGUCACGGGUAA 
GAACUGCUAUUUCCUCUAA 
Human RhoA 
(ON-TARGETplus, smart 
pool) 
Thermo Scientific 
Dharmacon 
CGACAGCCCUGAUAGUUUA 
GACCAAAGAUGGAGUGAGA 
GCAGAGAUAUGGCAAACAG 
GGAAUGAUGAGCACACAAG 
Human UNC 84A (SUN1) 
(ON-TARGETplus, smart 
pool) 
Thermo Scientific 
Dharmacon 
GAAAAGACCCGACGACACA 
GCGCUCAGUUCCAGCUAUU 
GGUACCAGUUUGUUACUUU 
GGUAACUGCUGGGGCAUUUA 
Human UNC 84B (SUN2)  
(ON-TARGETplus, smart 
pool) 
Thermo Scientific 
Dharmacon 
AGAGCUCGGUGGCGGAAGA 
GGAAACUGCUGCUCGCAUC 
CCUGAGGGCCUUCGACAAA 
CCAGAGACUCAUCGCCACA 
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Figure 2.1 Nesprin-1 and -2 siRNA and antibody target sites. Schematic representation of 
nesprin-1 and -2 giant isoforms. Figure includes examples of their potential N-terminal calponin 
homology domain and C-terminal KASH domain variants that have been recently published by 
Rajgor & Shanahan, 2013.
146
 Due to their sequence homology and the lack of isoform-specific 
tools, the exact nesprin content of VSMCs at present is unknown. Arrows indicate where (A) 
nesprin-1 and (B) nesprin-2 siRNA and polyclonal antibodies are designed to target.   
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2.1.5 DNA plasmid transfection  
 
U20S cells, seeded at a medium density, were transfected with DNA plasmid 
using the following protocol. For each mL of media, 1.5 µg plasmid was added to 75 µL 
Opti-MEM and vortexed for 5 sec before adding 5 µL Fugene HD transfection reagent. 
The transfection mix was vortexed for 10 sec and incubated for 15 min at RT to allow 
transfection complex formation. U20S cells were washed with PBS and incubated for 
16-24 hours with transfection mix before cells were prepared for immunofluorescence 
microscopy or fluorescence recovery after photobleaching (FRAP). 
 
2.2 Molecular biology techniques 
 
2.2.1 RNA extraction 
 
 Initially, all surfaces and labware were decontaminated using RNase away 
reagent. Cells from a confluent T75 culture flask were lysed using 1 mL RNA STAT-
60™ and incubated for 5 min at RT to allow complete dissociation of nucleoprotein 
complexes. Following the addition of 200 μL chloroform, samples were shaken 
vigorously by hand for 20 sec and incubated for 10 min at RT. This was followed by 
centrifugation for 15 min/10,500 rpm/4°C and the upper aqueous phase was 
transferred to an RNase-free microcentrifuge tube with 500 µL isopropanol for 10 min 
at RT. Total RNA was pelleted by centrifugation for 15 min/10,500 rpm/4°C and the 
supernatant removed. The pellet was washed with 1 mL 75% ethanol solution in 
diethylpyrocarbonate (DEPC)-treated water and centrifuged for 5 min/8,250 rpm/4°C. 
The supernatant was removed and the RNA pellet air-dried for 10 min before being 
resuspended in ~20 µL DEPC-treated water and stored at -80°C for subsequent 
analysis.   
 
2.2.2 Reverse transcription (cDNA synthesis) 
 
 Total RNA (1 μg) was incubated with 0.5 μL Oligo (dT) primers, 0.5 μL random 
primers and 2 μL dNTP for 5 min at 65°C. 4 μL 5x buffer and 1 μL RNase inhibitor were 
added and incubated for a further 3 min at 37°C. 1 μL Promega Avian Myeloblastosis 
Virus–RT (AMV-RT) was added and reverse transcription performed using the 
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following protocol in a thermal cycler 2720 (Applied Biosystems); 10 min at 25°C, 50 
min at 37°C and 5 min at 95°C. Total cDNA was diluted to the required concentration 
using nuclease-free water.  
 
2.2.3 Quantitative PCR (qPCR)  
 
 Prior to qPCR, primer sets were examined using Taq based PCR. Purified 
products were diluted to generate a 0.5 pmol stock which was serially diluted to create 
0.05, 0.005, 0.0005, 0.00005 and 0.000005 pmol standards. 
 
 cDNA was diluted 100 ng/µL and 900 ng was used per 20 µL reaction 
containing 1x SYBR green qPCR master mix and 5 µmol of each primer (Table 2.2). 
PCRs were performed at 95°C for 10 min followed by 40 cycles at 95°C for 5 sec and 
60ºC for 1 min using a RotorGene-3000 thermal cycler (Corbett Research). The cycle 
threshold (CT) for each sample was automatically determined (RG-3000 software) as 
the first cycle at which a significant increase in optical signal, above an arbitrary base 
line, was detected. mRNA expression was quantified using standard curves for each 
primer set and normalised to the internal control, GAPDH, from the same sample. All 
samples were tested in triplicate and fold changes were calculated using the delta-delta 
CT method. 
 
 
Table 2.2: Primers used for qPCR 
 
Primer Primer sequence  
Nesprin-1 CH domain forward AGAGTCTCTTGGTGTTGGCTTCGT 
Nesprin-1 CH domain reverse TCTCTTGCTCATCTTGCAGCCTCT 
Nesprin-2 KASH 2 domain forward AGAGCAGTGAGAACTACAGAAGGC 
Nesprin-2 KASH 2 domain reverse AGTGCAGCTGTAGTCTTCTTCGGA 
GAPDH forward CGACCACTTTGTCAAGCTC 
GAPDH reverse CAAGGGTCTACATGGCAAC 
FACE-1 Ordered from Qiagen 
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2.2.4 Generation of competent E.coli DH5  
 
E.coli strains DH5 were cultured overnight in antibiotic-free LB medium at 
37°C in a shaking incubator. The next morning the culture was centrifuged for 10 
min/4,000 rpm/4°C and the bacterial pellets stored at 4°C for 1 hour before being 
resuspended in 20 mL sterile ice cold 100 mM CaCl2. Bacteria were then re-pelleted for 
10 min/3,500 rpm/4°C and treated again with ice cold 100 mM CaCl2 before repeating 
centrifugation as above. Pelleted bacteria were stored at -80°C in 100 µL aliquots as 
15% glycerol stocks.  
 
2.2.5 Transformation of E. coli DH5 and plasmid isolation 
 
After thawing on ice, glycerol stocks of competent bacteria were incubated with 
1 µL plasmid DNA on ice for 20 min. Bacteria were submerged in a water bath at 42°C 
for 40 sec to heat shock, then immediately cooled on ice for 2 min. Bacteria were then 
added to 500 µL antibiotic-free LB medium and incubated in a shaking incubator for 1 
hour at 37°C. 50 µL transformed bacteria were plated out on an appropriate antibiotic-
treated LB agar plate and cultured overnight at 37°C for antibiotic-resistant gene 
expression. The next morning, a selected colony was cultured in 3 mL antibiotic-treated 
LB for a further 8-10 hours. At this point, bacteria were stored at -80°C as 15% glycerol 
stocks for future use or 1 mL was added to 100 mL antibiotic-treated LB and incubated 
overnight at 37°C. The next day, bacteria were pelleted by centrifugation 10 min/4,000 
rpm/RT and plasmid was isolated using an Endofree Plasmid Maxiprep kit (Qiagen) as 
per the manufacturer’s instructions. Initially, bacteria were lysed in 10 mL lysis buffer, 
which was subsequently neutralised by the addition of 10 mL neutralisation solution.  
Plasmid was separated from cell debris by passing the mixture through a filtered 
syringe. Plasmid-containing liquid was next incubated with 2.5 mL endotoxin removal 
buffer for 20 min on ice before the plasmid was captured and washed using a Qiagen-
tip column. DNA was eluted in 15 mL elution buffer and precipitated using 10.5 mL 
isopropanol followed by centrifugation 1 hour/4000 rpm/4C. The DNA pellet was 
washed in an ethanol-based wash buffer and re-pelleted by centrifugation for 1 
hour/4000 rpm/4C. Finally, the pellet was air-dried and resuspended in 500 µL TE 
buffer.   
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2.3 Biochemical techniques 
 
2.3.1 Whole cell lysate preparation 
 
 Cells were washed using PBS and harvested by scraping into IP buffer. 
Suspended cells were sonicated (Branson Sonifier 150) for 10 sec to lyse and cell 
debris was pelleted by centrifuging for 5 min/12,000 rpm/4°C. The pellet was discarded 
and the cell lysate (supernatant) protein concentration determined using a DC protein 
assay (Bio-Rad). Lysates were added to an equal volume of 2x sample loading buffer, 
vortexed and heated to 80°C for 5 min before Western blot analysis. 
 
2.3.2 DC protein assay 
 
 Purified BSA 1.48 mg/mL was serially diluted to make DC protein assay 
standards. 2 µL cell lysate, alongside 2 µL standards, were incubated with 25 µL Bio-
Rad DC Protein Assay Reagent A in a 96-well plate for 5 min at RT. Next, 200 µL Bio-
Rad DC Protein Assay Reagent B was added to each well for 5 min at RT. Protein 
concentrations were determined spectrophotometrically (Tecan GENios pro) at 710 nm 
by comparing to BSA standards.  
 
2.3.3 Subcellular fractionation 
 
A confluent T75 culture flask was washed with PBS and cells scraped into 400 
μL extraction buffer A (for all buffer recipes please refer to table 2.4). Homogenates 
were incubated on ice for 15 min to lyse. Centrifugation for 3 min/14,000 rpm/RT 
pelleted the nucleus and the supernatant was collected as the cytosolic fraction. The 
pellet was resuspended in 100 μL extraction buffer B and incubated for 30 min at 37°C. 
Centrifugation for 3 min/14,000 rpm/RT pelleted the nuclear insoluble fraction and 
supernatant was collected as nuclear soluble fraction. The nuclear insoluble fraction 
was resuspended in 1% sodium dodecyl sulphate (SDS), heated for 10 min at 100°C 
and sonicated for 10 sec. Each fraction was then added to an equal volume of 2x 
sample loading buffer, vortexed and heated to 80°C for 5 min before Western blot 
analysis. 
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2.3.4 GST pull-down assay 
 
PAK is an immediate downstream effector of stimulated Rac1 and was used in 
this experiment as a measure of Rac1 activity. E.coli BL-21 were transformed with 
GST-PAK1-PBD (p21-binding domain) plasmid (Addgene #12217) and cultured 
overnight on an ampicillin agar plate at 37°C.  A single colony was selected, diluted into 
5 mL ampicillin-LB medium and incubated in a shaking incubator overnight at 37°C. 
The next day, 500 µL culture was diluted into 200 mL fresh ampicillin-LB medium and 
grown for ~2 hours in a shaking incubator at 37°C. GST-protein expression was 
induced with 1 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) for ~2 hours at 37°C 
and bacteria were harvested by centrifuging for 15 min/2,500 rpm/RT. Pellets were 
then resuspended in 5 mL PBS with protease inhibitors (2 μL/mL) and sonicated for 10 
sec. Proteins were solubilised by incubating with 1% Triton-X for 1 hour at 4°C before 
bacterial debris was pelleted (15 min/2,500 rpm/RT). Supernatant was collected and 
recombinant protein was purified by adding 500 μL glutathione-sepharose beads (50% 
slurry) and rotating for 30 min at RT. Beads were washed (3 x 5 min) with PBS at 4°C 
and GST-protein expression was visualised by SDS-PAGE and coomassie staining.  
 
GST-protein beads (50 μL of 50% slurry) were mixed with 200 μg cell lysate on 
a rotator for 2 hours at 4°C. Beads were then pelleted by centrifugation for 2 min/2000 
rpm/4°C and washed with 200 μL IP buffer (3 x 5 min). Bound protein was eluted 
following the addition of 50 μL 2x sample buffer and boiling for 5 min at 95ºC. Pulled-
down proteins were analysed by SDS-PAGE and Western blot analysis. 
 
2.3.4.1 Quantification of GTPase activity 
 To determine Rac1 activity, Western blotting utilised anti-Rac1 antibody 
followed by densitometric analysis. Band intensity was measured using the Gel 
Analyser function of Image J software. GST-PAK1-PBD (active Rac1) lysates were 
loaded alongside control lysates of the same cell sample (retained to measure total 
Rac1). Active Rac1 intensities were normalised to control lysates, which then allowed 
us to compare active Rac1 between experimental samples i.e. proliferative vs 
presenescent VSMCs.  
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2.3.5 Western blot analysis 
 
 10% resolving gels were set in gel casting kits (Bio-Rad) before 4% stacking gel 
was poured on top, using combs to create wells within the gel for sample loading (for 
solution details see Table 2.4). Gels were submerged in running buffer and cell lysate 
samples loaded into individual wells, alongside a protein standard. Protein samples 
were then subjected to SDS-PAGE using a Mini PROTEAN 3 system (Bio-Rad). Gels 
were initially resolved at 80 V, until protein samples passed through the stacking gel, 
then increased to 120 V until samples reached the end of the resolving gel. Next, the 
resolving gel was laid on methanol-activated polyvinylidene difluoride (PVDF) 
membrane and sandwiched between blotting paper (3 layers on each side) soaked in 
1x transfer buffer. Proteins were transferred from the gel to PVDF membrane using a 
semi-dry transfer cell (Bio-Rad Trans-Blot® SD) for 1 hour at 25 V. Gels were stained 
with coomassie and membranes were blocked using 5% milk solution for 1 hour at RT 
on an orbital shaker. Membranes were then incubated with primary antibodies (Table 
2.3) diluted in 5% milk solution overnight at 4°C. After briefly washing with TBS-T, 
membranes were incubated with secondary antibody conjugated to horseradish 
peroxidase (HRP) (Table 2.3) diluted in 5% milk solution for 1 hour at RT. Membranes 
were further washed with TBS-T (15 min x 3), processed using an enhanced 
chemiluminescent (ECL) kit and developed (Compact X4 Automatic Processor) to 
visualise protein bands. 
 
 All commercially available antibodies were validated at the beginning of each 
experiment: individual protein bands were detected at the correct molecular weight 
(see Table 2.3). Nesprin-1 and -2 antibodies were produced in-house and different 
nesprin isoforms at varying molecular weights (~20, 80 and 220kDa). 
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Table 2.3: Antibodies used for immunofluorescence microscopy (IF) and Western blot 
analysis (WB). 
 
Primary antibodies & 
molecular weight 
Source & order number Dilution 
(WB) 
Dilution 
(IF) 
α-tubulin (55 kDa) Sigma-Aldrich (T9026) 1:10,000 1:1000 
β-actin (42 kDa) Sigma-Aldrich (A2228) 1:10,000 - 
Emerin (NCL) (34 kDa) Leica Biosystems (6012130) 1:500 1:50 
FACE-1 (ZMPSTE24) (54 kDa) Novus Biologicals (100-2387) 1:200 - 
Lamin A/C (N-18) (70 kDa) Santa Cruz Biotechnology (6215)  1:1,000 - 
Nesprin-1 (N1C2)  
(multiple bands) 
Made in-house (Figure 2.1A) 1:1000 - 
Nesprin-2 (N2CH3) 
(multiple bands) 
Made in-house (Figure 2.1B) 1:1000 1:100 
Prelamin-A (C-20) (74 kDa) Santa Cruz Biotechnology 
(H1312) 
1:250 1:250 
Rac1 (21 kDa) Millipore (05-389) 1:1000 - 
Rac2 (21 kDa) Millipore (07-604) 1:1000 - 
RhoA (22 kDa) Abcam (54835) 1:100 - 
Smooth muscle α-actin 
(SM-actin) (43 kDa) 
Sigma-Aldrich (75228) 1:1000 - 
SUN1 (90 kDa) Abcam (74758) 1:100 - 
SUN2 (80 kDa) Abcam (65447) 1:1000 1:100 
Vinculin (116 kDa) Sigma-Aldrich (V9264) 1:10,000 1:1000 
Secondary antibodies Source & order number Dilution 
(WB) 
Dilution 
(IF) 
Anti-mouse IgG, HRP-
conjugated 
GE healthcare (NA931) 1:5000 - 
Anti-goat IgG HRP-conjugated  Sigma-Aldrich (A9452) 1:5000 - 
Anti-rabbit IgG HRP-conjugated GE healthcare (NA934) 1:5000 - 
Donkey-anti-mouse Alexa flour 
488 
Invitrogen (A21202) - 1:500 
Donkey-anti-goat Alexa fluor 
488 
Invitrogen (A11055) - 1:500 
Goat-anti-rabbit Alexa fluor 488 Invitrogen (A11011) - 1:500 
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2.4 Cell biology techniques  
 
2.4.1 Immunofluorescence microscopy 
 
VSMCs cultured on 13 mm glass cover slips in 24-well plates or MRC-5 cells on 
chamber slides were washed with PBS and fixed for 5 min in 4% paraformaldehyde at 
RT. Cells were then washed in PBS x 2 and cell membranes permeabilised using 0.5% 
Nonidet P-40 (NP-40) alternative for 2 min at RT. To reduce non-specific background 
staining, cells were incubated with PBS containing 1% BSA for 1 hour at RT prior to 
incubation with primary antibody solution overnight at 4°C. The next day, cells were 
washed with PBS and incubated in fluorescence-conjugated secondary antibody 
solution or rhodamine phalloidin (1:2,000) for 1 hour at RT (see Table 2.3 for all 
primary and secondary antibodies used). Cell nuclei were stained using 4’,6’-
Diamidino-2-Pheylindoledihydrochloride (DAPI; 1:10,000) and subsequently washed in 
PBS x 3. Cells were mounted onto slides using Mowiol/Dabco mounting media and 
visualised using a Zeiss Axioplan 2 light microscope (20 or 40x objective) or Leica SP5 
confocal microscope, with an x63, 1.2NA oil emersion lens attached to a Hamamatsu 
Orca-R2 cooled CCD camera. Volocity software (Perkin Elmer, USA) was used to 
control exposure time and gain/offset measurements before storing captured images. 
Initially, all antibodies were tested individually to confirm antibody specificity. We also 
confirmed that dual antibody staining did not affect protein localisation.  
 
2.4.1.1 Analysing cell morphology 
 
Acquired images were exported from Volocity as TIFF files. Image J software 
was used to manually draw around individual cells and measure morphological 
parameters such as area (arbitrary value) and circularity/shape factor. Circularity is 
defined as 4π (area)/(perimeter) whereby values approaching 1 signify a rounded cell 
and 0 represents an elongated cell. During my project, I converted to Volocity software 
for image analysis as this automatically measures the same parameters by 
fluorescence detection. Rhodamine phalloidin (F-actin stain) and DAPI (DNA stain) 
were used to determine cell shape and nuclear shape, respectively. Additionally, anti-
vinculin was used to measure focal adhesion number, size and shape. Student’s t-tests 
were performed using GraphPad Prism software for statistical analysis.  
 
  
54 
 
2.4.2 Time-lapse video microscopy 
 
Time-lapse microscopy was used to monitor different modes of cell migration in-
vitro. Firstly, single cell migration was captured to determine the intrinsic capacity of 
cells to migrate without the influence of external factors. We also recorded the 
migration of cells towards a scratch in an attempt to imitate wound healing. Finally, a 
chemotactic assay was used to represent cell migration during injury responses. The 
Dunn chamber was used to capture directional cell movement towards a serum 
gradient. All time-lapse microscopy was conducted using an Olympus IX81 microscope 
attached to a Hamamatsu Photonics Orca-R2 cooled CCD camera maintained at 37°C 
with constant CO2 supply. Shutters were set for maximum sample protection against 
phototoxic damage during filming. Volocity software was used to control time-lapse 
image acquisition and for the compilation of time-lapse movies from which cell 
migration was analysed.  
 
2.4.2.1 Random single cell migration  
 
Cells were sparsely seeded (50-60% confluency) onto a 24-well plate 24 hours 
prior to time-lapse microscopy. The next day, cells were washed and medium replaced 
prior to filming. Multiple positions across each well were selected and phase contrast 
images at these x-y positions were captured using a motorised stage (LUDL Electronic 
products) every 5 min for 16-24 hours. A 4x objective was used for VSMC imaging and 
10x objective for MRC-5 cells. Images were compiled to generate time-lapse movies of 
random cell migration without chemoattractant influence. 
 
2.4.2.1.1 Image processing and analysis 
 
Time-lapse movies were exported from Volocity as TIFF files and cell tracking 
was conducted using Image J software (manual tracking plugin). Single cells were 
manually tracked by clicking on the centre of cell nuclei throughout consecutive frames 
(Figure 2.2A). Tracking was terminated upon cell-cell contact or during cell division as 
these influence migratory behaviour. Finally, a static artefact from each movie was 
tracked to correct for background drift that may have occurred during recording. Each 
movie was saved as a comma separated value (.CSV) file.  
 
Using these x-y coordinates, Mathematica 6.0 (Wolfram Research Ltd, USA) 
measured migrational velocity (distance/time) and persistence (calculated as the linear 
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displacement of the cell divided by total distance migrated; values approaching 1 define 
persistent cell migration in a linear fashion and 0 defines deviation from a straight line). 
This was achieved using custom-written Mathematica notebooks (Professor Graham 
Dunn & Daniel Soong, King’s College London) that were created for the analysis and 
statistical comparison of cell migration. Initially, .CSV files were converted to .CEL 
format and each movie corrected using static artefact coordinates. .CEL files were then 
imported into the Chemotaxis Analysis Notebook V1.6 and tracks plotted using the 
Track Plotter, Analyser and Editor (Figure 2.2B). This also generated histograms of 
velocity and persistence profiles (Figure 2.3). A Two Sample Tester was used to 
statistically compare cell migration between datasets.  
 
 
 
 
Figure 2.2: Tracking random single cells. (A) Individual cells were tracked throughout 
consecutive frames of a time-lapse movie using the Image J manual tracking plugin. (B) 
Coordinates from each movie were combined using Mathematica to visualise the migratory path 
of numerous cells. 
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Figure 2.3: Analysing cell migration. Mathematica software was used to generate mean 
velocity and persistence profiles of cell migration. Histograms illustrate the mean track speed 
(MTS) and mean track persistence (MTP) of a selected sampling time.  
 
 
2.4.2.2 Scratch assay 
VSMCs were seeded onto a 24-well plate and cultured until dense (90-100% 
confluency). A 200 µL pipette tip was used to scratch the centre of each well to 
simulate a wound, excess cells were removed with PBS and the culture medium 
replaced prior to filming. Multiple positions across each well were selected and phase 
contrast images were captured every 5 min for 16 hours using a 4x objective. Images 
were compiled to generate a time-lapse movie of collective cell migration into the 
scratch area. A limitation of this assay is that it does not account for proliferation that 
will also increase the cell number in the scratch assay. To overcome this, future studies 
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will use a proliferation inhibitor (mytomysin C for VSMCs) prior to filming, to ensure that 
migration alone is captured.  
 
2.4.2.2.1 Image processing and analysis 
Images exported from Volocity as TIFF files were subjected to a series of 
processing steps using Image J software to compare scratch size at T=0 compared 
with T=16 hours (Figure 2.4). Initially, the edge of the scratch was defined (process-
find edges, process-sharpen). To increase contrast between the scratch and cell front, 
an appropriate threshold was applied to each image to generate a binary image 
(image-adjust-threshold, process-find edges). Each image was then inverted (image-
lookup tables-invert LUT) and scratch area was measured from the area fraction value 
(analyse-analyse particles). The fraction size change between T=0 and T=16 hours 
determined scratch closure (%).  
 
(A) Phase contrast scratch images after 0 and 16 hours of time-lapse microscopy 
 
(B) The scratch edge was defined using Image J software (process image-find edges, process-sharpen) 
58 
 
 
(C) Binary images were produced (image-adjust-threshold, process-find edges) 
 
 
 
(D) Images were inverted to increase contrast (image-lookup tables-invert LUT) and scratch area was measured 
(analyse-analyse particles) 
 
Figure 2.4: Image processing steps using Image J software for scratch closure analysis 
 
 
2.4.2.3 Interference reflection microscopy (IRM) 
IRM is used to image cell-substrate interactions and is a widely used technique 
for quantifying the focal adhesion dynamics of live cells in culture. Initially, cells were 
sparsely seeded (50-60% confluency) onto a glass-bottom culture dish (MatTek Ltd) for 
24 hours. The next day, cells were washed using PBS and the culture medium 
replaced prior to filming. Multiple positions (5-10) across the dish were selected, 
focussing on the leading edge of cells. Images were captured every 2 min for 1 hour 
using an incident light fluorescence attachment and a 63x oil immersion objective.  
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2.4.2.3.1 Principles of IRM 
When cells are very close to the glass surface, reflected light from the cell 
membrane shifts out of phase with reflected light from the glass. This causes 
‘interference’ which manifests as a dark pixel against the cell-free background. When 
cell membrane is not attached to the glass, reflected beams will not interfere, resulting 
in a bright pixel in the image (Figure 2.5).242 Therefore, IRM enables clear imaging of 
the focal adhesion pattern at the base of the cell and can be used to measure focal 
adhesion turnover.  
 
 
 
 
 
Figure 2.5: Principles of interference reflection microscopy. Dark green waves represent 
emitted light from the fluorescence source and pale green waves represent reflected light. If the 
cell membrane is too close to the glass, reflected light from the cell membrane shifts half a 
wavelength. This interferes with waves reflected from the glass, resulting in a dark pixel in the 
image. A greater distance between the glass and cell membrane does not cause interference 
and results in a bright pixel.  
 
 
2.4.2.3.2 Image processing and analysis 
In our study, focal adhesion formation at the leading edge of VSMCs and MRC-
5 fibroblasts was analysed after 20 min and 1 hour of filming, respectively. Time-
separated images (t=0, t=20/60 min) were exported from Volocity as TIFF files and 
subject to a series of processing steps to increase contrast between focal adhesions 
and image background (Figure 2.6). This was achieved using Image J software in a 
method modified from previous studies.243 Firstly, an FFT bandpass filter was applied 
to each image (process-FFT-bandpass filter) and an appropriate threshold was 
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selected (image-adjust-threshold) to generate binary images, making focal adhesions 
strikingly obvious against the background. Any artefacts, not representing focal 
adhesions, were removed manually by selecting and inverting to colour-match the 
background. The cell leading edge was selected and Image J measured the pixel count 
of each focal adhesion (analyse-analyse particles-show outlines). Next, a composite 
image was created (image-colour-merge channels) to highlight newly formed focal 
adhesions (t=20/60; red) against original focal adhesions (t=0; green). The pixel count 
of newly formed focal adhesions were then was expressed as a percentage of the total 
number of original pixels to give focal adhesion assembly (%).  
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(A) IRM images of MRC-5 fibroblasts captured at 0 and 60 min 
 
(B) Images were subject to numerous processing steps to increase the contrast between focal adhesions and the image 
background (process-FFT-bandpass filter, image-adjust-threshold) 
 
(C) A composite image (image-colour-merge channels) distinguishes newly-formed focal adhesions (red) against those 
in the original image (green). The pixel count of new adhesions (T=60) was compared with the total number of original 
pixels (T=0) to provide a percentage of focal adhesion assembly (analyse-analyse particles-show outlines) 
 
Figure 2.6: IRM image processing and analysis 
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2.4.2.4 Chemotaxis assay 
  
Chemotaxis describes the movement of cells in response to spatial gradients of 
chemical cues. In our studies, Dunn chemotaxis chambers (Hawksley Technology, 
Lancing, UK) were used to determine VSMC migration towards a serum gradient. 
Initially, VSMCs were seeded onto glass coverslips (22x22 mm, 1.5 mm thickness) for 
8 hours in culture medium containing 20% FBS. Cells were then serum-starved 
overnight in culture medium containing 2% FBS before setting up Dunn chambers as 
described below.  
 
2.4.2.4.1 Principles of the Dunn chamber assay 
 
The Dunn chamber is a glass microscope slide into which two concentric 
annular wells are cut at a depth approximately half the thickness of the slide. These 
two wells are separated by a bridge. Filling the outer well with chemoattractant creates 
a gradient across the bridge and triggers cell migration into this area (see Figure 
2.7).244 In our experiments, the Dunn chamber slide was covered with 2% FBS culture 
medium containing 20 µm HEPES to maintain a physiological pH throughout filming. A 
glass coverslip was then inverted onto the Dunn chamber, just off-centre to leave a 
small filling slit at one edge. Surplus medium was removed and the edges, apart from 
the filling slit, were sealed using hot wax mixture (Vaseline: paraffin: beeswax 1:1:1). A 
gradient was created by placing 20% FBS culture medium (containing 20 µm HEPES) 
in the outer well via the filling slit before this slit was sealed. On the time-lapse 
microscope, multiple fields were selected and VSMC migration from the inner to the 
outer well was recorded every 10 min for 16 hours.  
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Figure 2.7: The Dunn chamber. The Dunn chamber is a glass microscope slide with an inner 
and outer well that are separated by a bridge. Cells are cultured on coverslips that are then 
inverted onto the slide. Applying a chemoattractant source to the outer well, via the filling slit, 
creates a chemotactic gradient across the bridge and cell migration from the inner to outer well 
is recorded using time-lapse microscopy.
244
  
 
 
2.4.2.4.2 Image processing and analysis 
 
Time-lapse movies were exported from Volocity as TIFF files and VSMCs were 
manually tracked using Image J software as previously described. These migratory 
coordinates were imported into Mathematica and .CEL files were subsequently 
analysed using the Chemotaxis Analysis Notebook V1.6. The angle at which each 
movie was captured was also used to normalise migrational directionality. 
 
A Rose plot (circular histogram) displayed distributions of VSMC trajectories 
relative to their gradient orientation (0°). Rayleigh tests assessed whether clustering of 
VSMC track directionality occurred and determined whether a significant chemotactic 
response was stimulated. A significant chemotactic response is indicated on Rose plots 
by a red arrow facing the mean angle of migration. The green section highlights the 
95% confidence interval.  
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2.4.3 Fluorescence recovery after photobleaching (FRAP) 
 
All FRAP experiments were conducted at the Randall Division of Cell and 
Molecular Biophysics by Dr Daniel Soong (King’s College BHF Centre Light 
microscopy research officer). FRAP is a non-invasive method of measuring protein 
mobility and dynamics within a living cell. FRAP uses a high-powered laser beam to 
irreversibly photobleach fluorescently-tagged protein within a small region of interest 
(ROI). Subsequently, fluorescence recovery occurs from the diffusion of surrounding 
unbleached molecules into the bleached area until a steady state is reached. This is 
monitored by capturing a series of images post-bleach and results in a characteristic 
recovery curve which is used to determine protein mobility and turnover.   
 
2.4.3.1 Cell preparation 
 
U2OS cells were seeded into T25 culture flasks at a medium density (50-60%) 
and incubated overnight. The next day, siRNA transfection mix was added as 
previously described (see section 2.1.4). After 48 hours, DNA transfection mix was 
prepared into 3 mL phenol red-free medium (see section 2.1.5) using GFP-mini-
nesprin-2G construct (kindly donated from Gregg Gunderson, Columbia University). 
During this time, U2OS cells were washed twice with PBS and trypsinised using phenol 
red-free trypsin. Trypsinised cells were then resuspended in DNA transfection mix and 
seeded onto glass-bottom dishes (MatTek Ltd) for 16-24 hours prior to FRAP 
experiments.  
 
2.4.3.2 FRAP imaging 
  
 FRAP images were acquired on a Ti Eclipse A1R laser scanning confocal 
microscope (Nikon, Tokyo, Japan) using a 60x 1.4 NA oil-immersion objective. A 488 
nm 40 mW diode laser (Coherent, Santa Clara, USA) was used for excitation and 
emitted light was collected via a 505/550 nm bandpass filter. Images were captured 
every second for 20 seconds before a circular ROI was bleached for 25 iterations at full 
laser power (100% transmission). FRAP was subsequently monitored for a further 300 
sec, again with images acquired approximately every second. In addition, a 
background ROI monitored the amount of non-bleached fluorescent signal lost during 
imaging.  
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2.4.3.3 FRAP analysis 
 
FRAP analysis was conducted by Dr Daniel Soong who specifically created a 
programme to determine the mobile fraction as well as binding rate constants (kon and 
koff) of bleached GFP-mini-nesprin-2G. Briefly, intensity curves were fit to an equation 
using Mathematica in accordance with published data determining FRAP rate 
fittings.245 All intensity plots we recorded were found to adhere most closely to the 
formula for a reaction dominant FRAP curve, in which the rate of diffusion is very small 
compared to the intensity increase (recovery) in the bleach region. This is caused by 
the release of bleached molecules from within and binding of unbleached molecules 
from outside of the beach region. The reaction dominant formula allows calculation of 
mobile fraction from the plateau of the curve, whilst the fit can extract values for Kon 
and Koff rates by rearranging the formulae: 
 
 
1)   intensity =        
          
2)        
   
        
 
 
 
This experiment was repeated numerous times to optimise this technique. Final 
analysis was performed by Dr Daniel Soong on data collated from 20-30 cells imaged 
during 4 independent experiments. Using GraphPad Prism, statistical significance was 
determined with a paired Student’s t test.  
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Table 2.4: Solutions used for experiments 
 
Solutions 
 
Solution components 
Extraction buffer A  50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 
0.1% Triton, 10 mM NaF, 10 mM ß-glycerophosphate, 1 
mM Na3VO4, 2 μL/mL protease inhibitors 
Extraction buffer B  50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 10 
mM NaF, 10 mM ß-glycerophosphate, 1 mM Na3VO4, 5 
mM MnCl2, 300 μg/mL DNase 1, 2 μL/mL protease 
inhibitors 
Freezing medium (tissue 
culture) 
1 mL DMSO, 1 mL FBS, 8 mL growth medium 
containing 20% FBS 
IP buffer 10 mM Tris-HCl pH7.5, 150 mM NaCl, 1 mM EDTA, 1% 
Triton, 2 μL/mL protease inhibitors 
Milk solution (5%) 5 g dried milk, 100 mL TBS-T 
Resolving gel 10% (~20 
mL) 
 
7.9 mL H2O, 6.7 mL 30% acrylamide, 5 mL 1.5 M Tris 
pH 8.8, 0.2 mL 10% SDS, 0.2 mL APS, 8 μL TEMED 
Running Buffer 15 g Glycine, 3 g Tris, 10 mL 10% SDS, 1 L H2O 
Sample loading buffer 2x 
(20mL) 
1 M Tris-HCl pH 6.8, 10% glycerol,  SDS, 0.1% 
bromophenol blue (w/v),  20% ß-mercaptoethanol 
Stacking gel 5% (~10 mL) 
 
6.8 mL H2O, 1.7 mL 30% acrylamide, 2.5 mL 0.5 M Tris 
pH 6.8, 100 µL 10% SDS, 100 µL 10% APS, 10 µL 
TEMED 
Transfer buffer 10x (1 L) 30 g Tris, 150 g glycine, 20 mL 10% SDS, up to 1L H2O 
Transfer buffer 1x (500 
mL) 
50 mL 10x transfer buffer, 100mL MeOH, 500mL H2O 
Mowiol/Dabco mounting 
media 
2.4 g Mowiol 4-88, 6 g glycerol, 6 mL H2O, 12 mL 0.2 M 
Tris pH 8.5, 2.5% DABCO 
TBS (Tris-buffered saline) 
10x (1 L) 
12.11 g Tris, 87.6 g NaCl, 1 L H2O, pH 7.6 (HCl) 
TBS-T (1 L) 100 mL 10x TBS, 900 mL H2O, 0.3% tween 20 
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Table 2.5: Details of laboratory reagents used 
 
Laboratory reagents 
 
Source 
 
Order number 
β-Mercaptoethanol (C2H6OS, βME) Sigma-Aldrich M-6250 
ß-glycerophosphate Sigma-Aldrich G9422 
5x buffer & RNase inhibitor kit  Promega M1705 
30% Acrylamide/Bis solution  BioRad 161-0158 
Ammonium Persulfate (APS) Bio-Rad 161-0700 
AMV-RT  Promega  M5101 
Bovine Serum Albumin (BSA) Sigma-Aldrich A4503 
Bromophenol Blue  Sigma-Aldrich 11,439-1 
Chamber slides (4 well) BD Falcon 354114 
Chloroform Sigma-Aldrich C2432 
Coomassie G-250 stain Bio-Rad 161-0786 
DABCO (1,4-diazabicyclo[2.2.2]octane) Sigma-Aldrich D-2522 
DAPI (4’,6’-Diamidino-2-
Pheylindoledihydrochloride) 
Sigma-Aldrich D-9542 
DC Protein Assay Bio-Rad 500-0113, 500-
0114 
DEPC-treated water  Invitrogen 750023 
DNase I Sigma-Aldrich AMPD1 
dNTPs master mix  Promega NU-0010-10 
Dulbecco’s Modified Eagle’s Medium 
(DMEM)  
Sigma-Aldrich D5671 
Dulbecco’s Modified Eagle’s Medium 
(DMEM) Phenol red free 
Sigma-Aldrich D5921 
DMSO (dimethyl sulfoxide) Sigma-Aldrich D8418 
Earl’s Balanced Salt solution (EBSS) Sigma-Aldrich E6267 
Enhanced Chemiluminescent (ECL) kit  Pierce  32106 
Ethanol (CH3CH2OH, EtOH) Sigma-Aldrich E7023 
Ethylenediaminetetra-acetic Acid (EDTA)  Sigma-Aldrich E-5134 
FACE-1 primers (ZMPSTE24) Qiagen QT00024627 
Foetal Bovine Serum (FBS)   Sigma-Aldrich F-7524 
Fugene HD transfection reagent Promega E2311 
Glycine  Fisher Scientific BP381-500 
HEPES  Sigma-Aldrich H4034 
Hiperfect transfection reagent  Qiagen 301707 
Isopropanol (C3H8O) Sigma-Aldrich I9516 
LB Agar  Sigma-Aldrich L2897 
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LB Medium Sigma-Aldrich  L3022 
Manganese chloride (MnCl2) Sigma-Aldrich 244589 
Maxiprep kit (endofree) Qiagen 12362 
Methanol (CH3OH,MeOH)  Sigma-Aldrich  322415 
Milk (dried skimmed) Marvel  
Mowiol  Calbiochem  475904 
M199 media  Sigma-Aldrich M4530 
NP-40 alternative Calbiochem  492016 
Oligo (dT) primers Promega C1101 
Opti-MEM Invitrogen  11058-21 
Paraformaldehyde powder  Sigma-Aldrich  P6148 
Penicillin-Streptomycin-Glutamine 
solution  liquid 
Invitrogen   10378-016 
Phosphate buffered saline (PBS) Sigma-Aldrich D1408 
Protease Inhibitor Cocktail Sigma-Aldrich P8340 
Protein standards (Precision Plus 
ProteinTM Dual Colour Standards 
Bio-Rad 161-0374 
PVDF membrane (Immobilon-PTM) Millipore  IPVH00010 
Random Primers  Promega  C1181 
Rhodamine Phalloidin Invitrogen R415 
RNase away  Molecular 
Bioproducts 
7003 
RNA STAT-60™ AMS Biotechnology CS-110 
ROCK inhibitor Y27632 dihydrochloride Sigma-Aldrich Y-0503 
SDS Fluka Analytical 05030 
Sodium Chloride (NaCl)  Sigma-Aldrich S7653 
Sodium fluoride (NaF) Sigma-Aldrich 201154 
Sodium orthovanadate (Na3VO4) Sigma-Aldrich S-6508 
SYBR green qPCR master mix  Eurogentec  RT-SY2X-
03+NRWOUB 
TEMED Bio-Rad 161-0801 
Triton-X 100  Sigma-Aldrich X-100 
TrizmaTM base Sigma-Aldrich T6066 
Trypsin 1x-EDTA solution Sigma-Aldrich T3924 
Trypsin (phenol red free) 10x Invitrogen 15400-054 
Tween 20 Sigma-Aldrich P2287 
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Chapter 3: Characterising the impact 
of in-vitro ageing and nuclear lamina 
disruption on smooth muscle cell 
and fibroblast phenotype 
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3.1 Introduction 
 
Ageing is the largest risk factor in the development of cardiovascular diseases 
such as atherosclerosis, however, our understanding of the mechanisms underlying 
ageing and how ageing impinges upon cell function remains poorly defined.198, 199 
Previous studies conducted in our laboratory discovered prelamin A accumulation as a 
biomarker of normal VSMC ageing.204 These studies demonstrate that prelamin A 
accumulated in VSMCs from aged vessels and atherosclerotic lesions, which did not 
occur in VSMCs from young, healthy vessels.204 Furthermore, prelamin A accumulates 
in presenescent VSMCs and prelamin A overexpression induces premature 
senescence, indicating that prelamin A drives VSMC senescence rather than 
accumulating as a consequence of it.204 However, the precise role of prelamin A in 
ageing and the pathophysiological implications of prelamin A accumulation have yet to 
be fully described.  
 
Emerging evidence illustrates that the LINC complex plays an important role in 
regulating actin organisation and cell motility.151, 165, 246 This is mediated by nesprin-
SUN-nuclear lamina interactions spanning the NE that physically couple the actin 
cytoskeleton and nuclear interior.128 Prelamin A accumulation occurs at the NE during 
ageing and induces nuclear dysmorphology.204 In light of this, we aimed to determine 
the impact of prelamin A accumulation upon the LINC complex; its organisation and 
role in regulating F-actin, focal adhesion dynamics and migration. As the current 
literature stands, we have a limited understanding of how ageing impacts on VSMC 
migration and contributes towards the development of cardiovascular diseases such as 
atherosclerosis.  
 
3.2 Aim of this chapter 
This chapter aims to investigate the impact of prelamin A accumulation upon 
LINC complex organisation and function in VSMCs and MRC-5 fibroblasts. We 
hypothesise that prelamin A accumulation alters LINC complex stability and disrupts 
the coupling between the NE and actin cytoskeleton. As a result, we expect this to 
impinge upon general cell morphology, focal adhesion organisation and migratory 
behaviour.  
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3.3 Results 
 
3.3.1 Prelamin A accumulation is associated with VSMC ageing 
To model ageing, young and healthy primary human VSMCs were serially 
passaged in-vitro until cell growth ceased. The VSMC growth curve (Figure 3.1A) has 
3 distinct stages: an initial proliferative phase when growth rate is high (population 
doubling time (PDT) 3-4 days) at early passage numbers (passages 6-12), a 
presenescent phase (passages 12-14) when VSMCs become ‘aged’ and growth rate is 
reduced (PDT 6-7 days) and finally, a senescent phase when proliferation terminates 
(passage ~15+). High-passage (aged) and early-passage (healthy) VSMCs were 
compared to investigate the morphological changes associated with ageing. As 
illustrated in earlier studies, prelamin A accumulation occurred at the NE of 
presenescent and senescent VSMCs, with no positive staining in proliferative VSMCs 
(Figure 3.1B).204 This further supports evidence that prelamin A accumulation occurs 
during presenescence rather than a result of senescence.  
 
3.3.2 FACE-1 downregulation induces prelamin A accumulation 
In healthy VSMCs, prelamin A is continually cleaved by FACE-1 to form lamin A 
which is incorporated into the nuclear lamina.140 During VSMC ageing, prelamin A 
processing is hindered causing prelamin A to accumulate at the NE.204, 239 In 
agreement with our previous findings, Western blot analysis comparing proliferative 
and presenescent VSMCs illustrated a reduction of FACE-1 levels in presenescent 
VSMCs which expectedly corresponded with prelamin A accumulation (Figure 3.2A).  
 
To specifically observe the impact of prelamin A accumulation at the NE, 
siRNA-mediated knockdown of FACE-1 was performed to artificially accelerate 
prelamin A accumulation in proliferative VSMCs. Western blot analysis confirmed that 
FACE-1 siRNA treatment successfully depleted FACE-1 levels leading to a subsequent 
increase in prelamin A (Figure 3.2B). This was further supported by qPCR data 
showing reduced FACE-1 mRNA expression (68.7 ± 3.680% reduction) in FACE-1 
siRNA cells compared with control cells (Figure 3.2C). Furthermore, 
immunofluorescence microscopy confirmed that prelamin A accumulated at the NE of 
most FACE-1 siRNA treated cells (79.23 ± 2.439%) with none detected in control cells 
(Figure 3.3B & D). This prelamin A staining mirrored that observed in in-vitro aged 
VSMCs. Most presenescent VSMCs stained positive for prelamin A (96.83 ± 1.740%) 
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which was scarcely detectable in proliferative VSMCs (3.03 ± 0.837%) (Figure 3.3A & 
C). Together, these experiments identified FACE-1 siRNA as a valuable tool to 
manipulate prelamin A levels at the NE and was used throughout this project to model 
VSMC ageing.  
 
Fibroblasts were also treated with FACE-1 siRNA to determine whether these 
cells could accumulate prelamin A and be used to model VSMC ageing. Fibroblasts 
were used in these experiments to preserve precious VSMC stocks whilst also 
modelling ageing in a cell type that doesn’t naturally accumulate prelamin A. 
Interestingly, the prelamin A mutant, progerin, is detected in fibroblasts derived from 
HGPS patients and its accumulation drives defective phenotypic changes. However, 
the impact of progerin accumulation on fibroblast migration is unknown.  
Immunofluorescence microscopy revealed that prelamin A accumulated at the NE of 
85.39 ± 3.036% FACE-1 depleted fibroblasts to mimic aged VSMCs and no prelamin A 
was detectable in control cells (Figure 3.4A & B). This was reinforced by Western blot 
analysis and qPCR, illustrating that diminished FACE-1 protein levels correlated with 
increased prelamin A (Figure 3.4C) and FACE-1 mRNA expression was depleted by 
69.23 ± 6.558% (Figure 3.4D).  
 
3.3.3 Aged VSMCs exhibit alterations to nuclear morphology 
Previous studies report that VSMC ageing induces nuclear morphology 
defects.204 Serial VSMC passaging in-vitro is associated with increased nuclear 
convolutions and cells from older patients have more dysmorphic nuclei compared with 
those derived from younger patients.204 In the current study, early-passage and 
presenescent nuclei from 3 VSMC isolates (52M, 54M, 35F) were stained with DAPI 
and immunofluorescence microscopy was used to determine the nuclear changes 
associated with ageing (Figure 3.5A). Volocity software measured nuclear parameters 
to reveal that presenescent nuclei were 2-fold larger and significantly more elongated 
than proliferative cell nuclei (Figure 3.5B & C). To establish whether prelamin A 
accumulation was causal for the nuclear changes detected during VSMC ageing, 
FACE-1 siRNA was used to accelerate prelamin A accumulation. VSMC nuclei were 
stained using DAPI and immunofluorescence microscopy revealed no change to the 
nuclear size or shape of FACE-1 depleted VSMCs (Figure 3.6).  
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3.3.4 VSMC ageing and prelamin A accumulation alters cell morphology 
Our evidence indicates that VSMC ageing induces alterations to nuclear 
morphology. As the actin cytoskeleton defines cell morphology, we next investigated 
the impact of ageing on F-actin organisation. Early-passage and presenescent VSMC 
actin filaments were stained using rhodamine phalloidin (Figure 3.7A). 
Immunofluorescence microscopy captured images of 3 VSMC isolates (52M, 54M, 
35F) and subsequent analysis using Image J software revealed that presenescent cells 
were 2.8-fold larger and significantly more elongated than proliferative VSMCs (Figure 
3.7B & C). These morphological changes mimicked those previously detected in aged 
VSMC nuclei (Figure 3.5). Based on our evidence so far, we speculate that prelamin A 
accumulation at the NE is capable of inducing morphological changes via its impact on 
the actin cytoskeleton. To ensure that ageing was not affecting the microtubule 
network, in-vitro aged VSMCs were stained at proliferative and presenescent growth 
stages with α-tubulin antibody. Apart from the morphological changes previously 
discussed (Figure 3.7), immunofluorescence microscopy found no gross change to 
microtubule organisation during in-vitro ageing (Figure 3.8). 
 
We next investigated whether the cell shape changes associated with ageing 
were specifically a result of augmented prelamin A at the NE. VSMCs were treated with 
control and FACE-1 siRNA and F-actin staining prior to immunofluorescence 
microscopy revealed that prelamin A accumulation had no impact on cell area but 
significantly reduced cell circularity (Figure 3.9). Therefore, prelamin A plays a part, but 
is not solely responsible, for driving the morphological changes that occur during 
VSMC ageing. This experiment was repeated in fibroblasts of 3 different passage 
numbers (passage 34, 38, 39). Immunofluorescence microscopy revealed that FACE-1 
depleted fibroblasts were significantly smaller and more elongated than control cells 
(Figure 3.10). Although these changes do not exactly reflect those detected in aged 
VSMCs, this data confirms that prelamin A accumulation influences cell architecture.  
 
In addition, confocal microscopy further assessed actin organisation in in-vitro 
aged and artificially aged (FACE-1 depleted) VSMCs. Actin filaments stained using 
rhodamine phalloidin were imaged at successive optical slices throughout individual 
VSMCs. This enabled finer-detailed imaging of the actin cytoskeleton and visualisation 
of the actin cap. The actin cap is a highly organised structure of thick F-actin bundles 
that tightly covers the apical surface of the nucleus via direct connection to LINC 
complexes.194 Because VSMC ageing influences nuclear and cell morphology, we were 
surprised to find no alterations in actin cap formation in either presenescent or FACE-1 
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siRNA treated VSMCs when compared to proliferative and control siRNA treated 
VSMCs, respectively (Figure 3.11). This supports more recent findings demonstrating 
that the actin cap is unaffected in cells possessing various lamin A mutations.247  
 
3.3.5 VSMC ageing and nuclear lamina disruptions alter focal adhesion 
organisation 
The actin cytoskeleton is connected to the cell membrane via a plethora of 
adaptor proteins that make up focal adhesion complexes.37 As in-vitro ageing and 
prelamin A accumulation significantly impacts upon nuclear and cell morphology, we 
expanded our study to examine the impact of VSMC ageing upon focal adhesion 
organisation. Immunofluorescence microscopy of vinculin-stained VSMCs revealed 
focal adhesions to be abundantly expressed throughout proliferative cells (99.61 ± 
5.170 focal adhesions per cell) which were largely reduced in presenescent VSMCs 
(74.03 ± 4.499 focal adhesions per cell) and redistributed to the cell periphery (Figure 
3.12A & B). Analysis with Volocity software revealed that focal adhesions were 
significantly smaller and more circular in presenescent VSMCs compared with 
proliferative VSMCs (Figure 3.12C & D). 
 
After observing that ageing impinges on focal adhesion organisation, we next 
investigated whether prelamin A accumulation was specifically accountable for these 
changes. Proliferative VSMCs and MRC-5 fibroblasts were treated with FACE-1 siRNA 
for 72 hours to accumulate prelamin A and focal adhesions were stained with anti-
vinculin. Immunofluorescence microscopy and subsequent analysis with Volocity 
software revealed that focal adhesions were abundantly expressed throughout control 
VSMCs and fibroblasts (53.49 ± 3.290 & 58.08 ± 3.420 focal adhesions per cell, 
respectively), whereas, FACE-1 depletion was associated with a loss of focal 
adhesions (43.04 ± 2.385 & 40.16 ± 1.710 focal adhesions per cell, respectively) 
(Figure 3.13A & B & 3.14A & B). Furthermore, focal adhesions primarily localised to 
the periphery of FACE-1 depleted cells similarly to those observed in presenescent 
VSMCs (Figure 3.13A & 3.14A). Following FACE-1 depletion, focal adhesions were 
significantly more spherical in both VSMCs and fibroblasts (Figure 3.13C & 3.14C) and 
were significantly smaller in VSMCs (Figure 3.13D). Fibroblasts showed no change to 
focal adhesion size (Figure 3.14D).  
 
Together, this evidence demonstrates that in-vitro VSMC ageing and prelamin 
A accumulation induce focal adhesion relocalisation to the cell periphery and increase 
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their circularity, attributes that are indicative of high focal adhesion turnover and cell 
motility.248 To study focal adhesion dynamics, interference reflection microscopy (IRM) 
measured focal adhesion assembly in in-vitro aged and FACE-1 depleted VSMCs. The 
leading edge of presenescent VSMCs was significantly more dynamic, with focal 
adhesion turnover (23.96 ± 2.615%) doubling that of proliferative (11.6 ± 2.844%) and 
senescent (15.37 ± 2.901%) VSMCs (Figure 3.15).  
 
IRM also illustrated that FACE-1 depletion significantly enhanced focal 
adhesion dynamics in both VSMCs and MRC-5 fibroblasts. As prelamin A is a 
dominant negative of lamin A, this experiment was repeated using lamin A siRNA as a 
positive control. Successful lamin A depletion in VSMCs and fibroblasts (63.07 ± 
4.042% & 46.35 ± 6.154% reduction, respectively) was demonstrated using 
immunofluorescence microscopy and Western blot analysis (Figure 3.17 & 3.19). 
Focal adhesion assembly in FACE-1 (20.44 ± 2.989%) and lamin A (20.47 ± 2.089%) 
depleted VSMCs nearly doubled that measured in control VSMCs (10.73 ± 1.875%) 
after 20 min (Figure 3.16). Control fibroblasts had little focal adhesion formation in 60 
min (9.08 ± 1.677%) which more than doubled in FACE-1 (21.38 ± 2.123%) and lamin 
A (26.96 ± 5.012%) depleted fibroblasts (Figure 3.18). This evidence illustrates that 
nuclear lamina remodelling is able to influence focal adhesion behavior at the cell 
membrane and strongly supports the notion that the LINC complex creates a 
continuously-coupled system throughout the entire cell.  
 
3.3.6 In-vitro ageing and nuclear lamina disruptions affect cell migration 
Due to accumulating evidence indicating that ageing impacts upon VSMC 
morphology and focal adhesion dynamics, we next characterised the effect of ageing 
upon migrational behaviour. Time-lapse video microscopy captured random single cell 
migration of proliferative, presenescent and senescent VSMCs over a 16 hour period. 
Individual cells were tracked throughout time-lapse movies using Image J software, x-y 
coordinates were plotted and migration was analysed using Mathematica software 
(Figure 3.20A).  
 
Presenescent VSMCs (0.180 ± 0.006 µm/min) were significantly faster than 
early-passage VSMCs (0.140 ± 0.007 µm/min). Once VSMCs reached the senescent 
growth stage, migration speed slowed (0.144 ± 0.006 µm/min) to match that of early-
passage, proliferative cells (Figure 3.20B). The increased migratory speed of 
presenescent VSMCs correlated with enhanced migrational persistence. Presenescent 
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VSMC persistence (0.406 ± 0.021) was significantly higher than that of proliferative 
(0.206 ± 0.03) and senescent (0.256 ± 0.027) VSMCs (Figure 3.20C). This clearly 
indicates that fundamental changes to cell migration occur throughout the 3 distinct 
stages of in-vitro ageing.  
 
To study the impact of nuclear lamina disruption on single cell migration, 
VSMCs and MRC-5 fibroblasts were treated with FACE-1 and lamin A siRNA for 72 
hours prior to time-lapse microscopy. As described above, Mathematica software 
plotted individual VSMC and fibroblast migration tracks before analysing migratory 
behaviour (Figure 3.21A & 3.22A). FACE-1 (0.193 ± 0.006 µm/min) and lamin A 
(0.185 ± 0.006 µm/min) depleted VSMCs exhibited no change to migrational velocity 
when compared with control siRNA-treated VSMCs (0.196 ± 0.007 µm/min) (Figure 
3.21B). However, FACE-1 (0.235 ± 0.018 µm/min) and lamin A (0.251 ± 0.023 µm/min) 
depleted fibroblasts were significantly faster than control fibroblasts (0.154 ± 0.009 
µm/min) (Figure 3.22B). FACE-1 depleted VSMCs (0.595 ± 0.019) were significantly 
more persistent than lamin A (0.55 ± 0.019) and control (0.501 ± 0.023) VSMCs 
(Figure 3.21C). Moreover, FACE-1 (0.266 ± 0.033) and lamin A (0.273 ± 0.038) 
knockdown increased the migratory persistence of fibroblasts compared with control 
cells (0.102 ± 0.029) (Figure 5.22C). Together, this evidence suggests that the nuclear 
lamina contributes to the migratory behaviour of both cell types studied. 
 
3.3.7 The impact of in-vitro ageing and nuclear lamina disruption on 
directional VSMC migration 
 After observing the impact of ageing and nuclear lamina disruption on single 
VSMC migration, we next employed a scratch assay to study migration more closely in 
these cells. A scratch was engraved into a confluent monolayer of VSMCs and time-
lapse captured migration into the scratch area over 16 h. Scratch closure was 
significantly higher in presenescent (15.28 ± 1.897%) and senescent (12.2 ± 0.835%) 
VSMCs compared with proliferative VSMCs (8.897 ± 1.417%) (Figure 3.23). 
Furthermore, scratch closure was significantly more efficient in FACE-1 (15.45 ± 
1.159%) and lamin A (14.79 ± 1.113%) depleted VSMCs than control siRNA-treated 
VSMCs (9.346 ± 0.8623%) (Figure 3.24).  
 
We also investigated the impact of in-vitro ageing on the ability of VSMCs to 
undergo chemotaxis. A Dunn chamber assay combined with time-lapse microscopy 
compared proliferative, presenescent and senescent VSMC migration towards a serum 
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gradient. Proliferative and presenescent VSMCs migrated directionally towards the 
serum gradient (mean direction; -20.637 ± 28.8962° & -17.5024 ± 43.338°, 
respectively). Rayleigh tests revealed that clustering in the direction of these gradients 
was significant in both proliferative (p < 0.0001, n = 119) and presenescent (p = 
0.0035, n = 87) VSMCs. However, senescent VSMCs were unable to sense and 
migrate directionally towards the gradient (p = 0.3902, n = 122) (Figure 3.25). Thus, 
proliferative and presenescent VSMCs were able to effectively chemotax, and only 
when cells reached senescence was chemotaxis impaired.  
 
3.3.8 VSMC ageing and nuclear lamina disruptions hinder Rho GTPase 
activity 
After observing the migratory changes associated with presenescence and 
prelamin A accumulation, we next explored the molecular changes underlying VSMC 
ageing, in particular, the impact of VSMC ageing on Rho GTPase proteins. Rho 
GTPases are well-established regulators of the actin cytoskeleton, cell motility and cell 
proliferation.45 Western blot analysis comparing proliferative and presenescent VSMC 
lysates revealed that total levels of Rac1 and RhoA were attenuated in presenescent 
VSMCs (Figure 3.26).  
 
To specifically assess the impact of ageing on Rac1 activity, proliferative and 
presenescent cell lysates were prepared for a GST pull-down assay. GST-PAK1-PBD 
(p21-binding domain) beads were used to specifically precipitate Rac1 in its GTP-
bound form. Western blotting revealed that Rac1 activity was significantly inhibited in 
presenescent VSMCs (66.21 ± 0.066% reduction) compared with proliferative VSMCs 
(Figure 3.27). Next, this experiment was repeated in nuclear lamina disrupted VSMCs. 
Control, FACE-1 and lamin A siRNA-treated VSMC lysates were prepared for GST-pull 
down with Rac1-GST. Western blotting revealed that Rac1 activity was repressed in 
FACE-1 and lamin A depleted VSMCs by 40 ± 0.079% and 77.11 ± 0.033%, 
respectively (Figure 3.28).  
 
 ROCK is a downstream effector of Rho and its activation generates contractile 
force required to drive cell movement and disassemble focal adhesions at the rear of 
migrating cells.113, 114 Time-lapse microscopy captured the effect of ROCK inhibition on 
random single VSMC migration using Y-27632. Y-27632 is the most widely used 
selective inhibitor of the ROCK family protein kinases; p160ROCK (ROCK-I) and 
ROKα/Rho-kinase (ROCK-II). Characterisation studies have revealed that Y-27632 
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inhibits the ROCK family of kinases with much greater affinity (>200-fold selectivity) 
than to other kinases, including citron kinase, PKN, PKC, cAMP-dependent protein 
kinase, and myosin light chain kinase.249, 250 Y-27632 can abolish stress fibres at low 
concentrations (10 µM) with little to no off-target effects or impact to the cell cycle or 
cytokinesis.250 
 
 
ROCK-inhibited VSMCs were significantly faster (0.248 ± 0.013 µm/min) than 
untreated VSMCs (0.139 ± 0.006 µm/min) (Figure 3.29A). ROCK inhibition also 
significantly increased migrational persistence (0.803 ± 0.020) compared with 
untreated cells (0.610 ± 0.022) (Figure 3.29B). In addition, we further tested the 
specific impact of Rac1 and RhoA depletion on MRC-5 fibroblast migration. Successful 
Rac1 and RhoA knockdown using siRNA was confirmed by Western blot analysis 
(Figure 3.30A & B). Time-lapse microscopy captured random single migration, cells 
were manually tracked using Image J (Figure 3.30C) and migration analysed using 
Mathematica software. Rac1 depletion reduced fibroblast migration speed (0.057 ± 
0.007 µm/min), however, this was not significant. Conversely, RhoA-depleted 
fibroblasts were significantly faster (0.132 ± 0.017 µm/min) than control cells (0.079 ± 
0.010 µm/min) (Figure 3.30D). No significant change to migratory persistence was 
detected across the 3 treatment groups (Figure 3.30E). These data suggest that RhoA 
is an important mediator of migration speed and loss of RhoA in aged VSMCs may be 
causal for their enhanced velocity.  
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Figure 3.1: Prelamin A accumulation is associated with in-vitro VSMC ageing. (A) Graph 
of VSMC population doubling time during in-vitro passaging (n=3, 35F VSMCs). The 3 distinct 
stages of VSMC growth are highlighted; proliferative, presenescent and senescent. (B) 
Representative immunofluorescence images compare prelamin A staining (red) in proliferative, 
presenescent and senescent VSMCs. DAPI (blue) stained VSMC nuclei. Scale bar represents 5 
μm. 
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Figure 3.2: FACE-1 depletion corresponds with prelamin A accumulation. Representative 
Western blot demonstrating prelamin A and FACE-1 levels in (A) presenescent (PS) and (B) 
FACE-1 siRNA treated 35F VSMCs when compared with proliferative (P) and control siRNA 
treated VSMCs, respectively. β-actin indicates equal protein loading (20 µg of each protein 
lysate was loaded). (C) Quantitative PCR revealed reduced FACE-1 expression in FACE-1 
siRNA treated 35F VSMCs compared with control cells. Experiments were performed in 
triplicate and a paired Student’s t test was used for statistical analysis (control vs treatment).  
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Figure 3.3: FACE-1 siRNA induces prelamin A accumulation in VSMCs. (A & C) 
Representative immunofluorescence microscopy images of prelamin A (green) in presenescent, 
and proliferative 35F VSMCs. The number of cells positively stained for prelamin A were 
counted and an unpaired Student’s t test was used for statistical analysis (proliferative vs 
presenescent). Data are based on counting >300 cells per group across 3 independent 
experiments. (B & D) Following FACE-1 siRNA treatment for 72 h, 35F VSMCs were positive for 
prelamin A (red). A paired Student’s t test was used for statistical analysis (control vs 
treatment). DAPI (blue) stained VSMC nuclei. Data are based on counting >300 cells per group 
across 3 independent experiments. Scale bar represents 5 μm. 
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Figure 3.4: Prelamin A accumulates at the nuclear envelope of FACE-1 depleted 
fibroblasts.  MRC-5 fibroblasts were treated with control and FACE-1 siRNA for 72 h. (A & B) 
Representative immunofluorescence microscopy images show prelamin A (green) in FACE-1 and 
control siRNA treated cells. DAPI (blue) stained nuclei. The number of cells positively stained 
for prelamin A were counted and a paired Student’s t test was used for statistical analysis 
(control vs treatment). Data are based on counting >300 cells per group across 3 independent 
experiments. (C) Representative Western blot showing FACE-1 and prelamin A levels in control 
and FACE-1 siRNA treated fibroblasts. Coomassie staining indicates equal protein loading (20 
µg of each protein lysate was loaded). (D) Quantitative PCR of FACE-1 mRNA expression in 
FACE-1 and control siRNA-treated MRC-5 fibroblasts. Experiment was performed in triplicate 
and a paired Student’s t test was used for statistical analysis (control vs treatment). 
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Figure 3.5: VSMC ageing induces nuclear morphology changes. (A) Representative 
immunofluorescence images of proliferative and presenescent 54M VSMC nuclei, stained using 
DAPI (blue), to visualise nuclear changes associated with in-vitro ageing. (B) Volocity software 
was used to measure nuclear area and (C) nuclear circularity in presenescent and proliferative 
VSMC isolates.(52M, 54M, 35F).  Data are based on the measurement of 50-100 nuclei from 3 
independent experiments.. Statistical significance was calculated using an unpaired Student's t 
test (proliferative vs presenescent nuclei). Scale bar represents 10 μm.  
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Figure 3.6: Prelamin A accumulation does not impact upon VSMC nuclear morphology. 
(A) Representative immunofluorescence images of control and FACE-1 siRNA treated VSMC 
nuclei stained using DAPI (blue). Scale bar represents 5 μm. Volocity software was used to 
measure the (B) area and (C) circularity of 35F VSMC nuclei. Data are based on the 
measurement of >100 nuclei from 3 independent experiments. Statistical significance was 
calculated using a paired Student's t test (control vs treatment).  
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Figure 3.7: In-vitro ageing drives VSMC morphology changes. (A) Representative 
immunofluorescence images showing proliferative and presenescent VSMC actin filaments (F-
actin) stained using rhodamine phalloidin (red). DAPI (blue) stained VSMC nuclei. Scale bar 
represents 50 μm. Image J software was used to manually measure (B) cell area and (C) cell 
circularity in presenescent and proliferative VSMC isolates (52M, 54M, 35F) . Data are based on 
the measurement of 50-100 VSMCs from 3 independent experiments. Statistical significance 
was calculated using an unpaired Student's t test (proliferative vs presenescent VSMCs).  
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Figure 3.8: In-vitro ageing does not affect microtubule organisation. Immunofluorescence 
microscopy images of proliferative and presenescent 35F VSMC microtubules stained using α-
tubulin (green). DAPI (blue) stained VSMC nuclei. Scale bar represents 50 μm.  
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Figure 3.9: The impact of FACE-1 knockdown on VSMC morphology. (A) Representative 
immunofluorescence images showing control and FACE-1 siRNA treated 35F VSMC actin 
filaments (F-actin) stained using rhodamine phalloidin (red). DAPI (blue) stained VSMC nuclei. 
Scale bar represents 35 μm. Image J software was used to manually measure the (B) area and 
(C) circularity of control and FACE-1 siRNA treated 35F VSMCs. Data are based on the 
measurement of >300 VSMCs from 3 independent experiments. Statistical significance was 
calculated using a paired Student's t test (control vs treatment).  
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Figure 3.10: The impact of FACE-1 knockdown on actin organisation in fibroblasts. (A) 
Representative immunofluorescence images of MRC-5 fibroblasts following treatment with 
control and FACE-1 siRNA for 72 h. Actin filaments (F-actin) were stained using rhodamine 
phalloidin (red) and DAPI (blue) stained nuclei. Scale bar represents 10 μm. (B & C) Image J 
software was used to manually measure the cell area and cell circularity of control and 
FACE-1 siRNA treated fibroblasts (passage 34, 38, 39). Data are based on the measurement of 
>50 MRC-5 fibroblasts from 3 independent experiments . Statistical significance was calculated 
using a paired Student's t test (control vs treatment).  
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Figure 3.11: In-vitro ageing and prelamin A accumulation do not affect actin cap 
formation. Confocal microscopy shows actin cap formation in presenescent and FACE-1 siRNA 
treated 35F VSMCs when compared to proliferative and control VSMCs, respectively.  
Rhodamine phalloidin stained actin filaments (red), DAPI stained nuclei (blue) and anti-vinculin 
stained focal adhesions (green). Scale bar represents 35 μm. The lower panel displays higher 
magnification images of the actin cap indicated by arrows.  
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Figure 3.12: VSMC ageing disrupts focal adhesion organisation. (A) Representative 
immunofluorescence images showing focal adhesions, stained with anti-vinculin (green), of 
proliferative and presenescent 35F VSMCs. DAPI (blue) stained VSMC nuclei. Scale bar 
represents 20 μm. Volocity software was used to measure (B) focal adhesion number, (C) size 
and (D) circularity in presenescent and proliferative 35F VSMCs.. Data represent the analysis of 
500-1000 focal adhesions from >100 cells (n=3). Statistical significance was determined using 
an unpaired Student's t test (proliferative vs presenescent VSMCs).  
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Figure 3.13: The impact of FACE-1 knockdown upon focal adhesion organisation. (A) 
Representative immunofluorescence images showing focal adhesion staining with anti-vinculin 
(green) of control and FACE-1 siRNA treated 35F VSMCs. DAPI (blue) stained VSMC nuclei. 
Scale bar represents 20 μm.  Volocity software was used to measure (B) focal adhesion 
number, (C) size and (D) circularity in control and FACE-1 siRNA treated 35F VSMCs. Data 
represent the analysis of 500-1000 focal adhesions from >100 cells (n=3). Statistical 
significance was determined using a paired Student's t test (control vs treatment).  
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Figure 3.14: FACE-1 knockdown disrupts focal adhesion organisation in fibroblasts. 
MRC-5 fibroblasts were treated with control and FACE-1 siRNA for 72 h. (A) Representative 
immunofluorescence images show focal adhesion staining with anti-vinculin (green) of control 
and FACE-1 siRNA treated cells. DAPI (blue) stained nuclei. Scale bar represents 10 μm. 
Volocity software was used to measure (B) focal adhesion number, (C) size and (D) circularity 
in control and FACE-1 siRNA treated fibroblasts. Data represent the analysis of >300 focal 
adhesions pooled from >50 cells per group (n=3, passage 34, 38, 39). Statistical significance 
was determined using a paired Student's t test (control vs treatment).  
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Figure 
3.15: Presenescent VSMCs exhibit increased focal adhesion dynamics. (A) Representative binary 
images of proliferative, presenescent and senescent VSMCs captured during interference reflection 
microscopy (IRM) at t=0 min (i) and t=20 min (ii). Composite images (iii) highlight focal adhesion 
formation at t=20 (red) compared with original focal adhesions at t=0 (green). (B) IRM analysis 
revealed adhesion turnover in presenescent and senescent 35F VSMCs compared with proliferative 
cells. Data are based on the analysis of 15-20 cells pooled from 3 independent experiments. Statistical 
significance was determined using ANOVA to show global differences between the VSMC growth 
stages (p = 0.0079), followed by a Tukey’s multiple comparison test.   
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Figure 3.16: Nuclear lamina disruption increases focal adhesion dynamics. (A) Representative 
binary images of control, FACE-1 and lamin A siRNA treated VSMCs captured during interference 
reflection microscopy (IRM) at t=0 min (i) and t=20 min (ii). Composite images (iii) highlight focal 
adhesion formation at t=20 (red) compared with original focal adhesions at t=0 (green). (B) IRM 
analysis revealed focal adhesion turnover in FACE-1 and lamin A depleted 35F VSMCs compared 
with control VSMCs. Data are based on the analysis of 15-20 cells pooled from 3 independent 
experiments. Statistical significance was determined using a paired Student's t test (control vs 
treatment).  
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Figure 3.17: siRNA-mediated lamin A depletion. VSMCs were treated with lamin A and control 
siRNA for 72 h prior to experimentation. (A) Representative immunofluorescence images showing 
lamin A (green) and DAPI (blue) stained 35F VSMC nuclei. Scale bar represents 50 μm. (B) The 
number of cells positively stained for lamin A were counted. Data are based on >300 cells counted 
across 3 independent experiments and statistical significance was determined using a paired 
Student's t test (control vs treatment). (C) Western blot analysis demonstrated lamin A/C levels of 
control and lamin A siRNA treated cells. Coomassie stain indicated equal loading (20 µg of each 
protein lysate was loaded).  
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Figure 3.18: Nuclear lamina disruption increases focal adhesion dynamics in fibroblasts. (A) 
Representative binary images of control, FACE-1 and lamin A siRNA-treated MRC-5 fibroblasts 
captured during interference reflection microscopy (IRM) at t=0 min (i) and t=60 min (ii). Composite 
images (iii) highlight focal adhesion formation at t=60 (red) compared with original focal adhesions at 
t=0 (green). (B) IRM analysis revealed focal adhesion turnover in FACE-1 and lamin A depleted 
fibroblasts compared with control fibroblasts. Data are based on the analysis of 13-17 cells pooled 
from 3 independent experiments. Statistical significance was determined using a paired Student's t 
test (control vs treatment).   
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Figure 3.19: Lamin A knockdown in MRC-5 fibroblasts. MRC-5 fibroblasts were treated with lamin 
A and control siRNA for 72 h prior to experimentation. (A) Representative immunofluorescence 
images show lamin A (green) and DAPI (blue) stained nuclei. Scale bar represents 50 μm. (B) ) The 
number of cells positively stained for lamin A were counted. Data are based on >300 cells counted 
across 3 independent experiments. (C) Western blot analysis demonstrated lamin A/C levels of control 
and lamin A siRNA treated cells. Coomassie stain indicated equal loading (20 µg of each protein 
lysate was loaded).  
.  
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Figure 3.20: Ageing impacts upon single VSMC migrational behaviour. Time-lapse 
microscopy was used to capture random migration of single proliferative, presenescent and 
senescent 35F VSMCs. Images were captured every 5 min for 16 h and Mathematica software 
plotted x-y coordinates to provide (A) an overlay of individual cell tracks and analysed (B) 
migratory velocity and (C) persistence. Data are based on the analysis of 61 (senescent) and 
108 (proliferative & presenescent) individually tracked cells pooled from 3 independent 
experiments. Statistical significance was calculated using an unpaired Student's t test. 
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Figure 3.21: The impact of FACE-1 knockdown on VSMC persistence. Time-lapse 
microscopy was used to capture random migration of single control, FACE-1 and lamin A siRNA 
treated 35F VSMCs. Images were captured every 5 min for 16 h and Mathematica software 
plotted x-y coordinates to provide (A) an overlay of individual cell tracks and analysed (B) 
migratory velocity and (C) persistence. Data are based on the analysis of 121 (control), 118 
(FACE-1 siRNA) and 98 (lamin A siRNA) individually tracked cells pooled from 3 independent 
experiments. Statistical significance was calculated using a paired Student's t test (control vs 
treatment).  
 
100 
 
 
 
Figure 3.22: Nuclear lamina disruption increases fibroblast migration speed and 
persistence. Time-lapse microscopy was used to capture random migration of single control, 
FACE-1 and lamin A siRNA treated MRC-5 fibroblasts. Images were captured every 5 min for 
16 h, Image J was used to manually track individual cells and Mathematica software plotted x-y 
coordinates to provide (A) an overlay of individual cell tracks and analysed (B) migratory 
velocity and (C) persistence. Data are based on the analysis of 98 (control), 105 (FACE-1 
siRNA) and 77 (lamin A siRNA) cells pooled from 3 independent experiments. Statistical 
significance was calculated using a paired Student's t test (control vs treatment).  
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Figure 3.23: The effect of in-vitro ageing on VSMC scratch closure. Proliferative, 
presenescent and senescent 35F VSMCs were seeded onto a 24-well plate and cultured until 
confluent before being scratched with a pipette tip. Time-lapse microscopy was used to capture 
VSMC migration into the scratch area. (A) Representative phase-contrast images compare 
scratch closure at 0 and 16 h post-scratch. (B) Images were processed and analysed using 
Image J to reveal the efficiency of scratch closure.. Data are based on the analysis of 10-20 
time-lapse movies per group pooled from 3 independent experiments. Statistical significance 
was determined using ANOVA to show global differences between the VSMC growth stages (p 
= 0.0159), followed by a Tukey’s multiple comparison test.  
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Figure 3.24: The effect of nuclear lamina disruption on VSMC scratch closure. Control, 
FACE-1 and lamin A siRNA-treated 35F VSMCs were seeded onto a 24-well plate and cultured 
until confluent before being scratched with a pipette tip. Time-lapse microscopy was used to 
capture VSMC migration into the scratch area. (A) Representative phase-contrast images 
compare scratch closure at 0 and 16 h post-scratch. (B) Images were processed and analysed 
using Image J to reveal the efficiency of scratch closure. Data are based on the analysis of 15-
19 time-lapse movies per group pooled from 3 independent experiments. Statistical significance 
was determined using a paired Student's t test.  
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Figure 3.25: The impact of ageing on VSMC chemotaxis. VSMCs (35F) at all 3 stages of 
growth (proliferative, presenescent, senescent) were seeded on to individual coverslips and 
incubated in low serum (2% FBS) medium overnight. Cell migration towards high serum (20% 
FBS) medium was assayed using Dunn chemotaxis chambers and captured using time-lapse 
microscopy over 16 h. Each segment of the Rose plot (circular histograms) represents the total 
number of cells with an average angle of migration falling within that particular interval. The 
Rayleigh test for unimodal clustering determined directional migration. The red arrow indicates 
the mean migration angle and the 95% confidence interval is highlighted in green. The data 
presented are based on >80 VSMCs tracked per group and pooled from 2-4 independent 
experiments.  
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Figure 3.26: VSMC ageing is associated with a loss of Rho GTPases. VSMCs (35F) were cultured 
in-vitro and both proliferative (P) and presenescent (PS) cells were subjected to Western blot analysis 
to assess Rho GTPase levels, including Rac1, Rac2 and RhoA. FACE-1 was used as presenescence 
marker and vinculin and β-actin indicated equal protein loading (20 µg of each protein lysate was 
loaded). This experiment was performed in triplicate. Rac2 is known to be expressed in VSMCs,
251
 
 
  
105 
 
 
 
 
 
 
 
 
Figure 3.27: Aged VSMCs exhibit reduced Rac1 activity. VSMCs (35F) were passaged in-
vitro and both proliferative and presenescent VSMCs were lysed for a GST pull-down assay 
with the GST-PAK1-PBD (p21-binding domain), which specifically precipitates Rac1 in its GTP-
bound form. (A) Western blot analysis revealed Rac1 activity in presenescent 35F VSMCs 
compared with proliferative 35F VSMCs (right panel). The left panel represents total Rac1 from 
whole cell lysates. (B) Bar graph representing the fold change in Rac1 activity between 
proliferative and presenescent VSMCs from 3 independent experiments. Statistical significance 
was calculated using a paired Student's t test. 
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Figure 3.28: Nuclear lamina disruption hinders Rac1 activity in VSMCs. VSMCs were 
treated with control, FACE-1 and lamin A siRNA for 72 h before being lysed for a GST pull-
down assay with the GST-PAK1-PBD (p21-binding domain), which specifically precipitates 
Rac1 in its GTP-bound form. (A) Western blot analysis revealed a significant reduction in Rac1 
activity (GST-Rac1) in FACE-1 and lamin A depleted VSMCs when compared with control cells 
(right panel). The left panel represents total Rac1 from whole cell lysates (n=3). (B) The bar 
graph represents the fold change in Rac1 activity from 3 independent experiments. Statistical 
significance was calculated using a paired Student's t test. 
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Figure 3.29: ROCK inhibition affects VSMC migration. Time-lapse microscopy recorded the 
migration of Y-27632 (10 µM) treated and untreated (control) 35F VSMCs for 16 h and 
individual cells were tracked using Image J software. Mathematica analysed the (A) velocity and 
(B) persistence of VSMC migration in the presence and absence of ROCK inhibitor. Data 
presented are based on >80 VSMCs tracked per group pooled from 3 independent experiments. 
Statistical significance was calculated using a paired Student's t test (control vs treatment).  
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Figure 3.30: RhoA knockdown enhances fibroblast migration speed. MRC-5 fibroblasts 
were treated with control, Rac1 and RhoA siRNA for 72 h prior to experimentation. (A & B) 
Western blot shows Rac1 and RhoA levels. Coomassie indicates equal protein loading (20 µg of 
each protein lysate was loaded). Time-lapse microscopy captured images of random cell 
migration every 10 min for 20 h. Image J  software was used to manually track individual cells 
and Mathematica software plotted x-y coordinates to provide an overlay of migratory tracks and 
analysed (D) cell migration speed and (E) migratory persistence. Data are based on the 
analysis of 69 (control), 82 (Rac1 siRNA) and 82 (RhoA siRNA) cells pooled from 3 independent 
experiments. Statistical significance was calculated using a paired Student's t test (control vs 
treatment).  
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3.4 Discussion 
 
It is well-documented that prelamin A accumulates at the NE of VSMCs during 
ageing, leading to nuclear morphology defects.204 However, the specific outcome of 
prelamin A accumulation upon cell function has not yet been extensively reviewed. To 
better our understanding of prelamin A as a as a driving force of VSMC ageing, this 
chapter extends on previous findings to characterise the impact of prelamin A upon 
general cell morphology, focal adhesion organisation and cell migration.  
 
3.4.1 Characterising the morphological changes associated with VSMC 
ageing 
During ageing it is normal for cells to undergo morphological changes. As the 
actin cytoskeleton defines cell structure and shape, it is heavily implicated in the 
morphological changes associated with ageing.23 Furthermore, previous studies 
demonstrate that cytoskeletal networks are disrupted in cells derived from older 
patients emphasising that F-actin alterations are an important aspect of the ageing 
process.252 In our work, presenescent VSMCs were elongated, with a spindle-like 
appearance and much larger than proliferative predecessors. This supports previous 
work illustrating that VSMCs from older donors have a large, flattened appearance 
compared with those derived from younger patients.204 Also, VSMCs from 
atherosclerotic plaques are enlarged and flattened with a stellar shape compared with 
those from normal arteries.13 We were able to replicate this spindle-like morphology in 
young VSMCs and MRC-5 fibroblasts by silencing FACE-1 with siRNA, suggesting that 
subsequent prelamin A accumulation at the NE is responsible for driving cytoskeletal 
reorganisation. This is potentially mediated by the LINC complex which tethers actin 
filaments via nesprins-1/2 to the nucleus.147 As the actin cytoskeleton regulates 
numerous cellular processes including contractility, motility and proliferation, age-
related alterations to cytoskeletal structure may be detrimental to general VSMC 
functioning and cell fate.253, 254  
 
3.4.2 Aged-related changes to focal adhesion formation 
Actin filaments are indirectly connected to the ECM via interactions with focal 
adhesion proteins at the cell membrane.147 Therefore, focal adhesions form important 
bidirectional signalling hubs between the cell interior and its external environment.44 
Our data illustrate that in-vitro VSMC ageing and prelamin A accumulation in both 
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VSMCs and MRC-5 fibroblasts is associated with a loss of focal adhesions per cell. In 
addition, the few remaining focal adhesions are more circular and primarily distributed 
at the cell periphery. This focal adhesion phenotype reflects that of motile cells, as focal 
adhesion number is inversely proportional to cell migration.248 Previous evidence 
shows that an overabundance of focal adhesions correlates with reduced fibroblast 
motility.255 Large focal adhesions form stable connections between the cell and ECM 
consequently inhibiting cell movement, whereas smaller and rounder adhesions are 
characteristic of faster migrating cells as they are rapidly formed and turned over.47, 48 
Smaller focal adhesions at the cell leading edge also exert stronger propulsive tractions 
and drive more rapid cell migration compared with large and more stable adhesions 
that mainly serve as anchorage points.256 Our IRM data also reveals that focal 
adhesion morphological changes in both in-vitro aged and FACE-1 depleted cells are 
reflected by increased focal adhesion dynamics at the leading edge. Taken together, 
this evidence suggests that the focal adhesion phenotype we describe in these ageing 
models is indicative of more migratory cells. We also demonstrate that nuclear lamina 
disruption, by prelamin A accumulation or lamin A depletion, can impressively drive 
changes as far as the cell membrane. We predict that this mediated by nesprin-
tethered F-actin which strongly supports our hypothesis that focal adhesions provide an 
extension of the LINC complex, creating a mechanically-coupled system between the 
cell membrane, actin cytoskeleton and nucleus. This may form an essential bridge 
between the cell exterior and nuclear interior and supports previous work describing a 
link between integrin signalling at the cell membrane and gene transcription.197 
 
3.4.3 Age-related changes to VSMC migration 
Cell migration is normally dictated by pro and anti-migratory cues from the local 
environment, however, emerging evidence suggests that VSMCs possess an intrinsic 
steering mechanism and can undergo directional migration independently of external 
chemotactic cues.257-260 Collectively, Rho GTPases, polarity signalling machinery, 
integrin trafficking and ECM architecture determine whether a cell exhibits a random 
crawl with repeated changes in direction (low intrinsic directionality) or persistent 
migration in a constant direction (high intrinsic directionality).261-263 In our study, we 
monitored single VSMCs throughout in-vitro passaging to determine the impact of 
ageing on their intrinsic migratory capacity. We detected significant differences in 
migration speed and persistence throughout the 3 distinct VSMC growth stages. 
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Actin cytoskeleton arrangement is a primary indicator of a cells motile capacity; 
cells with shorter actin filaments and a rounded shape migrate poorly compared with 
those possessing long actin filaments and a more polarised shape.264 As previously 
described, cell migration rate is also determined by focal adhesion turnover. Consistent 
with their more rounded morphology and low focal adhesion turnover, time-lapse 
microscopy revealed that single proliferative VSMCs are relatively slow and lack 
migratory persistence. This fits with earlier studies demonstrating that VSMCs are 
slow-moving cells that exhibit random migration patterns and continuously change 
direction.265, 266 Rapid and frequent retraction and reformation of the cell rear stimulates 
directional changes and is associated with less persistent cell migration.267 Therefore, 
future work will assess VSMC trailing-end retraction in finer detail as it is emerging as 
an important determinant of migratory behaviour. Lack of migratory persistence 
suggests that young, healthy VSMCs within the vessel wall are dispersive with an 
explorative nature. Interestingly, we uncovered a migratory switch in VSMCs at the 
presenescent growth stage. Our studies discovered that presenescent VSMCs are 
significantly faster and more persistent than proliferative VSMCs, suggesting that these 
cells migrate more efficiently. Moreover, presenescent VSMCs retain their chemotactic 
ability and display enhanced closure in scratch assays. Ultimately, when VSMCs reach 
their final stage of growth, migration rate slows, cells cannot chemotax and wound 
healing is impaired. The inability of senescent VSMCs to respond to chemotactic cues 
and conduct their migratory functions within the vessel may be detrimental to vascular 
health. 
 
Within the current literature, the impact of ageing upon cell migration remains 
undefined. Previous studies have demonstrated the inability of fibroblasts from old mice 
to complete wound closure when compared with those derived from young mice, 
whereas, VSMCs from old rats have enhanced migration rates compared with VSMCs 
from young rats.220, 268 Although contradictory, the differences in these results may be 
explained by the brief increase in speed associated with presenescent growth prior to 
migration subsiding. Therefore, the specific stage of VSMC growth has to be taken into 
consideration when conducting migration studies.  
 
In support of our notion that cell motility is regulated by the nucleus, we 
demonstrate that nuclear lamina disruption by FACE-1 or lamin A depletion enhances 
fibroblast focal adhesion turnover, migratory velocity and persistence, similarly to 
presenescent VSMCs. This suggests that nuclear lamina adaptations during VSMC 
ageing influence adhesion dynamics and the cells migratory capacity. However, rapid 
focal adhesion turnover in FACE-1 depleted VSMCs was not reflected by migratory 
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speed changes, suggesting that prelamin A accumulation alone does not drive the 
presenescent phenotype observed in in-vitro aged VSMCs. Therefore, alternate age-
related modifications, possibly to other LINC complex components such as SUN and 
nesprin proteins may also define VSMC phenotype. Focal adhesions are signalling 
hubs that regulate actin dynamics and cell migration, Because prelamin A 
accumulation induces focal adhesion reorganisation it cannot be ruled out that 
migratory changes observed are due to these indirect changes in signalling pathways 
associated with focal adhesions. As VSMC ageing is associated with diminished 
desmin levels and heightened tubulin, cellular retinol binding protein-1 (CRBP-1), 
MMP-2 and vascular cell adhesion protein-1 (VCAM-1) expression, these factors may 
also contribute towards morphological and migrational VSMC changes.220, 269-271 
 
3.4.4 Age-related changes to Rho GTPase expression 
The Rho GTPase family of signalling molecules regulate the actin cytoskeleton 
to control cell morphology, motility, polarity and invasion.272, 273 The three main classes 
of GTPases include Rho (A, B & C), Rac (1,2 & 3) and Cdc42, however, RhoA, Rac1 
and Cdc42 are the most widely studied and play several well-characterised roles in 
actin reorganisation during cell migration.274 Interestingly, our study reveals an age-
associated reduction in RhoA and Rac1 expression, coupled with reduced Rac1 
activity.  
 
Rac1 is the most studied of the Rac subfamily and particularly functions in 
lamellipodia formation and focal adhesion assembly at the cell leading edge.263, 275 Our 
study reveals that Rac1 expression and activity is diminished in presenescent and 
nuclear lamina disrupted VSMCs. Earlier studies illustrate that Rac1-deficient mouse 
neutrophils exhibit defects in actin assembly and migration towards chemotactic 
stimuli.276 However, more recent data demonstrate that raised Rac1 expression 
promotes random migration, whereas slightly lowering Rac1 levels by 30-50% 
enhances the migratory persistence of primary human fibroblasts.263 This closely 
supports our work, as low Rac1 expression and activity in in-vitro aged and FACE-1 
depleted VSMCs correlates with significantly increased migratory persistence. This 
evidence led us to believe that Rac1 suppression during ageing enhances VSMC 
persistence, however, subsequent experiments revealed that Rac1 knockdown does 
not influence the migratory behaviour of MRC-5 fibroblasts. This suggests that other 
factors are responsible for driving persistent migration in aged VSMCs. 
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Rho is important for stress fibre formation and regulates the contractile force 
necessary to drive cell movement.253 Rho also mediates focal adhesion formation and 
reduced Rho activity in endothelial cells is associated with the disassembly of focal 
adhesions and actin stress fibres.277 Furthermore, knocking down RhoA hinders 
fibroblast migration and the Rho inhibitor, C3 transferase, causes a loss of stress fibres 
and impedes VSMC cell migration.263, 278, 279 Contrary to this, transient Rho inhibition in 
Swiss 3T3 cells correlates with active cell spreading, an indicative measure of cell 
migration.280 In another study, stationary human VSMCs exhibit increased RhoA 
activity compared with migratory cells, suggesting that cell migration is stimulated by 
Rho deactivation.88 In support, cells lacking FAK, which normally inhibits Rho activity, 
are less migratory.281 In this study, FAK -/- mouse fibroblasts lack Rho inhibition and 
adopt a non-polarised, circular shape with increased focal adhesions across their 
surface. However, FAK+/+ cells have low Rho activity and are elongated with a 
polygonal morphology. Furthermore, focal adhesions were primarily located at the 
edges of FAK+/+ cells and exhibited rapid turnover compared with stable focal 
adhesions in FAK-/- cells. In summary, Rho inhibition promotes focal adhesion 
dynamics and cell migration which replicates the phenotypic changes associated with 
presenescent VSMCs in our studies. This suggests that loss of RhoA expression drives 
VSMC phenotypic switching from contractile to synthetic phenotype and contributes 
towards age-related changes in cell migration. Moreover, we show that RhoA 
knockdown enhances fibroblast migration speed and inhibiting ROCK, a downstream 
effector of RhoA, enhances VSMC migration speed and persistence. A study 
supporting our findings illustrates that human epithelial cell speed and persistence 
increases following ROCK inhibition, most likely through reduced myosin II-mediated 
contractility and increased rear-end stability.267 This study proposes that producing a 
‘drag’ at the cell rear, like a drogue does on a boat, enables cells to control 
directionality.267 This led us to speculate that a loss of RhoA/ROCK activity during 
VSMC presenescent growth reduces cell contractility and stabilises the cell rear to 
drive persistent cell migration, a theory that will be tested in the future. However, 
although migrational velocity was enhanced in RhoA-depleted MRC-5 fibroblasts, no 
change to directional persistence was observed. Other studies also demonstrate that 
the same ROCK inhibitor hinders VSMC migration and RhoA expression/activity is 
enhanced in aged rat arteries.282, 283 Therefore, further work is required to better 
understand the Rho GTPase changes associated with VSMC ageing. It is possible that 
other Rac and Rho genes (Rac2/3 and RhoB/C) contribute towards the intrinsic 
persistence of VSMCs but were not explored in the current study due to time restraints.  
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3.4.5 Chapter 3 conclusions 
This chapter clearly demonstrates that accumulation of the VSMC ageing 
marker, prelamin A, at the NE alters the cellular morphology and migratory behaviour 
of VSMCs and MRC-5 fibroblasts. We hypothesise that nuclear lamina disruptions 
impact upon LINC complex organisation and subsequently drive changes in cell 
morphology, Rho GTPase activity, focal adhesion formation and cell migration. This is 
because the LINC complex creates a physically-coupled system throughout the whole 
cell, allowing nuclear adaptations to be directly transmitted to the actin cytoskeleton 
and actin-regulated processes. Furthermore, actin tension regulates focal adhesion 
formation at the cell membrane, which in turn influences Rho GTPase activity. 
Therefore, we predict that the LINC complex directly and indirectly regulates cell 
motility via mechanical and biochemical pathways, respectively.  
 
 During in-vitro VSMC ageing, cell migration speed and persistence peaks at 
the presenescent growth stage before slowing down when VSMCs become senescent, 
however, the mechanisms behind this migratory switch remain unclear. Healthy 
VSMCs normally undergo phenotypic transformation from a contractile to a migratory 
phenotype in response to vessel damage. Therefore, we speculate that presenescent 
VSMCs exhibit an enhanced migratory phenotype as a protective repair mechanism 
prior to the onset of senescence when VSMC migration and proliferation ceases.  
 
3.4.6 Limitations and future work 
 
3.4.6.1 VSMC isolates 
 The experiments conducted throughout this chapter were performed in triplicate 
mostly using VSMCs derived from a 35 year old female (35Fs). Due to time restraints 
and accessibility to precious stocks of primary VSMCs, the results obtained in the 
current study are limited. In the future, our results will be validated using more VSMC 
isolates. 
 
3.4.6.2 Ageing model 
 Throughout this chapter, FACE-1 siRNA was used to model VSMC ageing by 
artificially accumulating prelamin A in young VSMCs and MRC-5 fibroblasts. However, 
it would be naïve of us to believe that prelamin A alone is causal for the phenotypic 
adaptations associated with VSMC ageing. Our studies illustrate that in-vitro aged 
VSMCs have larger, more elongated nuclei than young VSMCs, which is mirrored by 
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their general cell shape. However, FACE-1 depleted VSMCs exhibit no nuclear size or 
shape changes and become more elongated but not larger. In-vitro aged VSMCs 
migrate faster and more persistently yet FACE-1 depletion only increases migratory 
persistence. Despite our model not completely mimicking an aged VSMC, our study 
specifically focusses on the phenotypic similarities induced by prelamin A accumulation 
such as cellular elongation, enhanced focal adhesion turnover and increased migratory 
persistence. The efficacy of siRNA-mediated knockdown also poses another limitation 
to this work and functional studies in the future will overexpress prelamin A 
(lentiviral/adenoviral) to support our findings.  
 
3.4.6.3 VSMCs vs fibroblasts 
 Our studies highlight inconsistencies in the response of VSMCs and MRC-5 
fibroblasts to prelamin A accumulation. FACE-1 depletion did not impact on VSMC 
size, yet MRC-5 cells became significantly smaller following siRNA treatment. Despite 
both cell types exhibiting similar changes in focal adhesion morphology and turnover, 
fibroblast migration speed and persistence was enhanced in response to FACE-1 
knockdown whereas only slight increases in VSMC persistence were observed. Such 
discrepancies are unsurprising as VSMCs and fibroblasts exhibit differing functional 
roles within tissue. Fibroblasts are slow moving cells, possibly enabling small changes 
in migration to appear more striking against faster-moving VSMCs. Furthermore, we 
speculate that the LINC complex itself may vary between these cell types in its 
composition, stability and adaptability to nuclear lamina changes. This is an interesting 
concept as VSMCs uniquely undergo transient phenotypic switching between a 
contractile and synthetic phenotype which requires continuous cellular remodelling, 
most likely dependent on a malleable LINC complex. On the other hand, fibroblasts 
normally terminally differentiate into myofibroblasts thus reducing their phenotypic 
plasticity. Therefore, fibroblasts provide a cleaner model system enabling the impact of 
nuclear lamina disruption upon cellular morphology and motility to be exaggerated. 
 
3.4.6.4 Migrational model 
The migratory studies conducted throughout this chapter were performed on 2D 
rigid glass/plastic surfaces in-vitro which do not accurately represent a cells natural 
environment. Within tissue, cells are normally exposed to simultaneous pro and anti-
migratory cues and migratory behaviour is governed by numerous extrinsic factors 
including diffusible chemokines (chemotaxis), ECM-bound molecules (haptotaxis) or 
mechanical signals (durotaxis).284 Ultimately, all of these determinants must be 
considered when studying cell migration in order to truly reproduce a physiologically 
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relevant setting. We explored the impact of ageing on intrinsic VSMC migration in-vitro 
but did not consider that in-vivo the vessel wall itself will undergo age-related structural 
and mechanical changes that will influence cell migratory behaviour. Previous studies 
have demonstrated differences in cell morphology, signalling and migration between 
2D and 3D models.285, 286 Therefore, future studies utilising 3D matrices and confocal 
microscopy to monitor cell migration will generate more accurate and reliable results. 
Additionally, aged VSMCs secrete more MMP-2 than those derived from young 
aorta.198 MMPs are regulated by Rho GTPases and enhance migration by degrading 
ECM. Therefore, future work will also assess how VSMC ageing and prelamin A 
accumulation influence MMP expression/activity using gel zymography. 
 
3.4.6.5 The role of LINC complex in mechanotransduction 
To assess the mechanical strength that the LINC complex provides to the cell, 
future studies will assess the mechano-sensitivity of cells following NE disruption by 
applying cyclic strain followed by staining for apoptotic, proliferation and differentiation 
markers. Further work will also investigate how stretch/strain affects the activity of 
known regulators of mechanotransduction including Rho GTPases and the MAPK 
family proteins, ERK1/2, JNK1/2 and p38, using GST-pull down assays and phopsho-
specific antibodies. Atomic force microscopy (AFM) or optical/magnetic tweezers would 
also be useful to measure the mechanical strength of cells and determine whether cells 
are weakened following LINC complex disruption.   
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Chapter 4: The role of the LINC 
complex in regulating cell motility 
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4.1 Introduction  
 
Thus far, the focus of this thesis has been to characterise the impact of the 
VSMC ageing marker, prelamin A, on cell function. We propose that prelamin A 
accumulation at the NE drives cellular changes as a result of disrupting the LINC 
complex. This chapter further investigates the effect of prelamin A on LINC complex 
organisation, in an attempt to better understand its role as a driving force behind VSMC 
ageing. We will also explore the importance of other core LINC complex components, 
including SUN and nesprin proteins, in regulating cell morphology and migration. 
Current literature presents a LINC complex that is conserved in structure and function 
throughout different cell types. This chapter tests whether this holds true as we 
compare the result of LINC complex disruption between VSMCs and MRC-5 
fibroblasts.  
 
4.2 Aim of this chapter 
 This chapter will perform subcellular fractionations and Western blot analysis to 
specifically determine the impact of VSMC ageing and prelamin A accumulation on 
individual LINC complex components. We will also explore the role of SUN and 
nesprins in regulating cell morphology and migration using an siRNA-mediated 
approach to target these proteins. FRAP will study nesprin-2 mobility/dynamics 
following nuclear lamina disruption in U2OS cells. 
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4.3 Results 
 
4.3.1 VSMC ageing alters LINC complex organisation 
 Firstly, we investigated the impact of in-vitro ageing and prelamin A 
accumulation upon the VSMC LINC complex. Western blot analysis compared 
proliferative and presenescent whole VSMC lysates and demonstrated an 
accumulation of prelamin A in the latter. This inversely correlated with SUN2 
expression with SUN2 levels diminishing in presenescent cells compared with 
proliferative cells (Figure 4.1A). Nesprin-2 and lamin A/C remained unchanged 
between proliferative and presenescent growth stages. This experiment was repeated 
using FACE-1 siRNA and aside from increased prelamin A in FACE-1 depleted 
VSMCs, all other LINC complex proteins remained unchanged (Figure 4.1B).  
 
To further explore the effect of VSMC ageing on LINC complex organisation, 
subcellular fractionations were performed on early-passage and presenescent VSMCs. 
Western blotting confirmed that prelamin A accumulated in the nuclear insoluble 
fraction of presenescent VSMCs (nuclear insoluble fractions contain the NE, nuclear 
lamina and ER as these are contiguous structures). This corresponded with increased 
nesprin-2 isoforms and reduced lamin A/C within the same fraction whilst emerin and 
coomassie loading levels remained unchanged (Figure 4.2A). Immunofluorescence 
microscopy also revealed that nesprin-2, although distributed between the NE and ER 
of proliferative VSMCs, appeared stabilised at the NE and absent from the ER of 
presenescent VSMCs (Figure 4.2B). These collective data reveal that ageing impinges 
on nuclear morphology and LINC complex organisation. 
 
4.3.2 Prelamin A accumulation disrupts LINC complex organisation  
To specifically establish the impact of prelamin A upon LINC complex 
organisation, FACE-1 knockdown was performed in VSMCs prior to subcellular 
fractionation. Western blotting confirmed that FACE-1 depletion was successful as 
prelamin A accumulated within the nuclear insoluble fraction. Nesprin-2 isoforms and 
lamin A/C levels also accumulated within this fraction whereas emerin, SUN2 and 
coomassie staining remained unchanged (Figure 4.3). This suggests that prelamin A 
may be important for stabilising LINC complex components at the NE. Unexpectedly, 
lamin A also accumulated in the nuclear insoluble fraction which suggests that lamin A 
is also more stable at the NE in the presence of prelamin A. This finding is difficult to 
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explain but only highlights the complexity of the LINC complex further. In addition, the 
control sample in this experiment appears to be different from that in the previous 
experiment (Figure 4,2). This change can be explained by the different conditions in 
each experiment prior to fractionation including the presence of Hiperfect and siRNA in 
the cellular samples.  
 
Furthermore, immunofluorescence microscopy revealed that nesprin-2 was lost 
from the NE and accumulated at the ER in 46.07 ± 3.679% FACE-1 depleted cells 
(Figure 4.4B & D) whereas nesprin-2 localised at the NE and ER of 78.17 ± 3.940% 
control cells (Figure 4.4A & D). Lamin A siRNA was also used as a positive control 
and nesprin-2 mislocalised to the ER in 77.87 ± 7.806% lamin A depleted VSMCs 
(Figure 4.4C & D), suggesting that prelamin A accumulation at the NE severs the 
connection between the nuclear lamina and nesprins on the ONM. 
 
In addition, subcellular fractionations of control and FACE-1 siRNA treated 
fibroblasts confirmed that prelamin A accumulated in the nuclear insoluble fraction of 
FACE-1 depleted fibroblasts (Figure 4.5) to mimic FACE-1 depleted and in-vitro aged 
VSMCs. This correlated with increased nesprin-2 and lamin A/C levels in the same 
fraction, whereas emerin and coomassie levels were unchanged. This evidence 
supports VSMC data and further suggests that prelamin A accumulation at the NE 
effects LINC complex organisation.  
 
4.3.3 SUN2 is an important regulator of cell morphology and migration 
 Our data reveal that SUN2 levels were diminished during in-vitro VSMC ageing 
(Figure 4.1A) which encouraged us to further explore the role of SUN proteins as 
regulators of cell morphology and migration. siRNA was used to target SUN1, SUN2 
and both proteins together (SUN1/2). Western blotting confirmed SUN2 knockdown in 
VSMCs but we were unsuccessful in identifying an antibody to detect SUN1 (Figure 
4.6A). SUN1 and SUN2 depletion had no impact on nesprin-2 protein levels (Figure 
4.6A) and immunofluorescence microscopy confirmed that nesprin-2 localisation at the 
NE was retained in these cells to reflect control VSMCs (Figure 4.6B).  
 
To establish whether SUN disruption was responsible for driving the in-vitro 
aged VSMC phenotype described in chapter 3, we determined the importance of 
SUN1/2 proteins in regulating VSMC morphology. Immunofluorescence microscopy 
captured images of F-actin stained VSMCs following siRNA treatment (Figure 4.7A). 
121 
 
Both SUN1 and SUN2 depleted VSMCs were significantly smaller (Figure 4.7B) with 
no change to circularity (Figure 4.7C). Nuclear staining with DAPI mirrored the 
cytoskeletal changes (Figure 4.7D & E). Following SUN1 and SUN2 knockdown, 
VSMCs underwent 16 hours of time-lapse microscopy and random single cell migration 
was tracked using Image J software (Figure 4.8A). Mathematica software analysed 
VSMC migration to reveal that SUN1 depletion (0.196 ± 0.008 µm/min) did not affect 
cell migration when compared with control cells (0.196 ± 0.007 µm/min), whereas, 
SUN2 depletion (0.241 ± 0.010 µm/min) significantly enhanced VSMC velocity (Figure 
4.8B). No change to migratory persistence was detected between control (0.501 ± 
0.023), SUN1 (0.477 ± 0.028), or SUN2 (0.044 ± 0.026) siRNA-treated VSMCs (Figure 
4.8C). 
 
Fibroblasts were also treated with SUN1 and SUN2 siRNA and knockdown was 
confirmed using Western blot analysis (Figure 4.9A & B). Staining F-actin with 
rhodamine phalloidin followed by immunofluorescence microscopy revealed that, 
similarly to VSMCs, SUN1 and SUN2 knockdown reduced cell area but only SUN2 
significantly (Figure 4.9C & D). Both SUN1 and SUN2 depletion significantly reduced 
fibroblast circularity (Figure 4.9C & E). Furthermore, time-lapse microscopy revealed 
that migration speed significantly increased in both SUN1 (0.097 ± 0.013 µm/min) and 
SUN2 (0.125 ± 0.012 µm/min) siRNA-treated fibroblasts compared with control cells 
(0.065 ± 0.004 µm/min) (Figure 4.10A). However, no change to migratory persistence 
was detected following SUN1 or 2 knockdown (Figure 4.10B). Therefore, both VSMC 
and fibroblast data strongly implicate SUN proteins as key determinants of cell 
morphology and migrational velocity. 
 
4.3.4: Nesprin knockdown differentially effects VSMC and fibroblast speed  
 Nesprins mediate an essential link between the nucleus and cell cytoskeleton, 
play a key role in maintaining cell structure and are believed to be important regulators 
of cell motility.151 After studying the effects of nuclear lamina and SUN protein 
disruption upon cellular morphology and migration, we next progressed to target 
nesprins on the ONM using an siRNA-mediated approach. Nesprin-1 and nesprin-2 
mRNA depletion in VSMCs by 63.42 ± 9.587% and 66.85 ± 9.801%, respectively was 
confirmed using qPCR (Figure 4.11A & B). Time-lapse microscopy captured random 
VSMC migration over 16 hours and Image J software was used to manually track 
individual cells (Figure 4.11C). Subsequent analysis using Mathematica software 
revealed that both nesprin-1 (0.147 ± 0.006 µm/min) and nesprin-2 (0.117 ± 0.005 
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µm/min) depleted VSMCs were significantly slower than control (0.172 ± 0.007 µm/min) 
VSMCs (Figure 4.11D). No change to persistence was detected between control 
(0.615 ± 0.016), nesprin-1 (0.636 ± 0.020) and nesprin-2 (0.594 ± 0.020) siRNA-treated 
VSMCs (Figure 4.11E). This evidence suggests that nesprins are essential LINC 
complex components in VSMCs and without nesprins bridging F-actin to the nucleus, 
cell migration is significantly impaired.  
 
 The above experiment was repeated in MRC-5 fibroblasts and nesprin-1/2 
knockdown was initially confirmed in these cells by Western blot analysis (Figure 
4.12A & B). Time-lapse microscopy revealed that both nesprin-1 (0.075 ± 0.005 
µm/min) and nesprin-2 (0.086 ± 0.006 µm/min) depleted fibroblasts migrated faster, but 
only nesprin-2 to a significant extent, compared with control cells (0.065 ± 0.004 
µm/min (Figure 4.12C). No change to migrational persistence was detected (Figure 
4.12D). Therefore, nesprins differentially regulate the migratory capacity of VSMCs and 
MRC-5 fibroblasts. 
   
4.3.5 Nesprin-2 dynamics at the NE following LINC complex disruption 
 Based on our findings, we speculate that NE changes influence cell motility via 
nesprin-tethered F-actin. To better understand the importance of nesprin as a LINC 
complex component, we next studied nesprin-2 dynamics at the NE. Initially, GFP-
fused nespin-2 was expressed in U2OS cells. As the nesprin-2 giant is so large (6874 
amino acids), we used a shorter artificial construct, GFP-mini-nesprin-2 giant (GFP-
mini-N2G) containing an N-terminal actin-binding CH region, 2 adjacent spectrin 
repeats and C-terminal KASH domain (Figure 4.13A). Despite lacking all of the 
spectrin repeats known to exist within the nesprin-2 giant, this construct specifically 
localises to the ONM where it retains interactions with F-actin and SUN proteins.163 
GFP-mini-N2G was transfected into U2OS cells where it localised to the NE in low 
expressing cells and both the NE and cytoplasm when highly expressed (Figure 4.13 
B & C). FRAP revealed that nesprin-2 was relatively immobile at the NE and was 
extremely mobile in cytoplasm (Figure 4.14A & B). Only low expressing cells with NE 
staining alone were used to analyse nesprin-2 mobility throughout FRAP experiments 
and high expressers were used to standardise recovery curves.  
 
To determine the impact of LINC complex disruption upon nesprin-2 mobility, 
siRNA was used to knock down FACE-1, lamin A, SUN1 and SUN2 in U2OS cells co-
transfected with GFP-mini-N2G. This construct localised primarily to the NE of lamin A 
123 
 
and FACE-1 depleted U2OS cells (Figure 4.15A). However, GFP-mini-N2G localised 
to the NE and cytoplasm of SUN1 and SUN2 depleted U2OS cells (Figure 4.15B). 
Therefore, these cells could not be used in FRAP experiments as diffusion from the 
cytoplasm would provide an inaccurate account of nesprin-2 mobility at the NE.  
 
FRAP studies revealed that control (27.27 ± 2.75%), FACE-1 (28.87 ± 2.01%) 
and lamin A (26.89 ± 3.23%) siRNA-treated U2OS cells had similar nesprin-2 recovery 
rates after photobleaching the NE (Figure 4.16A & B). These data demonstrate that 
nuclear lamina disruption did not impact on the diffusional mobility of nesprin-2 at the 
NE, which was relatively low. FRAP data was further analysed to determine the binding 
rate kinetics of GFP-mini-N2G following nuclear lamina disruption. Interestingly, the 
association (Kon) and dissociation (Koff) of nesprin-2 was significantly higher (1.6 and 
1.7-fold increase, respectively) in lamin A depleted U2OS cells. This suggests that 
lamin A knockdown can potentially reduce the binding affinity of nesprin-2 to the ONM. 
Although there seemed to be an upwards trend, FACE-1 knockdown did not 
significantly affect nesprin-2 dynamics at the ONM (Figure 4.17A & B).  
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Figure 4.1: The impact of in-vitro ageing and prelamin A accumulation upon the LINC 
complex. (A) Proliferative (P) and presenescent (PS) and (B) control and FACE-1 treated 35F 
VSMC lysates were subjected to Western blot analysis to compare prelamin A, nesprin-2, SUN2 
and lamin A/C protein levels. Western blots are representative of 3 independent experiments. β-
actin and coomassie stain indicated equal sample loading (20 µg of each protein lysate was 
loaded).  
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Figure 4.2: Nesprin-2 localises to the NE of aged VSMCs. (A) Subcellular fractionation was 
performed on presenescent (PS) and proliferative (P) 35F VSMCs. Western blotting determined 
levels of prelamin A, nesprin-2 and lamin A/C. Emerin and coomassie stain indicated equal 
loading (20 µg of each protein lysate was loaded).. (B) Immunofluorescence images showing 
nesprin-2 (green) localisation in early-passage and presenescent 35F VSMCs. DAPI (blue) 
stained VSMC nuclei. Scale bar represents 10 μm. All images are representative of 3 
independent experiments. 
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Figure 4.3: FACE-1 knockdown affects nesprin-2 solubility at the NE. Subcellular 
fractionation was performed on control and FACE-1 siRNA treated 35F VSMCs.. Western 
blotting determined levels of prelamin A, nesprin-2 and lamin A/C.. . Emerin and coomassie 
stain indicated equal loading (20 µg of each protein lysate was loaded)..Blots are representative 
of 3 independent experiments. 
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Figure 4.4: Prelamin A accumulation mislocalises nesprin-2 from the NE. Representative 
immunofluorescence images showing nesprin-2 (green) localisation in (A) control (B) FACE-1 
and (C) lamin A siRNA treated 35F VSMCs. DAPI (blue) stains VSMC nuclei. Scale bar 
represents 35 μm. Far right panel displays higher magnification images of individual VSMC 
nuclei. (D) The number of cells containing nesprin-2 primarily at the NE were counted. Data are 
based on >300 cells counted across 3 independent experiments. Statistical significance was 
calculated using a paired Student's t test (control vs treatment).  
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Figure 4.5: FACE-1 knockdown and prelamin A accumulation at the nuclear envelope is 
associated with LINC complex stabilisation. MRC-5 fibroblasts were treated with control and 
FACE-1 siRNA for 72 h. Subcellular fractionation was performed on control and FACE-1 siRNA 
treated fibroblasts. Western blotting determined levels of prelamin A, nesprin-2 and lamin A/C. 
Emerin and coomassie stain indicated equal loading (20 µg of each protein lysate was loaded). 
Blots are representative of 3 independent experiments.  
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Figure 4.6: The impact ofSUN1/2 knockdown on nesprin-2 localisation in VSMCs. (A) Western 
blot analysis of SUN2 and nesprin-2 levels following the treatment of 35F VSMCs with control, SUN1, 
SUN1/2 and SUN2 siRNA. Vinculin and coomassie stain indicate equal protein loading (20 µg of each 
protein lysate was loaded). (B) Representative immunofluorescence images illustrating nesprin-2 
(green) localisation in SUN1 and SUN2 depleted VSMCs. Scale bars represent 34 μm. Lower panel 
displays these images at a higher magnification (x5 magnification). Images are representative of 3 
independent experiments. 
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Figure 4.7: SUN1/2 knockdown drives VSMC morphological changes. Representative 
immunofluorescence images showing 35F VSMCs treated with control, SUN1 and SUN2 
siRNA. (A) Actin filaments (F-actin) were stained using rhodamine phalloidin (red) and DAPI 
(blue) stained VSMC nuclei. Scale bar represents 60 μm. Volocity software was used to 
measure (B) cell area, (C) cell circularity, (D) nuclear area and (E) nuclear circularity in all 3 
treatment groups. Data are based on the measurement of 50-100 VSMCs pooled from 3 
independent experiments. Statistical significance was calculated using a paired Student's t test 
(control vs treatment).  
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Figure 4.8: SUN2 depletion increases VSMC migration speed. Time-lapse microscopy was 
used to capture random single cell migration of control, SUN1 and SUN2 siRNA treated 
VSMCs. Images were captured every 5 min for 16 h and Mathematica software plotted x-y 
coordinates to provide (A) an overlay of individual cell tracks and analysed (B) migratory 
velocity and (C) persistence. Data are based on the analysis of 121 (control), 84 (SUN1 siRNA) 
and 87 (SUN2 siRNA) individually tracked cells pooled from 3 independent experiments. 
Statistical significance was calculated using a paired Student's t test (control vs treatment).  
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Figure 4.9: SUN knockdown drives actin morphology changes. MRC-5 fibroblasts were 
treated with control, SUN1 and SUN2 siRNA for 72 h prior to experimentation. Western blot 
analysis indicated successful (A) SUN1 and (B) SUN2 knockdown. β-actin indicates equal 
protein loading (20 µg of each protein lysate was loaded). (C) Representative 
immunofluorescence images of F-actin stained fibroblasts with rhodamine phalloidin (red). DAPI 
(blue) stained nuclei. Scale bar represents 30 μm. Volocity software was used to measure (D) 
cell area and (E) cell circularity in both SUN1 and SUN2 depleted fibroblasts compared with 
control cells. Data are based on the measurement of >100 MRC-5 fibroblasts pooled from 3 
independent experiments. Statistical significance was calculated using a paired Student's t test 
(control vs treatment). 
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Figure 4.10: SUN knockdown increases fibroblast migration speed. MRC-5 fibroblasts were 
treated with control, SUN1 and SUN2 siRNA for 72 h prior to experimentation. Images were 
captured every 5 min for 16 h and Mathematica software plotted x-y coordinates to provide (A) 
an overlay of individual cell tracks and analysed (B) migratory velocity and (C) persistence.. 
Data are based on the analysis of 72 (control siRNA) and 47 (SUN1 siRNA) and 67 (SUN2 
siRNA) cells pooled from 3 independent experiments. Statistical significance was calculated 
using a paired Student's t test (control vs treatment).  
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Figure 4.11: Nesprin depletion hinders VSMC migration. VSMCs (35F) were treated with 
control, nesprin-1 and nesprin-2 siRNA for 72 h prior to experimentation. qPCR analysis 
indicated successful (A) nesprin-1 and (B) nesprin-2 knockdown. Time-lapse microscopy 
captured images of random cell every 5 min for 16 h and Mathematica software plotted x-y 
coordinates to provide (C) an overlay of individual cell tracks and analysed (D) migratory 
velocity and (E) persistence. Data are based on the analysis of 106 (control) and 77 (nesprin-1 
& 2 siRNA) individually tracked cells pooled from 3 independent experiments. Statistical 
significance was calculated using a paired Student's t test (control vs treatment).  
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Figure 4.12: Nesprin-2 knockdown increases fibroblast migration speed. MRC-5 
fibroblasts were treated with control, nesprin-1 and nesprin-2 siRNA for 72 h prior to 
experimentation. (A & B) Western blot analysis shows nesprin-1 and nesprin-2 levels. 
Coomassie and β-actin indicate equal protein loading, respectively (20 µg of each protein lysate 
was loaded). (C) Time-lapse microscopy captured images of random cell every 5 min for 16 h 
and Mathematica software plotted x-y coordinates to provide (C) an overlay of individual cell 
tracks and analysed (D) migratory velocity and (E) persistence. Data are based on the analysis 
of 72 (control siRNA), 54 (nesprin-1 siRNA) and 71 (nesprin-2 siRNA) cells pooled from 3 
independent experiments. Statistical significance was calculated using a paired Student's t test 
(control vs treatment).  
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Figure 4.13: GFP-nesprin-2 expression in U2OS cells. (A) A schematic representation of 
GFP-mini-nesprin-2 giant (GFP-mini-N2G). GFP fuses the N-terminal actin-binding calponin 
homology (CH) which binds 2 spectrin repeats and a C-terminal NE-targeting KASH domain. 
U2OS cells were transfected with GFP-mini-N2G and FRAP was performed to determine the 
recovery of nesprin-2 following photobleaching at (B) the NE of low expressing cells and (C) the 
cytoplasm of high expressing U2OS cells. Arrows indicate the bleached ROI. FRAP 
experiments were performed with the assistance of Daniel Soong, King’s College London.  
137 
 
 
 
Figure 4.14: GFP-nesprin-2 mobility is low at the NE of U2OS cells.  U2OS cells were 
treated with control, FACE-1 or lamin A siRNA and co-transfected with GFP-mini-nesprin-2 giant 
(GFP-mini-N2G) before FRAP experiments were performed. Typical profiles of GFP-mini-N2G 
recovery after photobleaching (A) the NE and (B) the cytoplasm of control, FACE-1 and lamin A 
siRNA treated U2OS cells. The x-axis represents the time scale (sec) and the y-axis is mobile 
fraction. The immobile fraction is highlighted by red arrows. Normalised fluorescence of 1 is the 
level before bleaching and bleaching occurred at 20 sec. FRAP experiments were performed 
with the assistance of Daniel Soong, King’s College London. 
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Figure 4.15: GFP-nesprin-2 expression in U2OS cells following LINC complex disruption. 
U2OS cells were treated with (A) control, FACE, lamin A siRNA and (B) control, SUN1, SUN2 
siRNA before being co-transfected with GFP-mini-nesprin-2 giant (GFP-mini-N2G). 
Representative immunofluorescent images demonstrate nesprin-2 localisation to the NE in 
these cells. Arrows indicate nesprin-2 mislocalisation to the ER in SUN1 and 2 depleted U2OS 
cells. Scale bars represent 10 µm. Intranuclear staining represents invagination of the NE in 
different focal planes. FRAP experiments were performed with the assistance of Daniel Soong, 
King’s College London. 
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Figure 4.16: GFP-nesprin-2 mobility at the NE is not affected by nuclear lamina 
disruption. U2OS cells were treated with control, FACE-1 or lamin A siRNA and co-transfected 
with GFP-mini-nesprin-2 giant (GFP-mini-N2G) before FRAP experiments were performed. (A) 
Normalised average rate plot. (B) Mobile fraction of GFP-mini-N2G following photobleaching at 
the NE of siRNA-treated U2OS cells. Data represent the analysis of 17-20 cells pooled from 4-5 
independent experiments.  FRAP experiments were performed with the assistance of Daniel 
Soong, King’s College London. 
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Figure 4.17: GFP-nesprin-2G is more dynamic following lamin A knockdown. U2OS cells 
were treated with control, FACE-1, lamin A siRNA and co-transfected with GFP-mini-nesprin-2 
giant (GFP-mini-N2G) prior to FRAP experiments. (A) Association (K
on
) and (B) dissociation 
(K
off
) rates of GFP-mini-N2G at the NE. Data represent the analysis of 17-20 cells pooled from 
4-5 independent experiments. An unpaired Student’s t test was used for statistical analysis. 
FRAP experiments were performed with the assistance of Daniel Soong, King’s College 
London. 
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4.4 Discussion 
 
This chapter further explored the relationship between LINC complex 
composition, cellular morphology and migratory behaviour. We also determined 
whether the role of individual LINC complex components was conserved across 
different cell types. To achieve this, we investigated the outcome of LINC complex 
disruption in VSMCs, MRC-5 fibroblasts and U2OS cells. This work provides strength 
to earlier findings described in chapter 3 to reveal that the LINC complex is an 
important regulator of cell morphology, focal adhesion organisation and cell migration 
which undergoes reorganisation at the NE during VSMC ageing. 
 
4.4.1 SUN proteins regulate cellular morphology and migratory behaviour 
SUN1/2 proteins are crucial LINC complex constituents as clearly indicated by 
the dramatic lethality of double knockout SUN1 & 2 mice.287 SUN1/2 located within the 
PNS form an integral nuclear-cytoplasmic connection between nesprins located at the 
ONM and the nuclear lamina.165 In this chapter, we uncover a striking age-related 
reduction in VSMC SUN2 expression. This reinforces previous work demonstrating that 
SUN2 is downregulated in fibroblasts during in-vitro passaging and both SUN1/2 are 
diminished in HGPS fibroblasts.157, 162 Furthermore, EDMD patients harbour mutations 
in the SUN1/2 gene and mutant SUN1/2 expression in a human keratinocyte cell line 
disrupts cell adhesion, migration and nuclear shape.162 This encouraged us to further 
study the LINC complex and the importance of SUN proteins in regulating migratory 
behaviour. We illustrate that silencing SUN1 and SUN2 significantly reduces VSMC 
size. However, we predict that VSMCs possess little SUN1 as antibodies failed to 
detect SUN1 in these cells. In addition, SUN2, but not SUN1, depletion significantly 
enhances VSMC migration speed to reflect that of in-vitro aged VSMCs.  
 
Both SUN1 and SUN2 depleted fibroblasts are smaller, more elongated and 
migrate faster than control cells. Although SUN1 and SUN2 are detectable in MRC-5 
fibroblasts, SUN2 is more abundant. Overall, SUN2 depletion has the most dramatic 
impact on fibroblast and VSMC phenotype, implicating SUN2 as the more important 
LINC complex component and regulator of cell migration. In support of this theory, 
studies show that SUN2 depletion increases nesprin-2 mobility at the NE, whereas 
SUN1 knockdown has no impact.163 This study speculates that SUN2, but not SUN1, is 
involved in anchoring nesprin-2 to the ONM and bridging the nuclear exterior and 
interior. 
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4.4.2 Nesprins regulate cell migratory speed 
 After observing the cellular changes associated with nuclear lamina and SUN 
protein disruption, we finally progressed to the ONM and targeted nesprins-1/2 using 
siRNA. It is well-established that nesprin-1/2 CH domains at the ONM tether F-actin to 
the cytoplasmic face of the nucleus and play an important role in regulating actin 
cytoskeleton organisation.147, 151 Previous studies demonstrate that a nesprin-2 
construct lacking CH is unable to rescue nuclear movement in nesprin-2 depleted cells, 
highlighting that nesprin-actin interactions are critical for nuclear orientation, cell 
polarity and cell migration.288 Our results reinforce this, as we also found VSMC 
migration to be hindered following nesprin-1/2 depletion. We predict that F-actin 
uncoupling from the nucleus in these cells prevents the actin reorganisation necessary 
to drive forwards cell movement. This supports previous data demonstrating that 
fibroblasts lacking nesprin-2 have impaired cell polarity and migration into a wound.289  
 
In contrast, we show that nesprin-2 knockdown significantly enhances MRC-5 
fibroblast speed, whereas nesprin-1 has no impact, suggesting that differences lie in 
LINC complex organisation between these cell types. Furthermore, the diversity of 
nesprin splice variants could also be producing very different outcomes on cell motility 
between different cell types. In support of this theory, SUN trimers are able to interact 
with varying nesprin isoforms to create flexible KASH-SUN assemblies at the NE which 
could enhance LINC complex versatility across different cell types.152, 156 Nevertheless, 
nesprin-2 depletion induces the most dramatic phenotypic change to fibroblasts and 
VSMCs compared with nesprin-1. Therefore, although the precise function of nesprins 
in regulating cell migration is not fully understood, nesprin-2 appears to be the most 
important. 
 
4.4.3 Nuclear lamina disruption affects nesprin-2 dynamics at the ONM 
FRAP studies enabled us to explore the importance of the nuclear lamina in 
regulating nesprin-2 mobility and dynamics at the ONM. Several studies have 
demonstrated A-type lamins to be essential for nesprin localisation, hence, lamin A/C 
alterations mislocalise nesprin from the NE to the ER.154, 290, 291 We also show that 
nesprin-2 is displaced from the ONM of nuclear lamina disrupted VSMCs following 
FACE-1 or lamin A depletion. However, we found that nuclear lamina disrupted U2OS 
cells retain nesprin-2 at the ONM. In fact, we show that both SUN1 and SUN2 are 
required to tether nesprin-2 in U2OS cells whereas individual SUN1/2 proteins support 
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nesprin-2 localisation to the ONM in VSMCs. Again, this evidence reiterates that LINC 
complex organisation and stability varies between cell types.  
 
Interestingly, our FRAP data illustrates that although nesprin-2 localisation and 
mobility at ONM was unchanged in U2OS cells, its dynamicity was enhanced following 
lamin A knockdown. This suggests that lamin A is responsible for indirectly maintaining 
nesprin-2 stability at the ONM, which is most likely mediated via SUN interactions. A 
more recent study supporting our data reveals that the absence of lamin A does not 
affect nesprin-2-SUN2 assemblies but makes the LINC complex more unstable and 
increases the mobile fraction of cytoplasmic actin.292 Therefore, we predict that nuclear 
lamina disruptions weaken the LINC complex across the NE, consequently increasing 
nesprin-2 dynamics, F-actin turnover, cytoskeletal remodelling and cell motility. 
Conversely, similar FRAP experiments also exploring the importance of lamins in 
retaining nesprin localisation reveal that GFP-mini-N2G is significantly more mobile in 
embryonic fibroblasts lacking A-type lamins compared with cells from wild-type mice.163 
However, caution should be taken when interpreting such data as slight GFP-mini-N2G 
overexpression results in its cytoplasmic localisation and increases its apparent 
mobility and dynamicity.  
 
4.4.4 Chapter 4 conclusions 
This chapter demonstrates that nesprin-2 and SUN2 proteins are important 
regulators of cellular morphology and motility, however, their specific roles vary 
between different cell types and remain inconclusive. In particular, we highlight 
substantial differences in the migratory capacity of fibroblasts and VSMCs following 
nesprin disruption and both SUN1/2 are essential for nesprin NE localisation in U2OS 
cells but not VSMCs. Therefore, although the basic elements are conserved, we 
believe that LINC complexes are specialised within different cell types and their 
arrangement is specifically adaptable to cell function. We finally progressed to 
investigate the implications of LINC complex disruption upon nesprin-2 mobility and 
dynamics using FRAP. Although lamin A depletion increases nesprin-2 dynamics, 
clearly much more remains to be discovered with regards to the structure, dynamicity 
and versatility of the LINC complex. 
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4.4.5 Limitations and future work 
 
4.4.5.1 A plethora of nesprin variants 
Recent data indicates that nesprins-1/2 possess multiple alternative start and 
termination sites throughout their genes, resulting in the production of numerous small 
nesprin variants.152 As nesprin-1/2 siRNA specifically targets the N-terminal actin 
binding region, an obvious limitation of our study is that we did not effectively deplete 
all nesprin-1 or nesprin-2 isoforms particularly C-terminal KASH variants that may also 
play a regulatory role in cell morphology and motility (Figure 2.1). Due to the plethora 
of nesprin isoforms that exist, it is also plausible that knocking down nesprin-1/2 results 
in the upregulation other nesprin variants at the ONM as a compensatory mechanism. 
Another limitation of our study was that giant nesprin isoforms were not detectable via 
Western blot analysis using in-house antibodies. Therefore, future studies will 
specifically determine which nesprins are important for regulating cell migration and 
isoform-specific siRNA and antibodies will be utilised. 
 
4.4.5.2 The impact of prelamin A on nesprin mobility 
Another limitation of this study is that FRAP experiments utilised a GFP-mini-
N2G construct lacking spectrin repeats known to exist in the full-length nesprin-2 giant. 
The spectrin repeat backbone of nesprins normally mediates protein-protein 
interactions, therefore, the absence of spectrin repeats in GFP-mini-N2G potentially 
effects its localisation, mobility and dynamic ability. Future studies will use nesprin-2 
constructs of differing length and spectrin repeat capacity to better interrogate the role 
of the LINC complex on nesprin-2 mobility and dynamics. Due to time constraints, 
FRAP experiments were only performed in U2OS cells. As previously described, the 
LINC complex appears to be utilised differently between cell types and enhanced 
nesprin dynamics in response to NE adaptations in U2OS cells are not necessarily 
reflected in other cell types. Therefore, this experiment will also be repeated in VSMCs 
and MRC-5 fibroblasts in the future.  
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Chapter 5: Characterising the role of 
cell traces in VSMC migration 
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5.1 Introduction 
 
 As cells migrate, cell membrane protrusions at the leading edge attach to the 
underlying ECM via focal adhesion complexes.28 These traction sites are continuously 
assembled at the leading edge and dissembled at the trailing end to facilitate forward 
movement.29 To date, much of the literature focusses on the leading edge processes 
that drive migration, with little interest on the cell rear. Although the rate of rear-end 
detachment is thought to determine migration speed, the mechanisms of detachment 
and its involvement in regulating migrational behaviour are yet to be clearly defined.293 
A combination of force driven by actin-myosin contraction and proteolytic cleavage by 
calpains and matrix metalloproteinases (MMPs) are required for cell detachment.30 This 
was originally thought to not result in the loss of any cell material, however, more 
recent evidence illustrates that cell debris is released at the rear of migrating cells, 
forming characteristic tracks that map cell migration.294 Although believed to be an 
artefact of in-vitro migration, studies describe the release of cellular material or ‘cell 
traces’ in numerous cell types, including fibroblasts, mammalian thymoma and 
sarcoma cells, cytotoxic T-lymphocytes and primary chondrocytes.295 As cell traces can 
only be visualised using high magnification techniques, the physiological relevance of 
these structures in cell migration has yet to be fully explored 
 
 
5.2 Aim of this chapter  
 
This chapter utilised IRM and time-lapse microscopy to closely study rear-end 
detachment and the release of cellular material from of migrating VSMCs. We aimed to 
determine whether cell traces are an in-vitro artefact or play a physiological role in 
VSMC migration. 
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5.3 Results  
 
5.3.1 Migrating VSMCs in-vitro release traces at their trailing end 
A number of studies describe the phenomenon of various cell types releasing 
cell traces at their rear during migration in-vitro.294-296 Such studies speculate a 
physiological role for cell traces, however, no specific function has yet been identified. 
We used IRM to capture high magnification images of randomly migrating VSMCs in-
vitro. Cell traces were visible at the trailing end of VSMCs using this technique which 
were not detectable using phase-contrast time-lapse microscopy. 
 
VSMC cell traces were long (often tripling the length of the host cell), branched 
structures that adumbrated the path of cell migration (Figure 5.1A i & ii). Because cell 
traces are thought to reflect a cells migrational capacity, IRM compared presenescent 
(91.9 ± 4.236%) VSMC traces with those derived from slower-moving proliferative 
(90.47 ± 4.767%) and senescent (82.40 ± 4.034%) VSMCs to reveal that almost every 
single VSMC presented similar trace formation during all 3 stages of VSMC growth 
(Figure 5.1B).294 Control (90 ± 3.841%), FACE-1 (92 ± 3.432%) and lamin A (82 ± 
2.500%) siRNA treated VSMCs also deposited traces at the rear (Figure 5.1C). This 
suggests that the release of cell material is a common occurrence during VSMC 
migration in-vitro and does not reflect migratory changes associated with ageing or 
nuclear lamina disruption.  
 
After studying the captured IRM images in more detail we detected that long, 
branched traces often terminated in bead-like structures (Figure 5.2A). As IRM is an 
established method of observing adhesion dynamics, we predicted these punctate 
structures to be focal adhesions retained at the cell rear. Immunofluorescent staining of 
VSMCs with anti-vinculin and rhodamine phalloidin revealed that focal adhesions were 
present in areas where a defined actin cytoskeleton was no longer visible and only a 
few fine actin filaments remained (Figure 5.2B). This implies that adhesions were 
released from the cell rear and retained on the substrate whilst the donor cell continued 
migrating.  
 
5.3.2 VSMCs migrate over pre-laid cell-derived traces 
For the first time, we provide strong evidence that VSMCs release traces during 
in-vitro migration similarly to those previously detected in fibroblasts and other cell 
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types.294 IRM and time-lapse microscopy were further utilised to determine whether cell 
traces exhibit a physiological role in cell migration. For example, IRM imaged a single 
migrating VSMC with a clear leading edge and cell traces detectable at its trailing end 
(Figure 5.3). Within 10 min, the leading edge started to retract and at 20 min cell traces 
at the rear were used to form a new leading edge. At 30 min, the original leading edge 
at 0 min was completely replaced by cell traces and the leading edge was re-
established, creating a change in VSMC direction. Therefore, VSMCs migrate towards 
and over their own traces and appear to be essential for aiding cell directionality. 
Furthermore, pre-laid traces derived from migrating VSMCs were sensed by proximal 
VSMCs leading to reorientation of their leading edge and direction of travel (Figure 
5.4). Therefore, cell traces at the trailing end of a migrating VSMC appear to play an 
important role in guiding the migration of neighbouring cells. To support this theory, an 
IRM movie captured a migrating VSMC releasing traces that outlined a path from which 
another VSMC started to follow (Figure 5.5). Furthermore, time-lapse microscopy 
showed that, despite the absence of chemoattractant gradient, a leading VSMC 
released cellular material on the underlying substrate which a neighbouring cell 
migrated directly towards (Figure 5.6). 
 
5.3.3 Cell traces provide a cell-derived matrix to assist VSMC migration 
  To better understand the importance of cell traces in VSMC migration, I 
attempted to reproduce cell traces in culture. VSMCs were seeded and cultured for 24 
hours before being sheared (cells were scraped from the culture flask using a cell 
scraper) to remove the cell body whilst retaining cell traces on the underlying 
substratum. This technique aimed to mimic the ‘ripping’ motion by actin-myosin-
generated force that normally detaches focal adhesions from the cell cytoskeleton, 
leaving integrins on the surface behind.30 Although a crude method, staining with 
rhodamine phalloidin and anti-vinculin revealed no remnants of cytoskeletal filaments, 
whereas, vinculin mirrored the appearance of previously stained traces (Figure 5.7A).  
 
To compare cell traces derived from proliferative and presenescent VSMCs, 
these cells were cultured for 24 hours and sheared before healthy VSMCs were 
seeded on top. Time-lapse microscopy recorded VSMC migration over cell-derived 
traces to reveal no change in migration speed (Figure 5.7B) or persistence (Figure 
5.7C) between cells migrating over proliferative (0.250 ± 0.013 µm/min) or 
presenescent VSMC-derived traces (0.257 ± 0.013 µm/min). However, VSMC speed 
significantly increased when seeded onto cell-derived traces in general (proliferative 
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and presenescent traces) compared with those migrating on plastic (control; 0.198 ± 
0.012 µm/min). Cell traces did not impact on migratory persistence.  
 
To test that enhanced VSMC speed was specifically a result of VSMC traces 
and not secreted ECM proteins, we compared VSMC migration over cell-derived traces 
with migration over collagen I, a known physiological ECM component within the vessel 
wall. As predicted, collagen I (0.192 ± 0.008 µm/min) significantly increased VSMC 
migration speed compared with VSMCs seeded onto plastic (control; 0.139 ± 0.006 
µm/min). However, VSMCs seeded onto cell-derived traces (0.240 ± 0.009 µm/min) 
were significantly faster than those on plastic and rat tail collagen I matrix (Figure 
5.8A). No change in migrational persistence was detected between VSMCs seeded 
onto plastic, collagen I or cell-derived traces (Figure 5.8B). Therefore, VSMCs release 
cell traces in-vitro which are important for cell migration, most probably by laying down 
a distinctive cell-derived matrix to aid the migration of neighbouring cells.  
 
5.3.4 The impact of ROCK inhibition on VSMC migration 
 As ROCK is essential for focal adhesion disassembly and generating the 
contractile force required for rear-end retraction, a ROCK inhibitor (Y-27632) was used 
to explore its impact on VSMC trace formation.114 IRM captured the effect of ROCK 
inhibition and illustrated that within as little as 10 min, VSMCs could not retract properly 
and exhibited exaggerated cell traces at the rear with no distinct leading edge (Figure 
5.9). This phenotype change was also detected using time-lapse microscopy up to 12 h 
following Y-27632 treatment. VSMCs became elongated and branched by extending 
long, narrow protrusions in multiple directions from the cell body (Figure 5.10A). 
Measurement of tail length was significantly increased following Y-27632 treatment 
(62.09 ± 4.486 µm2) when compared with control VSMC tail length (41.4 ± 2.081 µm2) 
(Figure 5.10B). Although ROCK-inhibited VSMCs produced cell traces at the rear, 
these appeared to be extensions of the trailing end that couldn’t detach due to lack of 
retraction force.  
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Figure 5.1: Migrating VSMCs leave traces at their trailing end. (A) Representative 
interference reflection microscopy (IRM) images of VSMC (35F) migration in-vitro following 1 h 
timelapse. Cell traces at the rear of migrating VSMCs are indicated by arrows (i & ii). (B) The 
number of proliferative, presenescent, senescent and (C) control, FACE-1 and lamin A siRNA 
treated 35F VSMCs releasing cell traces at their trailing end during migration were counted. 
Data are based on counting 20 cells per group from 3 independent experiments.  
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Figure 5.2: Migrating VSMCs leave adhesions at their trailing end. (A) Sequential images of 
a migrating VSMC (35F) in-vitro captured using IRM at 0, 30 and 60 min. Solid arrows indicate 
the leading edge and dashed arrows show adhesions at the trailing end of the VSMC. (B) 
Confocal images of VSMCs immunofluorescently stained for vinculin (green) and F-actin (red). 
Arrows indicate vinculin staining in areas where the actin cytoskeleton was not detectable.   
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Figure 5.3: Cell-derived traces assist leading edge formation. Sequential images of a 
VSMC (35F) migrating in-vitro captured during 30 min IRM. Solid arrows indicate the cell 
leading edge and dashed arrows indicate cell traces at the trailing end. At 0 min (i) a clear 
leading edge was visible with traces detectable at the rear. Over the next 20 min, the leading 
edge retracted and traces were used to establish a new leading edge (ii & iii). At 30 min (iv) 
cell traces outlined the original leading edge. 
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Figure 5.4: Cell traces aid the direction of VSMC migration. Sequential images of in-vitro 
VSMC migration captured over 1 h IRM. 3 examples represent VSMCs (35F) migrating towards 
traces derived from neighbouring cells. (A) Solid arrow indicates pre-laid traces in front of the 
leading edge (0 min). The VSMC migrated directionally towards these traces (30 min). Dashed 
arrow highlights traces at the trailing end of the VSMC (60 min). (B) Both solid and dashed 
arrows show 2 areas of pre-laid traces (0 min) and migration occurred towards these traces (30 
& 60 min). (C) At 0 min the solid arrow represents the cell leading and the dashed arrow 
indicates pre-laid cell traces. The VSMC reoriented itself towards the traces (30 min), leading to 
re-establishment of its leading edge (solid arrow; 60 min). The dashed arrow at 60 min shows 
traces left behind. 
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Figure 5.5: VSMCs follow traces derived from neighbouring cells. Representative IRM 
images of VSMC (35F) migration in-vitro. Solid arrow shows the cell leading edge (0 min) and 
cell traces left behind following migration (30 min). At 60 min, a neighbouring cell (dashed 
arrow) migrated directly towards the traces released by the leading cell (solid arrow).   
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Figure 5.6: VSMC sense and migrate towards neighbouring cells. Random VSMC (35F) 
migration was recorded over 12 h using time-lapse microscopy and sequential images (i – v) 
illustrate VSMC (dashed arrows) migration directly towards a neighbouring cell (solid arrows). 
The final image (vi) illustrates the migrational tracks of both cells that were generated using 
Image J tracking software.  
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Figure 5.7: Proliferative and presenescent VSMC traces aid VSMC migration. Proliferative 
and presenescent 35F VSMCs were cultured for 24 h before cells were sheared and stained for 
F-actin (red) and vinculin (green). (A) Representative immunofluorescence images show 
vinculin patches on the surface post scraping. Proliferative 35F VSMCs were seeded sparsely 
on top of the cell-derived matrix and time-lapse microscopy captured random single cell 
migration for 16 h. Individual cells were tracked using  Image J software and Mathematica 
analysed (B) the speed and (C) persistence of VSMC migration over proliferative (P) and 
presenescent (PS) cell traces compared with cells seeded on to plastic (control). Data are 
based on the analysis of 94 (control), 100 (proliferative cell traces) and 106 (presenescent cell 
traces) individually tracked cells pooled from 3 independent experiments. Statistical significance 
was calculated using a paired Student's t test. 
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Figure 5.8: A cell-derived matrix supports VSMC migration. Time-lapse microscopy 
recorded random migration of VSMCs (35F) seeded on to plastic (control), collagen I-coated 
plastic or a cell-derived matrix (cell traces). Images were captured for 16 h and individual cells 
were tracked using Image J tracking software. Mathematica analysed the speed (A) and 
persistence (B) of VSMC migration on the 3 different matrices. Data presented are based on 
>100 VSMCs tracked per group and pooled from 3 independent experiments. Statistical 
significance was calculated using a paired Student's t test 
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Figure 5.9: The impact of ROCK inhibition on VSMC migration. Representative IRM images 
of VSMC (35F) migration following Y-27632 (10 µM) treatment.at 3 separate time points (0, 5, 
10 min). Solid arrows represent cell traces at the trailing edge and dashed arrows show leading 
edge protrusions.  
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Figure 5.10: ROCK inhibition prevents rear-end VSMC retraction. (A) Representative phase 
contrast images of VSMCs (35F) following 12 h Y-27632 (10 µM) treatment. Arrows indicate the 
rear end ‘tails’ of migrating VSMCs. (B) Tail length of ROCK-treated and control VSMCs was 
measured using Volocity software. Data are based on the measurement of >30 cell tails pooled 
from 3 independent experiments. Statistical significance was calculated using a paired Student's 
t test (control vs treatment).  
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5.4: Discussion 
 
The aim of this chapter was to utilise specialised imaging techniques such as 
IRM to investigate the physiological role of cell-derived traces in VSMC migration. The 
release of traces at the cell rear has been previously described in many cell types, 
however, we are the first to describe this phenomenon in VSMCs.  
 
5.4.1 VSMCs release traces at the rear during migration 
The term ‘cell traces’ describes the release of cellular material at the rear of 
migrating cells that is retained on the underlying substrate.293 297 Because cell traces 
are difficult to detect under a light microscope the purpose of cell traces has not been 
fully explored. Using high magnification IRM, cell traces were detectable at the rear of 
migrating VSMCs, which have never been previously described in these cells. Similarly 
to other cell types, cell traces in VSMCs vary between long, parallel and short, 
branched structures. VSMC traces are distinct from the cell body with a pattern 
adumbrating their migratory path. Although our studies were performed in-vitro on an 
artificial surface, earlier evidence illustrates that cell traces are also released in a more 
physiological context, such as from cells migrating over cartilage or surface of other 
cells.296 
 
Earlier work states that cell traces are not identical with focal adhesion structure 
but can include focal adhesion components.294 The presence of vinculin in VSMC cell 
traces fits with previous studies demonstrating that membrane ‘ripping’ at the cell rear 
releases retraction fibres high in integrin that form characteristic migrational tracks.30 
Others also show integrin patches retained on the substratum following tail detachment 
of skeletal muscle fibroblasts as well as remnants of cytoplasmic material such as F-
actin and tubulin.294, 295 Therefore, further investigation of VSMC trace composition is 
required to better understand their physiological relevance.  
 
Despite been disregarded in the past as artefact or result of experimental 
stress, cell traces derived from fibroblasts, macrophages and cancer cell lines provide 
information about the activity of the donor cell, including its migrational velocity and 
direction of movement.294 Our data illustrates numerous examples of VSMCs using 
their own traces to assist and direct migration as well as following traces derived from 
neighbouring VSMCs. We speculate that focal adhesion components, including 
vinculin, are retained on the substrate at the rear of migrating VSMCs following 
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inefficient breakage of cell membrane-ECM contacts. These are clearly not redundant 
as this well-organised cell trace structure appears to form a path or ‘breadcrumbs’ for 
neighbouring cells to follow. We hypothesise that cell-derived traces dictate VSMC 
migration via a method of haptotaxis; directional cell migration towards an adhesion 
gradient formed by insoluble substratum-bound material in the ECM.284 In support of 
our hypothesis, earlier work demonstrates that VSMCs migrate in a concentration-
dependent manner towards gradients of substratum-bound vitronectin, a multifunctional 
glycoprotein found to be localised in atherosclerotic lesions.298 This study predicts that 
vitronectin deposition in the intima is important for recruiting VSMCs from the media. 
Therefore, cell trace formation may be fundamental for directing and assisting VSMCs 
to sites of injury or disease sites such as atherosclerotic plaques. Moreover, cell traces 
themselves could also be important in repair and possess wound healing properties.  
 
5.4.2 Recreating cell-derived traces 
To better understand the impact of cell-derived traces on a cells migratory 
capacity, we attempted to recreate traces in-vitro. A shearing method was used to 
mimic the ‘ripping’ motion that detaches the cell body from the substrate. Our evidence 
shows that cell-derived traces support VSMC migration more efficiently than collagen, 
the most abundant ECM protein of the vessel wall that is normally synthesised and 
secreted by VSMCs during cell migration.265 An earlier study used similar principals to 
investigate the role of fibroblast-generated ‘tracks’ (traces) in cancer cell invasion. 
Fibroblasts were cultured overnight to produce tracks before they were killed using 
puromycin or detergent extraction and cancer cells seeded on top. This work revealed 
that fibroblast-derived matrix supports cancer cell invasion and supports our notion that 
cell-derived traces provide a unique platform over which the host cell and neighbouring 
cells can migrate.299  
 
 Despite using a crude shearing technique to reproduce cell traces, the resulting 
cell material reflected that of cell traces and vinculin was retained on the substratum. 
Alternative techniques described in the literature involve the application of harsh 
detergents or freeze-fracture to physically break cell-ECM connections.300 Increasingly 
more studies now use micropatterned substrates to better mimic a tissue-like 
environment in-vitro. Lithography is used to create micropatterned surfaces and this 
technique was used in an earlier study to reconstruct cell traces.296 In this study, 
micropatterned surfaces were able to dictate the direction and path of cell migration. 
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Therefore, utilising this technique would be beneficial in future studies to manipulate 
VSMC migration and better understand the physiological function of cell traces.  
 
5.4.3 ROCK inhibition prevents rear-end retraction of VSMCs 
ROCK promotes actin-myosin force generation and is an important regulator of 
cell contractility, adhesion and migration.113, 114 Therefore, ROCK inhibition exaggerates 
VSMC trace formation most likely due to loss of actin-myosin crosslinking and force 
necessary to efficiently sever cell body-ECM connections. This results in impaired rear-
end retraction and formation of heavily-branched VSMCs, implying that trace 
generation is dependent on the contractile force generated by the host cell.   
 
5.4.4 Chapter 5 conclusions 
This chapter clearly demonstrates that VSMCs release traces of cellular 
material at the rear during migration. Our preliminary data reveal that VSMC-derived 
traces provide migratory paths that appear to assist and direct the migration of proximal 
cells in a haptotactic manner (Figure 5.11). We predict that that this is a novel 
mechanism of collective cell migration important for facilitating VSMC migration within 
the vessel to sites of damage.  
 
5.4.5 Limitations and future work 
Future work will investigate how cell traces are released from cells and 
determine their composition using immunofluorescence microscopy in combination with 
a proteomics approach. We will also investigate whether migration over pre-laid tracks 
involves the uptake of any cellular material that could further enhance cell migration. 
The use of more advanced microscopy including scanning electron microscopy (SEM), 
that was particularly useful in earlier cell trace studies, will enable us to better observe 
VSMC-derived traces in more physiologically relevant settings.296 Aforementioned, 
reproducing cell traces on micropatterned substrates is our ultimate goal in determining 
their specific role in VSMC migration. 
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Figure 5.11: Cell-derived traces aid the migration of neighbouring cells. This schematic 
provides a working model of the results summarised within this chapter. (A) During migration 
small nascent focal adhesions form at the cell leading edge which mature over time and form 
stable anchors with underlying ECM. VSMCs migrate randomly in the absence of a chemotactic 
gradient. (B) As migrating VSMCS retract they release cell traces behind them that form a 
skeleton of cell membrane and focal adhesion components. This adumbrates the migratory path 
of a leading VSMC and allows proximal VSMCs to follow. We speculate that cell traces aid 
collective migration by creating either a haptotactic or chemotactic gradient.   
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Chapter 6: General Discussion & 
Conclusions 
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6.1 Ageing and NE remodelling impacts on cell migration 
 
Directional cell migration is fundamental for tissue development and wound 
healing responses to injury and disease. During cell migration, Rho GTPases and their 
numerous downstream signalling targets regulate actin cytoskeleton remodelling, cell 
shape, adhesion and motility.23, 34 However, the LINC complex has recently emerged 
as a novel regulator of cytoskeletal organisation and cell motility as it physically tethers 
F-actin to the nucleus via nesprin-SUN-nuclear lamina interactions across the NE.127-130 
The LINC complex is an integral multi-protein complex that supports cell architecture 
and maintains structural tension throughout the cell.301 This is important as mechanical 
forces transmitted through a pre-stressed (tense) cytoskeleton are significantly faster 
(30msec/50µm) than the rate-limited diffusion of biochemical cascades 
(10sec/50µm).164, 302 Previous studies describe physical linkage between the cell 
surface, cytoskeleton and nucleus which is crucial for effective mechanotransduction 
signalling between the cell interior and local surroundings.186, 189, 197 It has also been 
reported that cell surface deformations (stretch/compression) influence nuclear 
morphology and gene transcription which is suppressed following LINC complex 
disruption.165, 186, 189, 197, 246, 303  Interestingly, our work demonstrates that focal adhesion 
formation is defined at a nuclear level as nuclear lamina disruptions subsequently alter 
focal adhesion organisation and dynamics at the cell membrane. We speculate that this 
is mediated by the LINC complex which extends beyond the NE to physically connect 
the nucleus, actin cytoskeleton and focal adhesion components. This mechanically-
coupled system throughout the cell would facilitate force transmission between the 
nucleus and cell membrane, ultimately modifying the cellular tension required for focal 
adhesion assembly/disassembly (Figure 6.1). As focal adhesion components regulate 
Rho GTPase activity, this also implicates a role of the LINC complex in Rho GTPase 
signalling.281 Therefore, our working model predicts that the LINC complex regulates 
cell migration via a combination of biophysical and biochemical mechanisms.  
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Figure 6.1: The LINC complex creates a mechanically-coupled system throughout the 
cell. Working model of the LINC complex based on our findings that nuclear lamina alterations 
impact on focal adhesion organisation/dynamics at the cell membrane. The nuclear lamina at 
the INM is indirectly connected to focal adhesions via LINC complex components spanning the 
NE (nuclear lamin-SUN-nesprin) and actin filaments bridging the nucleus and cell membrane.  
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The original aim of this thesis was to further explore the role of prelamin A, a 
novel biomarker of VSMC ageing in cell motility.204 Prelamin A accumulates at the NE 
where it uncouples lamin A from the nuclear lamina, however, until now the precise 
mechanisms of how this affects LINC complex function were undefined.138, 227 Previous 
studies show that lamin A/C deficient cells exhibit defective cytoskeletal organisation, 
cell adhesion, polarisation and motility.172, 186, 187, 196 In support, we demonstrate that 
age-associated prelamin A accumulation disrupts LINC complex organisation, drives 
cell elongation and focal adhesion reorganisation. We also reveal that in-vitro aged 
VSMCs exhibit faster migration rates and are more persistent during presenescent 
growth when prelamin A begins to accumulate. Artificially inducing prelamin A 
accumulation by FACE-1 knockdown also drives similar migratory changes in 
fibroblasts. However, FACE-1 depletion enhances VSMC persistence but is not causal 
for the enhanced speed associated with VSMC ageing. This led us to further explore 
the importance of other LINC complex components in regulating VSMC migration.  
 
Excitingly, this is the first study to reveal an age-related reduction in SUN2 
expression. Similarly to in-vitro aged VSMCs, SUN2 depleted VSMCs retain nesprin-2 
at the NE, which was mislocalised to the ER in nuclear lamina disrupted VSMCs. 
Furthermore, knocking down SUN2 reproduced the increased migration speed 
observed in presenescent VSMCs, suggesting that prelamin A accumulation combined 
with SUN2 attenuation brings about the migratory phenotype reflective of VSMC ageing 
(Figure 6.2). We speculate that NE remodelling during VSMC ageing uncouples 
nuclear lamina-SUN interactions leading to unstable SUN2 recruitment to the NE and 
its subsequent degradation. This is plausible as studies have shown that SUN2 
localisation is dependent on lamin A/C whereas SUN1 possesses other nuclear binding 
partners, namely emerin and nucleoplasmic nesprin isoforms.128, 157, 158 However, our 
studies reveal that prelamin A accumulation following FACE-1 knockdown does not 
directly impact on SUN2 expression, suggesting that SUN2 stability is regulated by 
other factors. Despite SUN1 and SUN2 exhibiting similar affinities for nesprin-2, other 
studies have illustrated that SUN2 knockdown, but not SUN1, enhances nesprin-2 
mobility at the ONM.163 Our data also show that SUN2 is more abundant than SUN1 in 
VSMCs, therefore, SUN2 is potentially the dominant SUN protein in LINC complex 
coupling of the nuclear lamina to nesprins and cytoskeletal networks. In summation, 
our data indicate that the accumulation of prelamin A and loss of SUN2 at the NE 
induce age-associated LINC complex alterations that compromise cell migration. 
However, FACE-1 and SUN2 depletion induce different morphological changes to in-
vitro aged VSMCs. Presenescent VSMCs are large and elongated, whereas prelamin A 
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elongates but does not affect VSMC size and SUN2 depleted VSMCs are smaller with 
no overall change to cell shape. Therefore, targeting individual LINC complex 
components induces varying morphologies and suggests that numerous factors, not 
only prelamin A and SUN2, are responsible for defining VSMC phenotype during 
ageing.  
 
The overall findings in this thesis reveal that the LINC complex is a dynamic 
structure with a composition uniquely adaptable to specific cell requirements. We 
envisage that individually disrupting LINC complex proteins, the nuclear lamina (FACE-
1 or lamin A/C), nesprins or SUN proteins mechanically weakens this biophysical 
network and consequently impinges on actin-regulated processes including cell 
morphology, focal adhesion organisation/turnover and cell motility. Therefore, we 
emphasise that the LINC complex as a whole is an important regulator of cell 
phenotype and our work sheds light on how the LINC complex aberrations associated 
with nuclear envelopathies and premature ageing diseases are characterised by 
abnormal cell functions. It is now well-established that prelamin A normally 
accumulates in VSMCs during ageing and we show that prelamin A impacts on cellular 
morphology and migratory capacity. As cell migration is essential for normal tissue 
repair and homeostasis, any defects in these processes will accelerate tissue 
degeneration and ageing. In agreement with this, mutant prelamin A accumulates in 
the premature ageing syndrome, HGPS. However, the full extent of the NE in 
regulating actin organisation and cell motility during tissue homeostasis remains to be 
defined.  
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Figure 6.2: Comparison of proliferative and presenescent VSMCs. (A) This model provides 
an overview of the phenotypic differences between proliferative and presenescent VSMCs that 
were characterised following in-vitro passaging. Proliferative VSMCs adopt a small, circular 
morphology with a high number of large focal adhesions distributed across the cell surface. 
Presenescent VSMCs are larger and spindle-like with fewer focal adhesions primarily localised 
to the cell periphery. These focal adhesions are small and rounded, correlating with enhanced 
focal adhesion turnover in presenescent VSMCs. Presenescent VSMCs also migrate faster and 
more persistently than proliferative VSMCs. (B) VSMC ageing is associated with a reduction in 
FACE-1 expression which correlates with prelamin A accumulation. We are the first study to 
describe an age-related attenuation of SUN2 as well as Rac1 and RhoA expression in VSMCs. 
Total levels of lamin A/C and nesprin-2 remained unchanged.   
170 
 
6.2 Pathological VSMC migration  
Despite previous studies indicating that cell migration is impaired during ageing, 
our work reveals that VSMC migration in-vitro increases progressively with age until a 
peak is reached at presenescent growth, after which migration subsides.218, 219 This 
supports recent data demonstrating that VSMCs undergo age-associated phenotypic 
switching and become dedifferentiated with diminished cytoskeletal myocitic markers 
and enhanced proliferation and migration rates.217 Efficient VSMC migration is 
fundamental for vessel development and repair. Moreover, VSMCs are a prominent 
cell-type at atherosclerotic sites where they aid the formation of a protective cap to 
stabilise rupture-prone lesions.12, 14 However, increased VSMC migration and 
proliferation also drives vessel remodelling and intimal thickening which are major 
pathogenic factors in atherosclerosis and restenosis.9, 215, 216 Current literature is 
divided as to whether VSMCs are beneficial or detrimental to vessel health, therefore, 
their role in atherosclerotic development remains undefined.  
 
Our findings demonstrate that presenescent VSMCs innately migrate more 
rapidly and persistently than their early-passage predecessors, which is believed to 
represent precise and efficient directional migration.260 We also demonstrate that 
presenescent VSMCs retain their chemotactic ability, suggesting that VSMCs at this 
growth stage are still recruited to areas of vessel damage and atherosclerotic plaques. 
However, we predict that age-related changes to migratory phenotype may ultimately 
lead to inefficient vessel repair and contribute towards inappropriate remodelling of the 
vasculature. Faster VSMC migration, coupled with enhanced ECM deposition would 
cause intimal thickening, a preferable site for atherosclerotic plaque development.215, 216 
Ageing also induces the VSMC secretion of chemokines including interleukins, 
monocyte chemotactic protein-1 and tumour necrosis factor-ɑ, leading to chronic 
vessel inflammation.304 Furthermore, recent evidence specifically demonstrates that 
prelamin A-containing presenescent VSMCs exhibit a heightened inflammatory 
profile.305 This pro-inflammatory phenotype may further enhance presenescent VSMC 
recruitment to wound sites, thus exacerbating the inflammatory response that underlies 
numerous vascular pathologies. We hypothesise that the age-related enhancement of 
VSMC migration is primarily a protective mechanism allowing presenescent VSMCs a 
final attempt to repair vessel damage with a migratory ‘boost’ before they become 
senescent. However, the inability of presenescent VSMCs to switch back to a 
differentiated phenotype once their synthetic function is complete, i.e. vessel damage 
repair or atherosclerotic cap formation, drives pathological vessel remodelling and 
atherogenesis. Ultimately, when VSMCs reach senescence, we reveal that migration 
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and proliferation ceases and VSMCs lose their chemotactic responses. The loss of 
VSMCs recruitment to wound sites would result in inefficient atherosclerotic cap 
formation, inevitably leading to plaque instability and rupture (Figure 6.3). 
 
At present, the literature describing the impact of ageing on cell migration is 
confusing and undefined. Our work highlights a clear explanation for these conflicting 
results as VSMC ageing appears to be associated with a progressive surge in 
migration speed and persistence during presenescence, prior to halting when cells 
become senescent. Our results provide an important insight into in-vitro VSMC ageing, 
however, repeating these experiments in VSMCs isolated from aged donors and aged-
related diseases would apply better physiological relevance to these findings.  
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Figure 6.3: Atherosclerosis at differing stages of VSMC growth. Working model 
demonstrating how VSMCs of different growth stages are involved in vessel repair and 
atherosclerotic cap formation. (A) Young and healthy VSMCs have a small and rounded 
morphology with relatively slow migration rates from the media to the intima in response to 
chemotactic cues. Intimal VSMCs are highly proliferative and directionally migrate towards 
atherosclerotic lesions or sites of vessel damage where they generate a uniform protective cap 
to stabilise atherosclerotic plaques and repair vessel damage. (B) Presenescent VSMCs are 
large and elongated with relatively fast migration speeds and high persistence. Increased 
VSMC migration towards the intima is potentially a protective mechanism that enhances 
atherosclerotic cap formation. However, exaggerated migration consequently leads to intimal 
thickening, vessel remodelling and exacerbated inflammatory responses that drive 
atherogenesis. (C) Senescent VSMCs have increasing levels of prelamin A at the NE and have 
a large, flattened appearance. These cells migrate slowly, lack persistence and cannot respond 
to chemotactic or haptotactic cues. This creates an unstable plaque and consequently leads to 
plaque rupture, myocardial infarction and strokes, all of which are prevalent age-related 
disorders. Blue arrows indicate direction of VSMC migration.  
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6.3 Cell-derived traces 
 
Originally the deposition of cellular material, known as cell traces, during 
migration were believed to occur as a result of experimental stress with no known 
function. However, increasing evidence suggests that cell traces are physiologically 
relevant and have been identified in numerous cell types.294, 296 Our data suggest that 
cell-derived traces play a regulatory role in VSMC migration. We show that VSMCs 
deposit long, branched structures of cell traces at the rear during migration which 
adumbrates their migratory path. We predict that cell traces result from the inefficient 
breakage of cell-ECM contacts and are composed of cell membrane and focal 
adhesion constituents that are retained on the underlying substrate. Even in sparsely-
seeded cultures, proximal cells sense and migrate directly towards these adhesion-like 
molecules in a haptotactic-like manner. Haptotaxis is defined by directional cell 
migration towards an adhesion gradient formed by insoluble ECM-bound molecules.284 
Therefore, cell-derived traces are clearly not redundant and act as migratory ‘footprints’ 
or ‘breadcrumbs’ to outline a path for neighbouring cells to follow in a novel form of 
collective migration. The notion that ‘leader’ cells guide ‘follower’ cells has been 
previously described in endothelial and epithelial cell migration, whereby leading cells 
display distinct polarised morphologies, sense directional cues and induce collective, 
sheet-like migration of multiple rows of successive cells.77, 306  
 
Collective cell migration underlies tissue development and repair as well as 
contributing towards tumour cell metastasis.85 It is defined by 2 distinct modalities; i) 
multicellular clusters that maintain strong cell-cell contact and migrate together in 
sheets or, ii) chain-like streaming of cells in single file that requires unstable cell-cell 
contact.75-77, 79, 80 The mode of VSMC migration we typically observed was similar to 
collective cell streaming, however, it will be interesting to test this in denser VSMC 
populations and in-vivo settings. Neural crest cells are commonly used to model cell 
streaming as they migrate over long distances in spatially segregated chain-like 
patterns or ‘streams’ during which loose cell-cell connections are retained by long, thin 
filopodia.92 These cellular extensions form a path to facilitate cell migration and can 
induce directional changes similarly to that observed by VSMC-derived traces in our 
studies. Furthermore, cell streaming is crucial for the in-vivo migration of human breast 
tumour cells and is more efficient than random migration as it facilitates higher velocity 
rates and further net travel.307 This leads us to speculate that cell-derived traces are a 
form of cell-cell contact that maintain communication between neighbouring cells and 
provide a guidance mechanism for long-range collective cell migration.  
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It is well-established that cell migration requires structural modifications to 
surrounding ECM, including clearing of a migratory track by MMPs and deposition of 
ECM proteins to generate a basement membrane for cells to follow.85 It is suggested 
that migrational tracks do not only directionally guide cell migration but, owing to their 
structural and molecular properties, could serve additional physiological functions. For 
example, newly secreted basement membrane might provide a smooth scaffold to 
assist cell migration into tissue in a collective and continuous manner.308 We 
demonstrate that VSMCs release vinculin-containing traces at the rear during migration 
whose specific role is currently unidentified. An earlier study illustrates that fibroblasts 
release migratory tracks or trails of fibronectin and tenascin-c within the ECM to 
enhance collective cancer cell invasion into connective tissue independently of soluble 
factors.299 This emerging evidence supports our hypothesis that cell-derived traces 
form physical tracks in the substrate that promote and support cell migration.  
 
Another mechanism of cell traces aiding collective cell migration potentially 
involves the release of soluble molecules to attract proximal cells via chemotaxis. A 
chemoattractant source directly influences cell polarisation, orientation and promotes 
directional persistence towards the chemotactic gradient. Work in dictystelium cells 
illustrates that this is coupled by the synthesis and secretion of additional 
chemoattractant which is packaged into cell-derived vesicles, also termed exosomes, 
which fuse to the rear membrane before their content is released.309 This release forms 
tracks at the rear of migrating cells which are important for amplifying chemotaxis by 
stimulating the migration of proximal cells in a positive feedback mechanism. This 
mode of migration has also been described in tumour cells that release cell fragments 
behind during migration which further stimulates the chemotaxis of neighbouring cells 
via streaming.310 Endothelial cells also secrete exosomes as well as capturing 
exosomes from proximal cells.311-313 A recent in-vitro study demonstrates that 
endothelial cell-derived exosomes are important mediators of cell-cell communication 
as they transfer signalling molecules to recipient endothelial cells to influence their 
migratory behaviour such as stimulation of movement into a wound.314 During wound 
healing or at infection sites, macrophages synthesise chemotactic factors to recruit 
other blood cells and more recent work reveals that macrophages also release 
epidermal growth factor (EGF) to promote tumour cell invasion and metastasis.315 
Based on this body of evidence, we speculate that cell traces serve as vehicles of 
exosome delivery and chemoattractant release into the extracellular environment 
during cell migration.  
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Our studies demonstrate that VSMC ageing does not impact on cell trace 
formation. In support, recent evidence reveals that ageing does not affect VSMC 
exosome release but is in fact associated with changes in exosomal content.305 
Furthermore, in-vitro VSMC passaging or prelamin A overexpression induces changes 
in the expression of chemokines, growth factors and proteases, which may contribute 
to the age-related alterations we detect in VSMC adhesion and migration.305 Future 
work will benefit from testing exosome-mediated signalling between VSMCs by 
harvesting VSMC-derived exosomes and resuspending increasing levels into culture 
medium. Alternatively, established exosome inhibitors could be used to determine the 
impact of exosomes on cell migration.  
 
Overall, we hypothesise that VSMC-derived traces guide neighbouring VSMCs 
and other cell types by laying down a migratory path through tissue and complex ECM. 
This potentially supports cell migration during development and to sites of injury 
including atherosclerotic plaques where VSMCs are heavily implicated. Furthermore, 
cell traces themselves could be important in vessel repair and atherosclerotic cap 
formation.  
 
6.4 Final conclusions 
Cell migration underlies many biological processes chiefly tissue development, 
maintenance and regeneration. The LINC complex has recently emerged as a critical 
regulator of cytoskeletal organisation and our data elaborates upon this to demonstrate 
that cellular morphology, focal adhesion formation, Rho GTPase activity and cell 
migration are also defined by the LINC complex. Moreover, we reveal that LINC 
complex disruption by prelamin A accumulation and attenuated SUN2 expression, 
hallmarks of VSMC ageing, increases VSMC migration speed and persistence. This 
exaggerated VSMC phenotype may ultimately drive inappropriate vascular remodelling 
and contribute towards the pathogenesis of age-related vascular disease. Therefore, 
improved knowledge of the processes involved in prelamin A and SUN2 regulation may 
highlight new strategies to counteract the age-related vessel reorganisation that 
accelerates atherosclerosis.  
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